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ABSTRACT 
Epidemiological Studies of Childhood Onset Type 1 Diabetes 
in Devon and Cornwall 
Hongxin Zhao 
A high quality register of children with type 1 diabetes, The Cornwall and Plymouth 
Children's Diabetes Register (CPCDR), has been successfully established in the far 
South West of England for this thesis. Children aged 0-15 years of age who were 
diagnosed with type I diabetes in the study area have been systematically registered on 
the database since 01 /0111975 until the present day. Children are now registered 
prospectively, to provide a database of the disease in this region and to allow 
epidemiological studies. Basic descriptive studies on the occurrence of the disease based 
on the CPCDR between I 975-1996 have been carried out for this thesis. In addition, 
space-time clustering analysis of the disease has been conducted, as well as an 
exploration of the association of some chemical contents in domestic drinking water, 
serum minerals and birth weight to the risk of developing the disease. 
The incidence study demonstrated that the overall incidence rate of childhood onset type 
1 diabetes was I 4.9 cases/1 00 000/year in this area during the 22-year study period 
(1975-1996). The case ascertainment was 94.4% for the whole register. A significant 
increase (2.49% per year) of overall incidence has been observed, mainly due to a 
significant increase in the 0-4-year age group (6.32% per year). The incidence 
significantly differed among the 22 years with peak incidences seen in the years 1977, 
1983, 1988, 1990 and 1993-94. Incidence increased with age, with a peak age of 12 
years for girls and 14 years for boys. Girls had a significantly higher incidence than 
4 
boys. The significant seasonal variations at diagnosis were detected with the peak 
incidence appearing in autumn and winter. 
Significant space-time clustering was found by the Knox test in the study region in the 
following combinations of critical cutoff values, 25, 35 and 50 km and 270 or 360 days 
(P values < 0.05), and 50 km and 90 days (P < 0.05) with the highest level of 
significance found at 35 km and 360 days (P < 0.01). Stronger clustering was found in 
the younger children (0-4 years). Therefore, there is evidence of space-time clustering in 
the onset of childhood diabetes in the far South West of England. These results lend 
some support to the hypothesis that viral infections in early life or other unknown 
environmental factor(s) may have a role to play in the development of childhood 
diabetes. 
The relationship between childhood diabetes and drinking water quality has been 
explored in the study area. The initial analysis with the Spearman's rank test and x2 test 
for trend on the tertiles of the dataset suggest that copper, magnesium and nitrate have 
some protective effect on children for developing type 1 diabetes. However, Poisson 
regression analyses revealed that zinc and magnesium were the main possible protective 
chemicals. The concentration ranges of zinc (22.27-27.00 J..Lg/L) and magnesium (>= 
2.61 mg!L) in domestic drinking water would significantly decrease the risk of 
childhood diabetes. The results indicated that zinc and magnesium in drinking water are 
protective factors against the development of childhood diabetes. 
No significant associations were detected between birth weight or serum minerals and 
the risk of developing the disease. 
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CHAPTERl.GENERALINTRODUCTOIN 
1.1 Aims and structure of the thesis 
1.1.1 Brief description of type 1 diabetes 
Type 1 diabetes is a severe and presently incurable autoimmune disease, resulting from 
cellular-mediated, autoimmune destruction of the pancreatic p cells leading to 
inadequate secretion of insulin (Atkinson and McLaren, 1994). This disease ranks as 
one of the most common chronic childhood diseases in developed nations (LaPorte et 
al., 1995), but it can occur at any age with various clinical presentations (Groop et al., 
1986; Molbak et al., 1994). The incidence of childhood onset type 1 diabetes has been 
well documented in children aged under 15 years throughout the world (Karvonen et al., 
1993; Onkamo et al., 1999; EURODIAB ACE Study Group, 2000), with the highest 
reported incidence of 45 cases/100,000/year in Finland (Tuomilehto et al., 1999) and the 
lowest of0.51 cases/100,000/year in China (Yang et al., 1998). In the UK children, the 
incidence varies from 13.4 to 23.9 cases/100,000/year (Crow et al., 1991; Staines et al., 
1993; Patterson et al., 1996; Rangasami et al., 1997; Zhao et al., 1999). The incidence of 
childhood onset type 1 diabetes is rapidly increasing in many parts of the world 
(Bingley and Gale, 1989a; Karvonen et al., 1993; Onkamo et al., 1999), particularly in 
young-onset cases (Tuomilehto et al., 1995a; Gardner et al., 1997; Zhao et al., 1999; 
EURODIAB ACE Study Group, 2000). The disease results in many severe long-term 
complications, including renal and cardiovascular diseases, amputations and blindness, 
and therefore it is the cause of substantial morbidity and mortality, so it represents a 
major public health problem in many countries (Dorman et al., 1995). However, the 
cause of the disease is still unknown. Both the necessary genetic susceptibility and 
unidentified environmental initiators are required to complete the disease process. The 
relatively low concordance rates of the disease in identical twins (Kaprio et al., 1992; 
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Kyvik et al., I995) and the rapid increases of incidence over time suggest the 
importance of environmental factors in the aetiology of the disease. 
After a thorough review of the current literature, it is apparent that it remains important 
to investigate the epidemiology of the disease in children using data from the local area, 
to establish if there is evidence for environmental factors contributing to the aetiology of 
type I diabetes. The aims of the present thesis are, therefore, set out as follows. 
1.1.2 Aims of the thesis 
I. To establish a high quality register of children under the age of I6 years with type I 
diabetes in the far South West of England, the Cornwall & Isles of Scilly and the 
former Plymouth Health Authority region from I975 to present day -- The Cornwall 
and Plymouth Children's Diabetes Register (CPCDR) -- by using a capture-
recapture method to collect the detailed information of the disease from all newly 
diagnosed children with type I diabetes from OI/OI/I975 onwards. The following 
aims are all set up based on using the CPCDR database. 
2. To establish the basic descriptive epidemiology of type I diabetes, including 
incidence rates of the disease in relation to time, place and population during I975-
I996 in this study region. 
3. To examine for evidence of space-time clustering of the disease both at diagnosis 
and at birth in the study area by applying the Knox-Mantel method. 
4. To seek an· association between trace elements (for example, nitrate, zinc and 
magnesium) in drinking water and the occurrence of the disease. 
5. To conduct a pilot case-control study to determine the relationship between birth 
weight and the subsequent development of the disease. 
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6. To carry out a pilot study of the relationship between the serum trace element levels 
and the childhood diabetes. 
1.1.3 Structure of the thesis 
The thesis has been written in the following way. In the opening chapter, Chapter 1 of 
this thesis, a brief description of the background and history of diabetes, and its 
definition, diagnostic criteria and classification standards have been given. Then in 
Chapter 2, the epidemiology of the disease has been described in relation to its 
occurrence patterns over time, geographical areas and populations nationally and 
internationally, and possible risk determinants influencing its occurrence (genetic and 
non-genetic factors). Chapter 3 describes various methods used in the thesis to 
determine the incidence in this region, disease clustering, and the relations between the 
occurrence of the disease and drinking water quality, serum minerals and birth weight. 
Chapter 4 includes all the results analysed for the incidence study, disease clustering, 
relationship between water quality, birth weight and serum minerals, and the disease. 
The last chapter, Chapter 5, discusses all the results in the context of the current 
literature and attempts to explain their significance. The appendices, references and 
copies of the publications generated from this thesis are attached in the end of the thesis 
as required by the University of Plymouth. 
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1.2 Background and history of diabetes 
Diabetes mellitus is a very old endocrine disorder and is now prevalent in large numbers 
throughout the world in people from a wide range of ethnic groups and all social and 
economic classes (de Courten et al., 1998). More than 100 million people today suffer 
from diabetes (WHO, 1994), and this is almost certainly an underestimate considering 
the rapidly increasing trend of its incidence world-wide. Recent projections suggest that 
there will be more than 220 million diabetics in the world and 3 million (a doubling) in 
the UK by 2010 (Amos et al., 1997; Zimmet, 1999; Dobson, 2000). The impact of this 
disease along with its micro- and macro-vascular complications, which lead to 
blindness, amputation, renal failure and cardiovascular disease, will be enormous to 
both health care systems and socio-economically in developing as well as in 
industrialised countries. Therefore, finding ways to prevent or delay the onset of the 
disease as well as discovering effective treatments to prevent retinopathy, nephropathy, 
neuropathy, and cardiovascular disease, are essential components of present and future 
public health strategies for the whole world. There will be a National Service 
Framework (NSF) for diabetes in the UK as announced by the Government in 1999 (UK 
Government, 1999) by stating that diabetes is now one of UK government's priorities 
and the NSF will be published in 2001. 
Diabetes mellitus was described more than 2000 years ago. The first description is 
usually credited to Arataeus of Cappadocia in Asia Minor in the first century AD, who 
gave the disease its name, 'diabetes', coming from Greek, meaning 'to pass through'. 
Celsus had also described this disease a few years earlier. Both had noticed one of the 
essential clinical features, an excessive volume of urine (Pyke, 1997). It is further back 
in the fourth century BC that diabetic patients with sweet tasting urine were observed by 
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the ancient Indians, who referred to it as Madhumeha (Pyke, 1997). Similar 
observations were also made in China at about the same time ( 400 BC) by Huang Di in 
his book- Su Wen (Plain Questions). He called diabetes Xiao Dan (Wasting Svndrome) 
(Bai, 1989). Since then, various people have made similar observations including Chen 
Chhuan in China in the seventh century AD, Avicenna, an Arab physician of the 
eleventh century, and finally in the seventeenth century by the Oxford physician, 
Thomas Willis. Willis made the distinction between the sweet (common type of 
diabetes) and non-sweet (rare type of diabetes) tasting urine. The sweet taste of diabetic 
urine was proved due to sugar by Matthew Dobson, a century after Willis. He also made 
the crucial observation of the excess of sugar in the blood (Pyke, 1997). Claude Bemard 
was the greatest figure in the history of diabetes in the first half of the l91h century. He 
was the first person to discover the important fact that the liver stored glycogen and 
secreted a sugary substance in the blood, which we now know to be glucose. In 1879 
Von Mering, a German physician in Strasburg, and his colleague, Oscar Minkowski, 
produced diabetes in a dog by removing the pancreas, thereby realising that the pancreas 
contained an antidiabetic substance, which we now call insulin. Before the discovery of 
insulin, diabetic patients, especially most with what is now called type l diabetes, lived 
a very miserable life, on a rigid diet tantamount to starvation which was the only 
treatment offered by the early diabetologists. At last came the final triumph in the long 
history of diabetes, the discovery of insulin by Frederick Banting, Charles Best, J.B. 
Col lip and J.J.R. MacLeod in Canada in 1921 (Pyke, 1997). They were awarded the 
Nobel Prize in physiology and medicine in 1923 for the discovery of insulin, a 
successful therapy for diabetes. 
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1.3 Definition of diabetes 
Diabetes mellitus is a group of metabolic diseases characterised by hyperglycaemia 
resulting from defects in insulin secretion, insulin action, or both (The Expert 
Committee on the Diagnosis and Classification of Diabetes Mellitus, I997). The p cells 
of the islets of Langerhans situated within the pancreas produce insulin, an essential 
hormone which regulates the metabolism of fat, carbohydrate and protein. As a 
consequence of the associated defective blood glucose absorption, glucose is excreted in 
the urine, giving it a sweet taste leading to diabetes originally being known as the 
"honey disease" (Bottazzo, I993). As more glucose concentrates in the urine, more 
water is excreted with it, resulting in excessive volumes of urine (an osmotic diuresis) 
and persistent thirst. Diabetes is etiologically more than one disorder, all with certain 
characteristics in common. The classic symptoms of hyperglycaemia are polyuria, thirst, 
weight loss, and lassitude (Alberti and Hockaday, I988), and the symptoms and signs 
vary from excreting large volumes of urine (polyuria) through to diabetic ketoacidosis 
(DKA). DKA is due to insulin lack and is an acute build-up of ketones released by the 
breakdown of stored fat, followed by an increase in the acidity of the blood (i.e. 
lowering blood pH) which interferes with respiration and, if not treated, rapidly leads to 
coma and death. There are two major forms of diabetes - type I (insulin-dependent or 
juvenile-onset) and type 2 (non-insulin-dependent or adult-onset) diabetes. In type I 
diabetes, there is a complete or partial loss of the ability to secrete insulin because of the 
destruction of the pancreatic p cells, with inevitable widespread metabolic changes. In 
type 2 diabetes, there is diminished and/or delayed insulin secretion in response to 
glucose, combined with varying degrees of diminished effectiveness of circulating 
insulin; when there is associated obesity, insulin resistance is also a problem. Diabetes 
can therefore also be defined as a state of diminished insulin action, due to its decreased 
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availability or effectiveness, in varying combinations (Alberti and Hockaday, 1988). 
1.4 Classification and diagnostic criteria of diabetes 
An appropriate classification and diagnostic criteria for diabetes mellitus is necessary 
for orderly epidemiological and clinical research, and also for the disease management. 
The current classification also reflects the aetiology of the disorder and its natural 
history. 
1.4.1 Classification 
No systematic categorisation existed until 20 years ago. In 1980, the World Health 
Organization (WHO) (WHO, 1980) modified and endorsed the classification system 
[revised in 1985 (WHO, 1985)] based on the substantive recommendations of the 
National Diabetes Data Group (NDDG) of the National Institute of Health, USA 
(National Diabetes Data Group, 1979), which has been accepted and used world-wide 
ever smce. 
In June, 1997, the American Diabetes Association (ADA) announced its new guidelines 
for diagnosing and classifying diabetes at the 57th Annual Scientific Sessions in Boston, 
USA. This new guidelines officially gave recommendations to lower the ·levels of 
fasting glucose deemed acceptable in the blood, and to rename Insulin-Dependent 
Diabetes Mellitus (IDDM) and Non-Insulin-Dependent Diabetes (NIDDM) as type I 
and type 2 diabetes, respectively (The Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus, 1997). The new proposed classification of diabetes 
by ADA has now been adopted by the WHO (Alberti et al., 1998) and listed bellow in 
34 
Table 1.1 Aetiological classification of disorders of glycaemia (WHO, 1998) 
Type 1 (beta-cell destruction, usually leading to absolute insulin deficiency) 
Autoimmune 
Idiopathic 
Type 2 (may range from predominantly insulin resistance with relative insulin 
deficiency to a predominantly secretory defect with or without insulin 
resistance) 
Other specific types 
• Genetic defects of beta-cell function 
• Genetic defects in insulin action 
• Disease of the exocrine pancreas 
• Endocrinopathies 
• Drug- or chemical-induced 
• Infections 
• Uncommon forms of immune-mediated diabetes 
• Other genetic syndromes sometimes associated with diabetes 
Gestational diabetes 
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Table 1.1. 
Type I and type 2 diabetes are the two main clinically distinguishable types and their 
main features are illustrated in Table 1.2 (Besser et al., 1988; Scheuner et al., 1997; . 
Williams and Pickup, 1999). Type 1 diabetes has two forms, the immune-mediated and 
idiopathic diabetes. Type 1 diabetes indicates the processes of ~-cell destruction that 
may ultimately lead to diabetes in which insulin is required for survival to prevent the 
development of ketoacidosis, coma and death. Type 1 diabetes is usually characterised 
by the presence of anti-GAD, islet cell or insulin antibodies which identify the 
autoimmune processes that lead to ~-cell destruction (Alberti et al., 1998). Only a 
minority of patients with type 1 diabetes fall into the later category, most of whom are 
of African or Asian origin. This form of diabetes (idiopathic type 1 diabetes) is strongly 
inherited, lacks immunological evidence for ~-cell autoimmunity, and is not HLA 
associated (The Expert Committee on the Diagnosis and Classification of Diabetes 
Mellitus, 1997). Type 2 diabetes is the most common form of diabetes, comprising up to 
85% of patients with diabetes (Zimmet, 1997). 
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Table 1.2 Characteristics of the two most common types of diabetes 
Feature Type I Type2 
Treatment insulin sometimes insulin 
oral hypoglycaemics 
diet control 
Age at onset most 0-25 years most 20+ 
Onset sudden gradual 
Obesity rare common 
Concordance in 
monozygotic twin <50% close to I 00% 
Aetiology genetic genetic 
environmental environmental 
Autoimmume yes no 
p cell degradation yes no 
HLA association yes no 
C peptide absent detectable 
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1.4.2 Diagnostic criteria 
A diagnosis of diabetes mellitus can be made without difficulty in clearly symptomatic 
subjects with a high fasting, casual, or random blood glucose level. The new ADA 
guidelines recommends that the point at which people are diagnosed with diabetes 
should be set at 126 mg/dl (7.0 mmoi!L) using the fasting plasma glucose (FPG) test, 
rather than 140 mg/dl (7.8 mmoi!L). This change reflects research evidence regarding 
the development of the complications of diabetes. Two abnormal test results, on two 
different days, are the prerequisite for diagnosis. For epidemiological studies, estimates 
of diabetes prevalence and incidence should be based an FPG ~ 126 mg/dl (7.0 
mrnol/L). The new ADA diagnostic criteria (The Expert Committee on the Diagnosis 
and Classification of Diabetes Mellitus, 1997) are shown in Table 1.3. The old term, 
impaired glucose tolerance (IGT), retains with 2-h postload glucose>= 140 mg/dl (7.8 
mmoi/L) and < 200 mg!L (1l.l mmoi/L). A new category, impaired fasting glucose 
(IFG), has been defined, where fasting plasma glucose is 110 mg/dl (6.1 mmol!L) or 
above, but less than 126 mg/dl (7.0 mmol/L). The terms IGT and IFG refer to a 
metabolic stage intermediate between normal glucose homeostasis and diabetes. Now, 
the IGT class will no longer be used. 
The new ADA criteria are controversial and a very hotly debated topic (Aiberti and 
Zimmet, 1998; Unwin et al., 1998; Wahl et al., 1998; The DECODE Study Group on 
behalf of the European Diabetes Epidemiology Study Group, 1998; 1999a; 1999b; 
Barzilay et al., 1999; Davies, 1999a; 1999b ). However, the WHO has endorsed the 
ADA recommendations with some modifications (Aiberti et al., 1998). The new WHO 
criteria are outlined in Table 1.4. The ADA makes a strong recommendation that the 
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Table 1.3 Criteria for the diagnosis of diabetes mellitus (ADA, 1997) 
I. Symptoms of diabetes plus casual plasma glucose concentration>= 200 mg/dl (11.1 
mmol!L). Casual is defined as anytime of day without regard to time since last meal. 
The classic symptoms of diabetes include polyuria, polydipsia, and unexplained 
weight loss. 
or 
2. FPG >= 126mg/dl (7.0 mmol!L). Fasting is defined as no caloric intake for at least 
8-h. 
or 
3. 2-h postload glucose>= 200 mg/dl (11.1 mmoi!L) during an OGTT. The test should 
be performed as described by WHO (WHO, 1985), using a glucose load containing 
the equivalent of 75-g anhydrous glucose dissolved in water. 
In the absence of unequivocal hyperglycaemia with acute metabolic decompensation, 
these criteria should be confirmed by repeat testing on a different day. The third 
measure (OGTT) is not recommended for routine clinical use. 
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Table 1.4 Values for diagnosis of diabetes mellitus and other categories of hyperglycaemia (WHO, 1998) 
Glucose concentration [mmol!L (mg/dl)] 
Whole blood Plasma 
Venous Capillary Venous Capillary 
Diabetes Mellitus 
Fasting ~6.1 (~110) ~6.1 (~110) ~7.0 (~126) ~7.0 (~126) 
or 
2-h post glucose load ~10.0 (~180) ~11.1 (~00) ~11.1 (~00) ~12.2 (~220) 
or both 
Impaired Glucose Tolerance (IGT): 
Fasting concentration (if measured) <6.1 (<110) <6.1 (<110) <7.0 (<126) <7.0 (<126) 
and 
2-h post glucose load ~6.7 (~120) and ~6.7 (~120) and ~7.8 (~140) and ~8.9 (~160) and 
<10.0 (<180) <11.1 (<200) <11.1 (<200) <12.2 (<220) 
Impaired Fasting Glycaemia (IFG): 
Fasting ~5.6 (~100) and ~5.6 (~100) and ~6.1 (~110) and ~6.1 (~110) and 
<6.1 (<110) <6.1 (<110) <7.0 (<126) <7.0 (<126) 
2-h (if measured) <6.7 (<120) <7.8 (<140) <7.8 (<140) <8.9 (<160) 
For epidemiological or population screening purposes, the fasting or 2-hour value after 75g oral glucose may be used alone. For clinical purposes, the diagnosis of diabetes 
should always be confirmed by repeating the test on another day unless there is unequivocal hyperglycaemia with acute metabolic decompensation or obvious symptoms. 
Glucose concentrations should not be determined on serum unless red cells are immediately removed, otherwise glycolysis will result in an unpredictable underestimation of 
the true concentrations. It should be stressed that glucose preservatives do not totally prevent glycolysis. If whole blood is used, the sample should be kept at 0-4 •c or 
centrifuged immediately, or assayed immediately. 
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FPG can be used on its own and that in general the 75g oral glucose tolerance test 
(OGTT) need not be used. However, The WHO consultation by contrast argues strongly 
for the retention of the OGTT and suggests using the FPG alone when circumstances 
prevent performance of the OGTT. 
Diabetes in children usually presents with severe symptoms, very high blood glucose 
levels, marked glycosuria and ketonuria. In most children the diagnosis is confirmed 
without delay by blood glucose measurements, and treatment (including insulin 
injection) is initiated immediately, often a life-saving measure. An OGTT is neither 
necessary nor appropriate for diagnosis in such circumstances. A small proportion of 
children and adolescents, however, present with less severe symptoms and may require 
a fasting blood and /or an OGTT for diagnosis. For children the oral glucose load is 
related to body weight: l.75glkg. The diagnostic criteria in children are the same as for 
adults (Alberti et al., 1998). 
Diabetes UK, -the former British Diabetic Association (BDA), recommends that all UK 
health care professionals adopt these new criteria from I June 2000 to ensure a 
simultaneous change over to the new definitions. The final global acceptance and 
adoption of the new version of the diagnostic criteria and classification should be seen 
before long. 
Since different types of diabetes have different etiological processes, it is necessary to 
investigate all types of the disease separately. The present research is concerned only 
with the type I (insulin-dependent) form and the rest of the thesis refers specifically to 
type I diabetes. 
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CHAPTER 2. EPIDEMIOLOGY OF TYPE 1 DIABETES 
2.1 Introduction 
As a scientific discipline, epidemiology is concerned with the patterns or distributions 
of a disease or a physiological condition in human populations, and the factors that 
influence these distributions or patterns (Lilienfeld, 1978; Lilienfeld and Stolley, 1994;). 
In this chapter I will describe what is known about the distribution of the disease and the 
factors that may influence the occurrence and distributions of childhood onset type 1 
diabetes. 
The frequency of type 1 diabetes is low compared to type 2 diabetes, accounting for 10 
to 15% of all cases of diabetes in European populations (de Courten et al., 1998). Type 
1 diabetes may occur at any age of human life but its peak incidence period is in 
childhood, especially around puberty. This disease is most common in European 
populations and is rare in Asia, American Indians, Pacific islanders, and populations of 
African descent (Karvonen et al., 1993). Basically, type 1 diabetes is a disorder of 
carbohydrate, fat and protein metabolism in which sugars in the body are not oxidised to 
produce energy due to lack of the pancreatic hormone, insulin, for various reasons. The 
accumulation of sugar leads to its overloading in the blood (hyperglycaemia), and then 
its appearance in the urine. 
Type 1 diabetes affects 0.3% of the world's population (von Boehmer and Sarukhan, 
1999) and about 2 per 1000 population in the UK (Cavan and Barnett, 1993). The 
incidence and prevalence rates in Scotland were 23.9/100,000 and 1.5/1000, 
respectively in children under 15 years old (Rangasami et al., 1997). This disease affects 
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about 2-3/1,000 of the population of the USA (Mehta and Palmer, 1996; Dotta and 
Eisenbarth, 1997). The annual incidence among persons from birth up to 16 years of age 
in the USA is 12- 14 per 100,000 (Atkinson and Maclaren, 1994). In Western Europe, 
there is an estimated overall prevalence of 3 per l ,000 of insulin-treated diabetes and 
therefore about l.S million diabetic people taking insulin. These include both those with 
true type l (insulin-dependent) diabetes and other patients selectively treated with 
insulin. Owing to problems with classification, relatively less is known about type l 
diabetes in patients over the age of 30 (Green and Gale, 1993). 80% of type l diabetes 
presents below the age of 30 years (Douglas et al., 1999), with peaks of onset at S years 
of age and in early adolescence, 12-14 years. The incidence rates are higher in 
Scandinavia, especially in Finland which has the highest rate in the world, 4S/l 00,000 
in children under IS years old in 1996 (Tuomilehto et al., 1999). It is lower in Asian 
countries, especially in China which has the lowest rate, O.SIIIOO,OOO during 198S-94 
(Yang et al., 1998). There is mounting evidence that the incidence of the disease is 
increasing worldwide (Bingley and Gale, 1989a; Karvonen et al., 1993; Rangasami et 
al., 1997), most evidently in Scandinavia (Dahlquist, 1998). A recent study predicted 
that if the trend continues, the incidence in Finland will be approximately SO per 
I 00,000 per year in the year 20 I 0 (Tuomi lehto et al., 1999). The incidence of type I 
diabetes is highest among the population aged under IS years but only about 20-SO% of 
the patients with type I diabetes are diagnosed before this age (Karvonen et al., 1993). 
In order to detect the subtle changes of incidence in and between populations in a 
disease which typically has a prevalence of under l %, considerable precision is required 
in the expression of data. However, t)rpe I diabetes is a common childhood disease, the 
incidence rate being about the same as all childhood cancers combined, and three times 
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that of cystic fibrosis or juvenile rheumatoid arthritis (Humphrey et al., 1995). The 
WHO Multinational Project on Childhood Diabetes, known as the DIAMOND project, 
was established in 1990 in order to collect standard information on incidence, risk 
factors and mortality associated with Type I diabetes, to evaluate the efficiency and 
effectiveness of healthcare and economics of diabetes and to establish national and 
international training programmes in diabetes epidemiology (WHO DIAMOND Project 
Group, 1990; The WHO Multinational Project for Childhood Diabetes Group, 1991). A 
similar project has been established in Europe, the EURODIAB ACE project (Green et 
al., 1992; Levy-Marchal et al., 1995), in the Baltic region, the DIABAL T project 
(Tuomilehto et al., 1992) and several other regional comparative studies have been 
performed under the auspices of the Diabetes Epidemiology Research International 
(DERI) GROUP (Karvonen et al., 1993). 
Epidemiological and genetic studies have already provided very much useful 
information about the pattern and risk factors of the disease. The following sections 
briefly describe certain features of the epidemiology of type I diabetes. 
2.2 Population distribution of type 1 diabetes 
The study of the incidence of childhood-onset type I diabetes mellitus in different 
countries and continents demonstrates the vast geographic variation and provides 
valuable information for research of the aetiology of the disease (Karvonen et al., 1993; 
Lounamaa, 1996). 
2.2.1 Age distribution 
The distribution of age at diagnosis of type I diabetes has been similar in most studies 
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throughout the world. It is rare in the first few months of life then rises gradually 
throughout early childhood, increasing abruptly to a major peak in the pubertal years in 
both sexes. The age-specific incidence then falls fairly sharply. Although the incidence 
in young adults is much lower than in children, it has been estimated that some 30% of 
all cases with type 1 diabetes are diagnosed after the age of 20 (Bingley and Gale, 
1990). In terms of age-group, the incidence rates are lowest in the 0-4 age-group and 
highest in the 10-14 age group (Green et al., 1992; Levy-Marchal et al., 1995). The 
characteristic age distribution of the occurrence of diabetes in childhood shows an 
increasing incidence up to puberty and a decline thereafter (Lounamaa, 1996). The 
highest incidence was found in the 10-14 year age group in the Oxford region, England, 
1985-86 individuals under 21 years old (Bingley and Gale, 1989b) and also in Scotland 
during 1984-93 (0-4yr: 15.3; 5-9yr: 24.4; 10-14yr: 31.9/100,000) (Rangasami et al., 
1997). The age distribution from the study of the British Isles was bimodal with a main 
peak at about 11 years and a secondary peak at about 5 years (Bloom et al., 1975). The 
incidence was higher in the 5- to 9-year-old age group (10.4/100,000) in Rome and its 
region (Lazio region) in the 5-year period, 1989-93 in the population under 15 years old 
(Sebastiani et al., 1996). In Finland, where the incidence has been high and consistently 
increasing, there has been a clear change in the age distribution over the last 30 years. In 
the late 1960s and early 1970s the age distribution was similar to that described above. 
However, more recently, following a higher rate of increase in the number of newly 
diagnosed diabetic children at a younger age, the incidence has been remarkably high 
and similar throughout childhood (Lounamaa, 1996). 
2.2.2 Sex distribution 
The epidemiology of auto-immune disease shows most have a high female:male ratio. 
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This is not the case for type I diabetes. The difference between males and females is, 
however, quite small. Most studies have reported a slight male excess. The EURODIAB 
ACE study gave a similar result of a slight male excess in incidence (male/female: 1.06) 
with no statistical significance, which provided no evidence of a difference between the 
sexes in the age distribution of incidence (Green et al., 1992). A recent study from 
Scotland found a similar sex ratio of 1.08 with a slight male excess (M:F, 95% Cl: 1.00 
to 1.12) between 1984 and 1993 (Rangasami et al., 1997). During 1983-88 a slight male 
excess in incidence in the under IS's was found in the Baltic countries with higher 
incidence- Finland and Estonia, but in the lower incidence countries (Latvia, Lithuania 
and Poland) the sex ratio was the opposite (Tuomilehto et al., 1992). No significant 
differences in incidence were observed between boys and girls under the age of 15 in 
Rome and the Lazio region during 1989-93, whose overall incidence was 7.9 per 
I 00,000 (Sebastiani et al., 1996). A study in the Oxford region, England, 1985-86 
demonstrated that males had a higher incidence than females (16.8 vs. 14.3/1 00,000) 
under 21 years old (Bingley and Gale, 1989b ). A slight female excess has been observed 
in countries with a low incidence of the disease, such as the investigation from 
Australia, which showed that girls were more likely than boys to have a diagnosis of 
Type I diabetes during 1985-89 in children ages 0-14 (P = 0.006) (Kelly and Byrne, 
1992). However, there were 41% more girls than boys in a recent Japanese study (Kida 
et al., 2000). The reason for this is unknown. Studies on the incidence of the disease in 
patients older than 15 years have in general shown a larger male excess with an 
incidence almost twice as high in males than in females (Lounamaa, 1996). Sex 
difference in incidence is most unlikely to be attributable to genetic factors and the 
possible explanation for this difference is that gender modifies the individual risk of 
developing diabetes by altering individual susceptibility, maybe at certain stages of 
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development and high growth velocity (Green and Gale, 1993). 
2.2.3 Ethnic distribution 
Migration studies show that immigrants tend to acquire the incidence rate of the native 
inhabitants, which supports the idea that non-genetic factors are important in the 
aetiology. Icelanders living in Iceland, who are believed to originate from Norway, have 
a lower incidence of Type I diabetes than the people in Norway (Lounamaa, 1996). The 
incidence of childhood diabetes among non-Estonians (predominantly Russians) living 
in Estonia has been shown to be significantly higher than among Russians living in 
Novosibirsk, but in the youngest age group of0-4 years there was no difference between 
the populations. The offspring of Asian parents living in Yorkshire shows a rising 
incidence (Bodansky et al., 1992). A study from Montreal, Canada reported that the 
incidence was highest among children of Jewish origin, followed by the British-
Canadian and Italian-Canadian children, and the incidence was lower among the 
French-Canadian children than among the remaining population. When comparing the 
incidence rates between the selected groups with reported rates in similar ethnic groups 
residing elsewhere the rates were higher in Montreal, for the French twofold and for the 
Ashkenazi Jews nearly threefold (Siemiatycki et al., 1988). The explanations given by 
the authors for the difference between the French in Montreal and the French in France 
were firstly, those in Montreal had undergone genetic intermingling with descendants 
from the British Isles thus increasing the frequency of Type 1-prone genotypes; 
secondly, it was. pointed out that there are myriad environmental differences between 
Montreal and France, which could conceivably play an etiological role. 
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2.2.4 Family history 
Approximately 5% of first degree relatives of individuals with type I diabetes also have 
the disease. Nearly 50% of identical twins are concordant for the disease. While a 
familial influence is evident, it should be emphasised that most individuals who develop 
type I diabetes do not have a first degree relative with type I diabetes mellitus (Mehta 
and Palmer, 1996). Some studies have shown that the children of fathers with type I 
diabetes have a much higher risk of type I diabetes than do children of diabetic mothers 
(Lounamaa, 1996). In Finland the prevalence of type I diabetes in parents is higher than 
elsewhere (6% in fat~ers, 3% in mothers) (Tuomilehto, 1997). 
2.3 Geographical distribution 
2.3.1 Global distribution 
An enormous worldwide difference in type 1 Diabetes incidence was first demonstrated 
in the early 1980s. The highest incidence was in Scandinavia and the lowest in Asia. 
Globally, type I diabetes occurrence is now being monitored by the WHO DIAMOND 
Study which has demonstrated that the incidence rates range from 0.1 per 100,000 in 
China to 35.3 per I 00,000 person-years in children under 15 years in Finland. The over 
300-fold variation in rate is the greatest for any chronic disease (Table 2.1). It generally 
follows the classical North-South gradient with some exceptions (Tajima, 1997). 
The wide variation in the incidence has also been confirmed in European countries 
(Green et al., 1992; EURODIAB ACE Study Group, 2000). Over 10-fold difference 
(range 3.2 - 40.2 cases per I 00,000 per year) in incidence rate of the disease during 
1989-94 has been recently reported (EURODIAB ACE Study Group, 2000). The results 
from five Baltic populations showed that the average age-standardized yearly incidence 
49 
of type l diabetes per l 00,000 during 1983-88 was in males under 15 years of age 36.9 
in Finland, 10.7 in Estonia, 6.4 in Latvia, 6.5 in Lithuania and 6.0 in Poland; and in 
females the incidence was 31.6, I 0.0, 6.9, 7.0 and 6.4 in these five populations, 
respectively (Tuomilehto et al., 1992). A study from Rome and the Lazio region, Italy 
indicated that the overall incidence was 7.9 per l 00,000 during 1989-93 in the under 15 
year-old children, which was comparable to that of the other continental Italian regions, 
(but not Sardinia, which has the world's second highest rate, 30.2 (Green et al., 1992) 
and other Southern European countries (Sebastiani et al., 1996). In western Australia the 
mean annual incidence of 13.2 per l 00,000 person-years during a 5 year period, 1985-
89 among 0-14 years old children (Kelly and Byme, 1992). The worldwide incidence 
data are summarised in the following table (Table 2.1 ). 
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Table 2.1 Global geographical distribution of the incidence of type 1 
diabetes (number of cases per 100,000 per year) 
Country (area) 
Europe 
Finland 
Finland 
Flnland(2 regions) 
Finland 
Poland 
ltaly(Sadinia) 
Sweden 
UK(Scotland) 
UK(Scotland:Tayside region) 
Denmark (3 counties) 
UK(Scotland) 
Norway(8 counties) 
UK(Scotland:Tayside region) 
UK(Northem Ireland) 
UK(Northem Ireland) 
UK(Oxford region) 
UK(Oxford region) 
UK(Piymouth) 
UK(Scotland) 
UK(Yorkshlre) 
UK(including The Republic of Ireland) 
Luxembourg(Whole nation) 
Nether1ands(5 regions) 
Spain(Catalonia region) 
UK(Leicestershire) 
Estonia 
Italy( eastern Sicily) 
Belgiun(Antwerp region) 
Greece(Athens region) 
Czech Republic 
UK(Includlng The Republic of Ireland) 
Austrian (whole nation) 
Italy (Rome and Lazio region) 
France (4 regions) 
Austrian (whole nation) 
UK (Whole nation) 
Hungary(18 counties) 
Portuga1(3 regions) 
Germany 
ltaly(Lombardia region) 
Lithuania 
ltaly(Lazio region) 
Slovenia 
La !via 
Poland (3 cities) 
Russia (Moscow) 
Israel (Whole nation) 
Poland(9 western provinces) 
UK(Leicestershire) 
UK(Leicestershire) 
UK(northem England) 
Romania(Bucharest region) 
Greece(5 northern region) 
Boys Girls Total Age Period 
36.9 31.6 Q-14 1983-1988 
44.8 Q-14 1996 
47 38.8 42.9 0-14 1989-1990 
37.6 33.5 35.7 Q-14 1987-1992 
6 6.4 Q-14 1983-1988 
33.5 26.9 30.2 Q-14 1989-1990 
25 23.8 24.4 Q-14 1978-1987 
23.9 Q-14 1984-1993 
23.5 19.3 21.7 Q-18 198Q-1983 
21.5 21.4 21.5 0-14 1989-1990 
21.7 20.2 21 0-18 1977-1983 
22.3 19.3 20.8 0-14 1989-1990 
20.6 0-14 198Q-1983 
19.9 19.3 19.6 0-14 1989-1994 
17.8 15.4 16.6 Q-14 1989-1990 
17.8 14.9 16.4 0-14 1989-1990 
16.8 14.3 15.6 Q-20 1985-1986 
13.6 16.3 14.8 Q-14 1975-1996 
14.4 13.2 13.8 0-18 1968-1976 
13.7 0-14 1978-1990 
13.8 13.3 13.5 0-14 1988 
12.1 12.6 12.4 0-14 1989-1990 
11.2 10.8 11 0-14 1989-1990 
10.5 10.6 10.6 0-14 1989-1990 
10.6 Q-14 1971-1980 
10.7 10 10.3 0-14 1983-1988 
11.2 9 10.1 0-14 1989-1990 
9.2 10.4 9.8 0-14 1989-1990 
10.9 7.7 9.3 0-14 1989-1990 
10.0 10.2 10.1 0-14 199Q-1997 
9. 7 8.8 9.3 0-5 1992 
7.9 0-14 1979-1993 
7.9 7.8 7.9 0-14 1989-1993 
7.8 7.8 7.8 0-14 1989-1990 
7.9 7.5 7.7 0-14 1989-1990 
7.7 7.5 
10.1 4.9 
7.6 5.9 
6.5 7 
7.2 5.8 
5.2 7.7 
6.4 6.9 
5.7 6 
7.7 0-15 1973-1974 
7.6 Q-14 1989-1990 
7.5 0-14 1989-1990 
7.4 0-14 1960-1989 
6.8 Q-14 1989-1990 
6.8 0-14 1983-1988 
6.5 0-14 1989-1990 
6.5 Q-14 1989-1990 
6.5 Q-14 1983-1988 
5.8 Q-14 1989-1990 
5.6 0-14 1989-1990 
4.4 6.7 5.5 0-14 1989-1990 
5.3 5.8 5.5 0-14 1989-1990 
5.3 Q-14 1961-1970 
3.8 Q-14 1951-1960 
14.8 13.4 Q-15 1977-1986 
4.6 5.7 5.1 Q-14 1989-1990 
5.3 3.8 4.6 Q-14 1989-1990 
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Pub Year Ref no. 
1992 
1999 
1992 
1995 
1992 
1992 
1993 
1997 
1986 
1992 
1988 
1992 
1986 
1996 
1992 
1992 
1989 
1999 
1983 
1993 
1991 
1992 
1992 
"1992 
1989 
1992 
1992 
1992 
1992 
2000 
1995 
1995 
1996 
1992 
1992 
1975 
1992 
1992 
1993 
1992 
1992 
1992 
1992 
1992 
1992 
1993 
1992 
1992 
1989 
1989 
1991 
1992 
1992 
1 
2 
3 
4 
1 
3 
5 
6 
7 
3 
8 
3 
7 
8 
3 
3 
10 
11 
12 
13 
14 
3 
3 
3 
15 
1. 5 
3 
3 
3 
16 
17 
18 
19 
3 
3 
20 
3 
3 
5 
3 
1, 5 
3 
3 
1, 5 
3 
5 
3 
3 
15 
15 
21 
3 
3 
Country (area) 
Oceania 
Australia(Westem Australia) 
New Zealand(Canterbury) 
New Zealand(Canterbury) 
New Zealand(Auckland) 
New Zealand 
Algeria(Oran) 
Sudan(Khartoum) 
Tanzania(Dar es Salaam) 
North American 
Canada (Prince Edward Island) 
USA (Wisconsin (part)) 
USA(AIIegheny County, Pennsylvania) 
Whites 
Nonwhites 
USA(AIIegheny County, Pennsylvania) 
Whites 
Nonwhltes 
USA(Philadelphia, Pennsylvania) 
Whites 
Blacks 
Hispanics 
Puerto Rico 
Cuba 
Mexico(Mexico City) 
South America 
Brazii(State of Sao Paulo) 
Chile 
Peru 
lndia(south part) 
Kuwait 
Oman(Sultanate) 
Oman(Sultanate) 
Japan(Hokkaldo) 
Japan 
China(Shanghai) 
China(Shanghai) 
China(whole nation) 
Korea(Seoul) 
Boys Girls Total Age Period 
13.2 0-14 1985-1989 
12.7 12.6 12.7 0-19 1982-1990 
10.2 12.9 11.6 0-14 1981-1986 
9 10.5 9.8 0-14 1978-1985 
8.6 9.1 8.9 0-14 1968-1972 
8.1 0-14 1980-1989 
6.4 0-14 1987-1990 
0.8 0.9 0.8 0-14 1982-1991 
27 20.8 23.9 0-14 1975-1986 
20.2 16.2 18.2 0-14 1970-1985 
17.0 17.5 17.3 0-14 1970-1985 
9.7 13.3 11.5 0-14 1970-1985 
16.5 0-19 1990-1994 
17.6 0-19 1990-1994 
12.7 13.6 13.3 0-14 1985-1990 
9.1 13.3 11.19 0-14 1985-1990 
10.6 19.5 15.0 0-14 1985-1990 
10 0-14 1985-1989 
2.5 2.8 2.7 0-14 1978-1980 
0.4 0.7 0.6 0-14 1984-1986 
5.8 9.5 7.6 0-14 1987-1991 
2.2 2.8 2.5 0-14 1990-1991 
1 0-14 1980-1988 
12.6 9.6 10.5 0-14 1991-1994 
3.2 4.7 4 0-14 1980-1981 
2.91 1.95 2.62 0-14 1994 
3.23 1.99 2.45 0-14 1993 
1.3 2.1 1.7 0-14 1974-1986 
1.2 1.8 1.5 0-14 1986-1990 
0.75 1.11 0.93 0-14 1989-1993 
0.64 0.79 0.71 0-14 1980-1991 
0.47 0.59 0.51 0-14 1985-1994 
0.6 0.9 0.7 0-14 1985-1988 
Pub Year Ref no. 
1992 
1992 
1993 
1993 
1993 
1993 
1992 
1993 
1993 
1993 
1989 
1989 
1998 
1998 
1993 
1993 
1993 
1993 
1993 
1993 
1993 
1993 
1993 
1996 
1993 
1996 
1996 
1993 
2000 
1996 
1994 
1997 
1994 
22 
23 
5 
5 
5 
5 
5,24 
5 
5 
5 
25 
25 
26 
26 
27 
27 
27 
5 
5 
5 
5 
5 
5 
28 
5 
29 
29 
5 
30 
31 
32 
33 
34 
1: Tuomilehto et al., 1992; 2: Tuomilehto et al., 1999; 3: Green et al., 1992; 4: Tuomilehto et al., 1995a; 5: Karvonen 
et al., 1993; 6: Rangasami et al., 1997; 7: Waugh, 1986; 8: Patterson et al., 1988; 9: Patterson et al., 1996; 
10: Bingley and Gale, 1989b; 11: Zhao et al., 1999; 12: Patterson et al., 1983; 13: Staines et al., 1993; 14: Metcalfe 
and Baum, 1991; 15: Burden et al., 1989; 16: Cinek et al., 2000; 17: Wadsworth et al., 1995; 18: Schober et al., 
1995; 19: Sebastiani et al., 1996; 20: Bloom et al., 1975; 21: Crow et al., 1991; 22: Kelly and Byrne, 1992; 23: Scott 
et al., 1992; 24: Elamin et al., 1992; 25: Rewers et al., 1989; 26: Libman et al., 1998; 27: Lipman, 1993; 28: 
Ramachandran et al., 1996; 29: Soliman et al., 1996; 30: Kida et al., 2000; 31: Shen et al., 1996; 32: Fu et al., 1994; 
33: Yang et al., 1998; 34: Ko et al., 1994. 
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2.3.2 UK national distribution 
The first systematic and comprehensive register of childhood onset type I diabetes in 
the UK (incidence study) started in 1972 when the British Diabetic Association (BDA) 
sponsored a register collecting newly diagnosed diabetic children under the age of 16 
years for use as a basis for studies in epidemiology, virology and other fields (Bloom et 
al., 1975). Its preliminary results were published in the British Medical Journal in 1975 
(Bloom et al., 1975) showing the incidence of all regions in the UK and Ireland during 
1973-74 with a mean incidence rate of 7.7/100,000/year. Although the reported 
incidence rates may be underestimated due to the unknown, probably low, degree of the 
ascertainment in these early years, this study did stimulate the interest of the 
epidemiological studies in this disease and since then, a number of registers have been 
set up across the UK (Waugh, 1986; Patterson et al., 1988; 1996; Bingley and Gale, 
1989b; Burden et al., 1989; Crow et al., 1991; Green et al., 1992; Staines et al., 1993; 
Gardner et al., 1997; Rangasami et al., 1997; Zhao et al., 1999). Results of these UK 
studies are reviewed as follows. 
Research from the UK generally shows a weak North-South gradient pattern with 
Scotland and Northern Ireland having the higher rates while England has the lower rates 
(Table 2.2). Some of these studies also demonstrated an increasing trend of incidence 
(Patterson et al., 1983; 1988; Burden et al., 1989; Gardner et al., 1997; Rangasami et al., 
1997; Zhao et al., 1999; Feltbower et al., 2000). The Yorkshire study shows the obvious 
increase in diagnosis in the age group 10 - 14 years in an early report (McKinney et al., 
1995) and recently, the authors have reported increases in all age groups (Feltbower et 
al., 2000). The Oxford study and our own data demonstrate significant increases in 
incidence rates, especially in 0-5 years of age group (Gardner et al., 1997; Zhao et al., 
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Table 2.2 Overall incidence per 100,000 persons per year reported from the UK 
Study (Reference) Year of study Age (years) Incidence 
Scotland (I) 1984-93 0-14 23.9 
Scotland (2) 1977-83 0- 18 21.0 
Scotland {Tayside) 1980-83 0- 14 20.6 
(3) 
Scotland ( 4) 1976-86 0- 11 17.6 
Scotland (5) 1968-76 0- 18 13.8 
Northern Ireland (6) 1989-94 0- 14 19.6 
Northern Ireland (7) 1989-90 0- 14 16.6 
Newcastle (8) 1977-86 0- 14 13.4 
Oxford (9) 1985-86 0- 19 15.6 
Oxford (10) 1985-95 0- 14 18.6 
Oxford (7) 1989-90 0- 14 16.4 
Far South West of 1975-96 0- 15 14.9 
England*{l1) 
Yorkshire (12) 1978-90 0- 14 13.7 
Leicestershire ( 13) 1971-80 0- 14 10.6 
Leicestershire (13) 1961-70 0- 14 5.3 
Leicestershire (13) 1951-60 0- 14 3.8 
British Isles ( 14) 1988 0- 14 13.5 
British Isles ( 15) 1973-74 0- 15 7.7 
*Present Study; 1: Rangasami et al., 1997; 2: Patterson et al., 1988; 3: Waugh, 1986; 4: 
Barclay et al., 1988; 5: Patterson et al., 1983; 6: Patterson et al., 1996; 7: Green et al., 
1992; 8: Crow et al., 1991; 9: Bingley and Gale, 1989b; 10: Gardner et al., 1997; 11: 
Zhao et al., 1999; 12: Staines et al., 1993; 13: Burden et al., 1989; 14: Metcalfe and 
Baum, 1991; 15: Bloom et al., 1975. 
54 
1999). Seasona1ity at diagnosis is obvious with fewer cases being diagnosed in summer 
time in the far South West of England (Zhao et al., 1999), British Isles (Bloom et al., 
1975; Metcalfe and Baum, 1991 ), Scotland (Patterson et al., 1988; Rangasami et al., 
1997; Douglas et al., 1999), Northern Ireland (Patterson et al., 1996), Oxford (Bingley 
and Gale, 1989b) and Yorkshire (Staines et al., 1993). The seasonal variation of the 
disease might have something to do with an individual's susceptibility to virus 
infections, or increased demand for endogenous insulin in cold weather, or the 
heterogeneity of the natural history in that some cases may be epidemic with rapid 
development, particularly in winter months, whereas the remaining cases have a more 
prolonged natural history (Green and Gale, 1993). Significant seasonality of birth in 
diabetic children was found in Scotland, Yorkshire and Leicester (Rothwell et al., 1996; 
1999) but not in the South West of England (Zhao et al., 2000), or in England and 
Wales (Rothwell et al., 1999). The abnormal seasonality of birth of children with 
diabetes might be due to intrauterine infections (Rothwell et al., 1996; 1999). Most 
studies (Bloom et al., 1975; Patterson et al., 1983; 1988; 1996; Bingley and Gale, 
1989b; Metcalfe and Baum, 1991; Staines et al., 1993; Wadsworth et al., 1995; 
Rangasami et al., 1997) have demonstrated a slight excess of boys among newly 
diagnosed cases. A few studies have shown a slight female excess (Crow et al., 1991; 
Zhao et al., 1999). Urban/rural differences have been found with higher rates in rural 
areas (Waugh, 1986; McKinney et al., 1996; F eltbower et al., 2000). Areas with a high 
population density and the most material deprivation were observed to have the lowest 
incidence rates (Patterson et al., 1983; 1988; 1996; Staines et al. 1997), whereas in 
another study (Crow et al., 1991 ), the incidence rates were higher in the more materially 
deprived areas than in the less deprived areas. Offspring of an Asian transmigratory 
population had a rising incidence of childhood diabetes approaching that of the 
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indigenous population (Bodansky et al., 1992), and providing strong evidence for an 
environmental effect in the aetiology of type I diabetes. Both parasitic infestation 
(Bodansky et al., 1999) and improved hygiene in the first year of life may increase the 
risk of developing diabetes (Parslow et al., 1999; McK.inney et al., 2000). No 
association between parental occupational social mixing and the risk of childhood 
diabetes was found, but the possible protective effect of a mother's high occupational 
social mixing among children aged 0-4 years needs further study (Fear et al., 2000). 
2.4 Temporal distribution 
2.4.1 Annual distribution 
The incidence of childhood diabetes has been shown to have been increasing in the 
many populations for which incidence data have been collected over a number of years 
(Lounamaa, 1996). A linear increase in type I diabetes risk for people under 15 years of 
age was observed in most of Europe and the Western Pacific, but not in North America 
in the population-based registries with collections of 6 to 21 years, published by the 
Diabetes Epidemiology Research International Group (I 990). The incidence in Finland 
has increased dramatically from 13 to 45/100,000 between 1953 and 1996, and the 
predicted incidence for Finland is approximately 751100,000/year for the year 2050 if 
the current trend were to continue (Tuomilehto, 1997). Tuomilehto et al. (1995a; 1997) 
suggested that the increase may not necessarily be attributable to environmental factors 
alone, and might in fact better be explained by an increase in the genetic pool of 
susceptible individuals. However, the more widely held belief is that the large 
geographical variations and the increase observed in many countries could more 
reasonably be due to unidentified environmental factors (Lounamaa, 1996). Recently a 
new hypothesis has been introduced by stating that the increased incidence of type I 
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diabetes could be caused by the decrease in incidence of enterovirus meningitis 
infections in Finland (Viskari et al., 2000). This needs to be evaluated in other 
populations. 
2.4.2 Seasonal distribution 
It has consistently been found from both the northern and the southern hemispheres that 
relatively more cases of childhood type I diabetes are diagnosed during the autumn and 
winter seasons as compared with spring and summer (Bloom et al., 1975; Bingley and 
Gale, 1989b; Green and Gale, 1993; Levy-Marchalet al., 1995; Sebastiani et al., 1996). 
There is a suggestion that this seasonal trend is most marked at ages around puberty and 
less obvious during the first years of life (Green and Gale, 1993). It has also been 
suggested that the seasonal variation might be explained by a higher likelihood of 
observing the early symptoms of diabetes during the school terms, and that a lower 
incidence in the summer ·would be explained by school holidays. However, a more 
plausible explanation links the seasonal pattern to that of infectious disease, suggesting 
that an infection might precipitate symptoms in a pre-diabetic child by causing an 
increase in the insulin requirement (Dahlquist, 1993). It has also been postulated that the 
Jack of seasonality of onset of type I diabetes in certain age groups might imply a true 
aetiological distinction of the disease between different age groups, in particular 
juvenile and late-onset type I diabetes (Lounamaa, 1996). Rothwell et al. ( 1996) found 
that more diabetic children were born during the spring and summer and fewer during 
the winter months. Therefore the authors concluded that environmental factors of a 
seasonal nature must be important in the aetiology of diabetes and that these factors 
must exert their influence in utero or in the first year of life. Their finding is consistent 
with indirect evidence that the early environment is important in the causation of type I 
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diabetes (Leslie and Elliott, 1994) and supports the hypothesis that the disease may be 
initiated by viral infection early in life. 
2.4.3 Space-time clustering 
Although a recent study (Patterson et al., 1996) failed to find positive results for space-
time clustering at diagnosis and at birth, most studies have shown evidence for 
clustering in childhood diabetes. Samuelsson et al. (1994) detected significant space-
time clustering in 584 newly diagnosed Swedish diabetic children during 1977-1990, at 
distances of up to 15km and time intervals of up to 7 months and these clusters in 
diagnosis tended to be specially pronounced during the period with the highest 
incidence of type l diabetes. A study from Yorkshire (Law et al., 1997) with l ,490 
diabetics during the period 1978 to 1990 also demonstrated a significant diagnostic 
clustering with the strongest clustering in the youngest children (0-4 and 5-9 years of 
age). However, no clustering of the disease was detected in Yorkshire at the time of 
birth (Law et al., 2000). Siemiatycki et al. (1986), in Montreal, found evidence for 
clustering in the first three years of their study, but not later on. Bodington et al. ( 1995) 
found that a diabetic child in Leicestershire would have attended the same nursery or 
primary school as another diabetic child significantly more often than control children. 
Dahlquist and Kallen ( 1996) found a clustering according to place and time of birth for 
later risk to develop type l diabetes using the nation-wide Swedish Childhood Diabetes 
Registry with 3, 725 diabetic children diagnosed between July 1977 and December 1992. 
These studies are further evidence of an environmental factor contributing to the genesis 
of diabetes and support the hypothesis that infectious agents (possibly viral) or localised 
environmental sources give rise to at least a proportion of childhood diabetes. 
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2.5 Aetiology and pathogenesis of type 1 diabetes 
2.5.1Introduction 
Type I diabetes is thought to be triggered by an environmental factor or factors such as 
viruses, chemicals (toxins) and nutrition in individuals who are genetically predisposed 
to developing the disorder. This triggering factor initiates changes in the p cells of the 
pancreas that produce insulin; these are destroyed, resulting in a lack of insulin and 
subsequent hyperglycaemia. The aetiology of type I diabetes is still not clear and could 
be multifactorial (Haverkos, I997). It certainly involves a genetic predisposition, 
environmental factors, immunological factors and their interactions with respect to 
inducing and maintaining the pathological process that eventually leads to pancreatic P 
cell destruction. There is no evidence for one single overriding cause for type I diabetes. 
Both genetic and non-genetic exposures appear to be necessary but need complementary 
factors to result in clinically overt disease (Dahlquist, I997). In addition, different types 
of interactions between risk factors as well as timing, dosage and sequence of events 
must be considered. The current evidence for the etiological importance of genetic, 
environmental and immunological factors is briefly described below. 
2.5.2 Genetic factors 
Evidence for genetic predisposition comes from studies in. twins that demonstrate a 
higher probandwise concordance rate in monozygotic twins (23-70%) than in dizygotic 
twins (5-25%) (Kaprio et al. I992; Kumar et al., I993; Kyvik et al., I995) In addition, 
the empirical risk of type I diabetes is increased among first-degree relatives of 
probands with the disease (WHO, 1994). This genetic susceptibility to type I diabetes 
appears to be inherited as a polygenic trait. However, more than 80% of cases of type I 
diabetes occur sporadically in individuals with no apparent family history of the disease. 
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In the remaining 20%, patients aggregate in families (Friday, et al., 1999). Family 
studies have also indicated that familial type 1 diabetes patients have a younger age at 
onset than non-familial patients (Metcalfe and Baum, 1992; Pociot et al., 1993; The 
EURODIAB ACE Study Group and The EURODIAB ACE Substudy 2 Study Group, 
1998). In siblings of probands with the disease, the risk is about 5% (WHO, 1994), 
whilst offspring of diabetic parents have a 2-3% risk if the mother has the disease, and a 
5-6% risk if the father has the disease (Warram et al., 1984). A preferential transmission 
of the disease from father to child (particularly from father to daughter) has been 
observed in many studies (Warram et al., 1984; Dahlquist et al., 1985; Pociot et al., 
1993; Tuomilehto et al., l995b; Dahlquist and Mustonen, 1995; The EURODIAB ACE 
Study Group and The EURODIAB ACE Substudy 2 Study Group, 1998). 
Although it has been suggested that multiple genes play a role in disease susceptibility, 
there is evidence that two chromosomal regions are associated with and linked to type I 
diabetes, most strongly the Major Histocompatibility Complex (MHC) on chromosome 
6p2l (IDDMJ) (Todd et al., 1987; 1991; Davies et al., 1994), and the insulin gene region 
(INS, IDDM2) on chromosome llpl5 (Bell et al., 1984; Hitman et al., 1985; Bain et a., 
1992). The contribution of these two loci to familial inheritance is approximately 42% 
for IDDMJ and 10% for IDDM2, and it can be further extrapolated that while other 
susceptibility genes of type I diabetes exist, none can have the relatively large 
contribution that has been described for IDDMJ (Davies et al., 1994; Hashimoto et al., 
1994; Owerbach and Gabbay, 1996). During a genome-wide search for susceptibility 
genes (Davies et al., 1994), associations between other non-MHC genes and a 
susceptibility to type I diabetes have also been proposed. These loci along with some 
potential candidate genes are listed in Table 2.3 (adapted from Friday et al., 1999) and 
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the locations of these main diabetes-related genes on chromosome 6 are illustrated in 
Figure 2.1 (Cavan and Barnett, 1993; Friday et al., 1999). 
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Table 2.3 Summary of human type 1 diabetes susceptibility loci 
Chromosome Locus Linkage status 
6p2l IDDMJ; HLA-DQB Confirmed 
llpl5.5 IDDM2; INS S'VNTR Confirmed 
15q26 IDDM3; IGFJR Suggestive 
llql3 IDDM4;FGF3 Confirmed 
6q25 IDDM5; ESRJ Confirmed 
18q21 IDDM6 
2q3l IDDM7; ILl, HOXDB Suggestive 
6q27 IDDMB; IGF2R Confirmed 
3q2l-q25 IDDM9 
I Op 11.2-q 11.2 IDDMJO 
l4q24.3 IDDMJJ Significant 
2q33 JDDM/2; CTLA-4 
2q34 IDDM/3; IGFBP2, IGFPB5 
6q21 IDDM/5 
7p Not assigned; GCK;IGFBPJ;IGFBP3 
xq Not assigned 
xp Not assigned Significant 
lq Not assigned Suggestive 
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Chromosome 6 HLA Region 
Class IT Class Ill Class I 
Centromere DP DN DO DQ DV DQ DR 21 C4 21 C4 Bf C2 HSP70 TNF BC E A 
DPB2 DPA2 DPBIDPAI DNA DMA DMB LMP2 TAP! LMP7 TAP2 DOB DQB2 DQA2 DQBI DQAI DRBI DRB2 DRB3 DRB9 DRAI 
Figure 2.1. The gene for coding HLA complex molecules is located on human chromosome 6. This region can be 
divided into class I, class II and class m, respectively. 
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Approximately 90-95% of Caucasians with type I diabetes have either HLA-DR3 
and/or HLA-DR4 but only 40% ofnormals do so. Nearly half of the patients with type 1 
diabetes are HLA-DR3/DR4 heterozygotes in contrast to 5% of normals (Mehta and 
Palmer, I996). In addition, affected siblings tend to share at least one and frequently 
both HLA haplotypes (Platz et al., 1981; Wolf et al., I983). Conversely, the haplotype 
DR2 is negatively associated with the occurrence of the type I diabetes, since HLA-
DR2-positive patients with type 1 diabetes are rare (Baisch et al., 1990; Erlich et al., 
I991). Therefore, these HLA-DRIDQ alleles can either be predisposing or protective 
(The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997). 
Polymorphism of the HLA-DQP chain at position 57 in Europeans might play a role in 
determining susceptibility or resistance to the development of type I diabetes. Aspartic 
acid at this position is either neutrally associated with the disease or protects against the 
disease, whilst non-Asp-57 haplotypes (either alanine, valine or serine alleles) increase 
the susceptibility of the disease (Todd et al., 1987; More! et al., I988), although Asp-57 
is not a risk marker in Japanese patients (Awata et al. 1990; lkegami et al., 1990). 
Genetic epidemiological studies (Bao et al., 1989; Dorman et al., 1990) even showed 
that the variation in the distribution of non-Asp-57 alleles might explain much of the 
world-wide geographic variation in incidence of type 1 diabetes. The strong association 
and linkage between certain MHC class II allele and type 1 diabetes have also been 
studied in animal models. In non-obese diabetic (NOD) mice, the MHC class II region 
encodes a unique 1-A molecule (1-At), which has a serine (Ser) instead of aspartic acid 
(Asp) at position 57 (Hattori, et al.; 1986; Acha-Orbea, et al., 1987). Several studies 
have produced NOD mice that have an Asp at position 57 of MHC class 11 1-A P chain 
using transgenic technique. These 1-A transgenic mice display remarkebly decreased 
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levels of insuli!is and diabetes (Slattery, et al., 1990; Miyazaki, et al., 1990; Singer, et 
al., 1993). Another study (Lund et al., 1990) has demonstrated that the transgenic NOD 
mice carrying an I-AB7 mutated at positon 56 (histidine to proline) or 57 (Ser to Asp) are 
partially or completely protected from both diabetes and insulitis. These results indicate 
that I-A p chain position 57 is the major MHC-Iinked genetic factor which will 
determine susceptibility or resistant to type I diabetes. A recent study (Chao et al., 
1999) has shown that these two amino acid substitutions at positions 56 and 57 within 
the l-Ap chain are sufficient to alter peptide binding and MHC restriction and may also 
affect antigen presentation and the selection of the T cell repertoire by peptide-binding 
studies. 
DQAI genes that code for an arginine at position 52 are also identified as risk makers in 
European populations and this is associated with both HLA-DR3 and DR4 (Khalil et al., 
1990; Lipton et al., 1992; Sanjeevi et al., 1995). 
An association between the INS gene on chromosome llpl5 (IDDM2) with type I 
diabetes has also been found (Bell et al., 1984; Hitrnan et al., 1985; Bain et a., 1992). 
Detailed sequence analysis of the INS gene identified a polymorphic locus which 
consists of a variable number of tandem repeats, or VNTR, present within the 5' 
regulatory region (promoter) adjacent to the consensus nucleotide sequence of the INS 
gene (Lucassen et al., 1993; Bennett et al., 1995). A number of studies have suggested 
that the INS VNTR may have a biological role in the genetic regulation of insulin 
expression (Kennedy et al., 1995; Lucassen et al., 1995; Owerbach and Gabbay, 1996). 
Nevertheless, the exact functional role of how the expression of the INS VNTR may 
influence type 1 diabetes susceptibility still remains to be a subject of discussion and 
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debate. 
However, the MHC genes, and the second locus, the INS VNTR (IDDM2), cannot 
account for all of the observed clustering of disease in families (Todd, 1997). Genome-
wide searches for type 1 diabetes susceptibility genes yielded preliminary evidence for 
an association of 18 loci with type 1 diabetes (Davies et al., 1994; Hashimoto et al., 
1994) and a recent search (Mein et al., 1998) for type 1 diabetes susceptibility genes in 
families from the UK showed evidence of linkage of two loci: chromosome lOp 13-p 11 
and chromosome 16q22-16q24. These and other novel regions, including chromosome 
14q12-q21 and chromosome 19pl3-19q13, could potentially harbour disease loci (Mein 
et al., 1998). Because of the large number of markers tested, many of these putative 
regions suggestive of a genetic linkage with type 1 diabetes susceptibility may have 
occurred by chance alone. It is of interest that there is a familial linkage to different 
autoimmune diseases in the same pedigree (Becker et al., 1998), a relationship among 
different autoimmune disorders including type 1 diabetes in the same individual (Sattar 
et al., 1988; Yamato et al., 1997), and common clinical indicators of different 
autoimmune disorders (Rose 1997) might have a common biological basis in a number 
of autoimmune and inflammatory diseases. eo-localisation and overlapping of 
candidate loci in auto immune disorders, for example type. I diabetes, suggests that 
common biological pathways may be involved in the immunopathogenosis of a 
subgroup of autoimmune diabetes and other clinically diversified autoimmune diseases 
(Friday et al., 1999). 
Animal studies have provided additional evidence which support the hypothesis that 
genes in the MHC are involved in type 1 diabetes. Researchers working with the NOD 
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mouse, an animal model of type I diabetes, have identified the major locus encoded by 
the MHC and at least I 5 other regions on 11 other chromosomes that contribute to the 
risk of type 1 diabetes (Todd et al., 1991; Ghosh et al., 1993; Risch et al., 1993; Vyse 
and Todd, 1996). In short, our current understanding of exactly how genetics relates to 
type 1 diabetes is still in the formative stages. What we can say now is that the 
expression of a particular HLA gene is not by itself the cause of any autoimmune 
disease but is likely to be one of several factors that contribute to autoimmunity (Mehta 
and Palmer, 1996). 
2.5.3 Immunological factors 
An autoimmune pathogenesis for type 1 diabetes is supported by the observation that 
patients who die shortly after the onset of the disease exhibit an infiltrate of 
mononuclear cells in and around the islets of Langerhans (Gepts, 1965). In addition, the 
presence of circulating antibodies against components of islet p cells in the large 
majority of newly diagnosed type 1 diabetic patients suggests an autoimmune origin 
(Lendrum et al., 1975; Baekkeskov et al., 1982; Landin-Olsson et al, 1989). Type I 
diabetes results from cell-mediated autoimmune destruction of the P cells of the 
pancreas (Atkinson and Maclaren, 1994). Markers of the immune destruction of the p 
cell include islet cell autoantibodies (ICAs), autoantibodies to insulin (IAAs), 
autoantibodies to glutamic acid decarboxylase (GAD65), autoantibodies to the tyrosine 
phosphates IA-2 and IA-2P (Baekkeskov et al., 1982; Atkinson et al., 1986; Christie et 
al., 1992; Kaufman et al., 1992; Schott et al., 1994; Schmidli et al., 1994; Myers et al., 
1995; Lan et al., 1996; Lu et al., 1996). One and usually more of these autoantibodies 
are present in 85-90% of individuals when fasting hyperglycaemia is initially detected 
(The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997). 
ICAs, IAAs and GAD antibodies may be detected in the circulation some years before 
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the clinical onset of the disease, providing a powerful tool for individual assessment of 
subsequent risk of overt disease (Bonifacio et al, I990; Bingley et al., 1994; I997). 
These markers clearly indicate that the pathogenesis of type I diabetes involves the 
immune system. Five years after diagnosis some IS to 20% patients still show positive 
plasma antibody tests. This proportion declines only slowly thereafter, so even after 20 
years I 0% may still show circulating islet cell antibodies (Alberti and Hockaday, 1988). 
Although pancreatic ~ cell destruction has immunological associations, the mechanisms 
concerned have not yet been clearly defined. One hypothesis of the autoimmune basis 
has been proposed as follows (Atkinson and Maclaren, 1994). Autoimmunity to ~ cells 
can be initiated by one of two processes. One is an immune response against a viral 
protein that shares an amino acid sequence with a ~ cell protein (e.g. Coxsackie virus 
protein) which could result in the appearance of antiviral cytotoxic ens+ lymphocytes 
that react with self protein on the ~ cells. A second possibility could be an 
environmental insult generating cytokines and other inflammatory mediators that induce 
the expression of adhesion molecules in the vascular endothelium of the pancreatic 
islets, resulting in extravasation of circulating leukocytes and the presentation of ~ cell 
antigens from the damaged ~ cells by infiltrating macrophages to lymphocytes. 
A number of potentially relevant initiating autoantigens have been identified through 
studies of ICA, IAA and GAD. The epitopes on these antigens are often but not always 
present early in the course of the disease, prior to clinical diagnosis (Palmer et al.,l983; 
Baekkeskov et al., 1990; Rowley et al., 1992; Muir et al., 1992). T -cell reactivity to GAD 
has been found (Honeyman et al., 1993). A recent animal experiment (Yoon et al., 1999) 
has shown that the expression of GAD is required for the initiation of diabetes in NOD 
68 
mtce by usmg antisense GAD transgenic NOD mtce. The suppression of GAD 
expression in the p cell was produced by transgenic NOD mice with an antisense GAD 
transgene. The results have demonstrated that autoimmune diabetes could be prevented 
in the transgenic NOD mice with the p cell-specific suppression of GAD expression, 
whereas persistent GAD expression in the p cell in the NOD mice would result in 
diabetes. This finding may provide the benefits for developing new therapeutic 
strategies to treat this disease. A further possibility is a pancreatic P cell surface protein 
p69, to which antibodies were initially found to be directed against a sequence of 17 
amino acids in bovine serum albumin, which has led to the proposal that exposure to 
cow's milk proteins may be an environmental trigger initiating the immune attack on P 
cells (Katjalainen et al., 1992). 
Identification of the antigens responsible for initiation of the immune attack would 
permit the design of potentially specific therapies, in particular vaccination using the 
antigens themselves, relevant epitopes of these antigens or competitive peptide 
analogues that could serve to counter the immune attack. Yet, most of the antibodies 
detected so far (especially islet-cell cytoplasmic antibodies) seem only to be circulatory 
markers reflecting p cell damage and/or ongoing immune activity (WHO, 1994). 
In addition to the above described humoral components, considerable evidence now 
implicates cell-mediated immune mechanism in the pathogenesis of type 1 diabetes. 
Transplantation of pancreatic tissue from a non-diabetic monozygotic twin its diabetic 
eo-twin fails because an inflammatory infiltrate develops in the islets of Langerhans of 
the transplanted pancreas and the p cells are destroyed by the immune response of the 
diabetic recipient (Sibley et a., 1985). Other studies reported the transfer of type 1 
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diabetes from patients with type I diabetes to non-diabetic recipients by bone marrow 
transplantation (Lampeter et al., 1993; Viallettes and Maranichi, 1993). Animal studies 
showed that non-diabetic mice were converted to the diabetic ones after receiving 
injections ofT -cell subsets from the diabetic and prediabetic donor mice (Christianson 
et al., 1993). These observations strongly suggest that cytotoxic T lymphocytes are the 
effector cells in type I diabetes, and it is the cellular (T cells) rather than the humoral 
limb of the immune system that is actively and predominantly involved in creating the 
islet lesions that lead to pancreatic ~ cell destruction (Bach, 1994, Atkinson et al, 2000). 
2.5.4 Environmental factors 
Current knowledge_ of human genetics suggests that environmental factors may be 
obligatory for the development of type I diabetes. Monozygotic twins are considered 
genetically identical and the relatively low concordance rate indicates that the disease is 
not purely genetically determined and therefore, there must be non-genetic factors 
causing or promoting the onset of type 1 diabetes (Bamett et al., 1981; Olmos et al., 
1988; Kaprio et al. 1992; Kumar et al., 1993; Leslie et al. 1993; Matsuda and Kuzuya, 
1994; Kyvik et al., 1995; Dotta and Eisenbarth, 1997; Hatters1ey, 1997). Also, in the 
past 40 years the global incidence of diabetes appears to have increased at a rate 
exceeding potential changes in the genetic pool leading to diabetes susceptibility. The 
identification of environmental factors of type I diabetes is of particular importance, as 
these are potentially modifiable with the ultimate goal of disease prevention. Although 
the search for non-genetic determinants of the disease has intensified, the results have 
not yet led to a unified hypothesis of the environmental contribution to the disease 
(Mandrup-Poulsen, 1996). Most research has focused on exposure to infectious diseases 
(viral infections), nutritional factors, toxins, socio-economic status and stressful life 
70 
events. 
2.5.4.1 Viral infections 
Viruses are suspected to be causative factors in some cases of type I diabetes for at least 
three reasons. Firstly, it was noted more than 70 years ago, that there appears to be a 
seasonal incidence in the onset of acute type I diabetes with a peak in the autumn, 
which has now been confirmed world wide (Green and Gale, I993; Karvonen et al., 
I996; Lounamaa, I996; Sekikawa and LaPorte, 1997; Zhao et al., I999). Diseases with 
significant seasonal incidence are often caused by viral infections (Yoon, I996). There 
have also been many reports of a viral infection preceding or coinciding with the onset 
of type I diabetes (Yoon and Park, I993). Development of the disease after infection 
with rubella (congenital rubella syndrome), has for many years been known to 
predispose the individual to diabetes (Szopa et al., I993). Yoon and colleagues (1979) 
isolated a diabetogenic variant of the Coxsackie 84 in a newly diagnosed and deceased 
diabetic patient, and induced diabetes in inoculated mice. Secondly, epidemiological 
studies find that fetal exposure to enteroviruses increase the risk of the childhood onset 
type I diabetes (Dahlquist et al., 1995a; I995b; Hyoty et al., 1995). Examining newly 
diagnosed, recent-onset patients with type I diabetes for the presence of virus-specific 
IgM antibodies have also suggested a role for viruses in the aetiology of type I diabetes 
(Szopa et al., I993; Hyoty et al., I995). Mumps virus was one of the first viruses to be 
associated with human type I diabetes and mumps-related type I diabetes may have an 
autoimmune basis where the virus may induce an autoimmune response against ~ cell or 
might intensify a pre-existing autoimmune attack (Yoon, I997). Thirdly, in animal 
studies, several viruses have been demonstrated definitely to cause diabetes. These 
include encephalomycarditis (EMC) virus (Craighead and McLane, I968), Coxsackie 
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B4 virus (Y oon et al., 1978), Kilham 's rat virus (KRV) (Guberski et al. 1991 ), and 
rubella virus (Rayfield et al., 1986), while other virus, such as retrovirus and bovine 
viral diarrhea-mucosal disease virus are suspected of causing diabetes in NOD mice and 
cattle respectively (Suenaga and Yoon, 1988; Tajima et al., 1992). 
Virus may be involved in the pathogenesis of type 1 diabetes in at least two different 
ways. First of all, viruses may directly infect and destroy insulin producing pancreatic p 
cells, or by an autoimmune response due to a cross-reactivity of viral and islet p cell 
antigens, resulting in clinically overt disease (Y oon, 1996; Dotta and Eisenbarth, 1997). 
Alternatively, other diabetogenic viruses may alter the expression by p cells of potential 
autoantigens or other immune molecules, or induce a general immune response that is 
misdirected against the P cells (Y oon, 1997). Some of the major viruses implicated in 
causing type I diabetes in humans and animals are shown in Table 2.4a (RNA viruses) 
and Table 2.4b (DNA viruses). 
In marked contrast to the above potential diabetogenic viruses, some others such as 
lymphocytic choriomeningitis virus (LCMV) (Oldstone, I988; Dyrberg et al., I988) and 
mouse hepatitis virus (MHV) (Wilberz et al., I991 ), can protect against the development 
of autoimmune type I diabetes in the spontaneously diabetic BB rat and NOD mouse. 
However, the mechanisms for these protective effects are still not known although 
various possibilities have been proposed. For example, neutralizing antibodies might be 
raised against the non-diabetogenic, protective viruses (i.e. EM C-B), and crossreact with 
and destroy the diabetogenic viruses (i.e. EMC-D) (Notkins and Yoon, I983). Another 
possible mechanism proposed was that some viruses (i.e. LCMV) might infect and 
72 
Table 2.4a. RNA Viruses associated with the development of type 1 diabetes in 
humans and animals 
Virus Host Involvement of Reference 
genetic factors 
1. Coxsakie B Mice Yes Yoon et al., 1978 
Monkey Yes Yoon et 1., 1986 
Humans Not determined Gamble et al., 1969; 
Yoon et al., 1979; 
Jensen et al., 1980 
2.Encephalomyocarditis Mice Yes Craighead and McLane, 1968; 
(EMC) virus Yoon et al., 1980 
Hamsters Yes Sugawara et al., 1991 
3. Mengovirus Mice Yes Yoon et a., 1984 
4. Foot-and-mouth Pigs, cattle Not determined Barboni et al., 1966 
disease virus 
5. Retrovirus Mice Yes Nakagawa et al., 1992 
Humans Not determined Hao et al., 1993 
6. Rubella Hamsters Not determined Rayfield et al., 1986 
Rabbits Not determined Menser et al., 1978 
Humans Not determined Ginsberg-Fellner et al. 1984 
7. Bovine viral Cattle Not determined Tajima et al., 1992 
diarrhoea-mucosal 
disease viruses 
8. Mumps virus Humans Yes Gamble, 1980; Helmke et al., 1980 
9. Reovirus Mice Yes Onodera et al., 1978; 1981 
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Table 2.4b. DNA Viruses associated with the development of type 1 diabetes in 
humans and animals 
Virus Host Involvement of Reference 
genetic factors 
1. Kilham's rat virus Rats Yes Guberski et al., 1991 
2. Cytomegalovirus Humans Not determined Ward et al., 1979; 
(CMV) Pak et al. 1988; 1990 
3. Epstein-Barr virus Humans Not determined Chikazawa et al., 1985; Sairenji et 
al., 1991; Parkkonen et al., 1994 
4. Varicella zoster virus Humans Not determined Jali and Shankar, 1990 
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deplete a subgroup of CD4+ lymphocytes, which could inhibit the immune responses 
(Oldstone, 1990). 
2.5.4.2 Nutrients 
The association between type 1 diabetes and breast-feeding has been extensively studied 
since Borch-Johnsen et al. (1984) found evidence that a short duration of breast-feeding 
during infancy seemed to be associated with an increased risk of developing type 1 
diabetes. Some studies have confirmed this link (Mayer et al., 1988; Blom et al., 1989; 
Waldhoer et al., 1997), whereas others (Kyvik et al., 1992; Samuelsson et al., 1993) 
were unable to do so. A very recent prospective study failed to find the positive 
association between breast-feeding and development of islet autoimmunity (Couper et 
al., 1999). In general, the associations described have been weak and, even if causal, 
could explain the development of diabetes in only a limited number of cases. 
Furthermore, changes in breast-feeding habits over time and the possibility of recall 
biases in such case-control studies are potential confounders that are difficult to exclude 
(Green et al., 1997). The possible association between reduced breast-feeding and type 1 
diabetes risk may point to an etiological role for cow's milk protein (CMP). Antibodies 
against cow's milk (CM) are much more prevalent and found at higher titres in children 
with recent-onset type 1 diabetes than in control subjects (Krujalainen et al., 1992; 
Verge et al., 1994). It has been suggested that the increased risk of type 1 diabetes 
among children with only brief exposure to breast-feeding might be explained by early 
introduction to a protein that triggers the immune destruction of the p cells (Robinson et 
al., 1993). Dahl-Jorgensen et al. (1991) have shown a strong linear correlation between 
the incidence of the disease and cow's milk consumption in different countries and Fava 
et al. ( 1994) demonstrated a significant association between the incidence rates and 
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cow's milk and cheese consumption in nine regions of Italy. Several epidemiological 
studies suggest that early CM exposure is a risk factor for type 1 diabetes in humans 
(Scott et al., 1990; 1996; Gerstein, 1994; Gerstein and V anderMeulen, 1996). Although 
this evidence cannot be used directly to distinguish between the possibility of a 
diabetogenic effect of early CM exposure and a protective effect of breast feeding, a 
multivariate analysis of data from a large Finnish case-control study (Virtanen et al., 
1993) indicated that all of the association with breast feeding was explained by its 
correlation with CM exposure. Thus it seems that exposure to CM proteins, and not the 
protection by breast-feeding, is important for the development of type 1 diabetes 
(Akerblom and Knip, 1998). It has been hypothesised and tested that the limited amino 
acid homologies between bovine serum albumin (BSA) and the ICA69 islet autoantigen 
may contribute to the development of type 1 diabetes (Martin et al, 1991; Katjalainen et 
al., 1992; Pietropaolo et al., 1993). An American group (Atkinson et al., 1993) has been 
unable to demonstrate a proliferative T-cell response to either BSA or ABBOS (a 17-
amino-acid BSA peptide), which suggests that this area requires further investigation. 
On the contrary, the Toronto group demonstrated significantly higher proliferation 
responses of peripheral blood mononuclear cells to BSA and ABBOS peptide in patients 
with newly diagnosed type 1 diabetes than in non-diabetic children and adults (Cheng et 
al, 1994; Miyazaki et al., 1995). Furthermore, the reactivity was lower in patients with 
long duration of type 1 diabetes, suggesting that increased cellular reactivity to BSA and 
ABBOS is related to the onset of the disease. Constituents of CMP may, at least, be one 
of several possible factors initiating p cell destruction. Recently, cow's milk protein 
variants, P-casein A 1 variant and P-casein (A 1+ B), (EIIiott et al., 1999) have been shown 
to be positively associated with the incidence of type 1 diabetes. This study (EIIiott et 
al., 1999) suggests that not only the role of total milk consumption or its time of 
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introduction into the weaning diet, but also the role of individual milk protein variants 
should be taken into consideration in the aetiology of type I diabetes, whilst a 
prospective study denied the association between the cow's milk and islet autoimmunity 
(Couper et al., 1999). However, another very recent Finnish study (Virtanen et al., 2000) 
supports the hypothesis that high consumption of cow's milk during childhood can be 
diabetogenic in siblings of children with type 1 diabetes, particularly in these bearing 
the highest risk HLA DQB 1 *0302 and *02 haplotypes. 
In the BB rat and NOD mouse, other food components have been shown to affect the 
development of diabetes. The source of dietary protein (milk protein) seems to be the 
most important diabetogenic factor (EIIiott and Martin, 1984; Issa-Chergui et al 1988). 
Diabetes occurs in about 70% of diabetes-prone rats fed unrefined, natural ingredients, 
but in fewer than 20% of those eating a diet containing simpler, refined products such as 
casein or hydrolysed casein, corn oil, starch and micronutrients (Bieri et al., 1977). 
Wheat gluten exposure and the development of type 1 diabetes have been linked 
together in animal studies (EIIiott and Martin, 1984; Coleman et al., 1990; Hoorfar et 
al., 1993). Other dietary factors such as soya-bean flour, alfalfa and skimmed milk have 
also been studied in animals (see reviews of Yoon, 1997 and Akerblom and Knip, 
1998). 
A report from Iceland suggested that exposure to nitrosamines in women at the time of 
conception may increase the risk of the disease in their children, particularly males 
(Helgason and Jonasson, 1981) and this finding was confirmed later in their own animal 
experiment (Helgason et al., 1982). Some support for this concept has come from 
Sweden (Dahlquist et al., 1990; 1991 ), and a Finnish study indicated that as dietary 
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nitrite increased so did the odds of developing type 1 diabetes (Virtanen et al., 1994a). 
A study from Montreal, Canada found no evidence that nitrosamines in the diet were 
associated with type 1 diabetes (Siemiatycki et al., 1989). Two ecological studies 
(Kostraba et al., 1992; Parslow et al., 1997) have found an association between the 
nitrate content of drinking water and incidence of childhood diabetes. These findings 
need wider confirmation and do not explain the high incidence of type I diabetes in 
populations with less exposure to nitrosamines than in Iceland. Recent studies from the 
Netherlands (van Maanen et al., 1999; 2000) and Sardinia, Italy (Casu et al., 2000) can 
not confirm this association. 
Another very recent study (Muntoni et al., 2000) demonstrated that the incidence of type 
1 diabetes varied worldwide according to dietary patterns, i.e. that energy from animal 
sources was positively associated and energy from vegetable sources was inversely 
associated with diabetes incidence. 
2.5.4.3 Cold environment 
Several reports have demonstrated a strong gradient in the risk of type 1 diabetes, with 
incidence increasing with the distance from the equator (Diabetes Epidemiology 
Research International Group, 1988; Matthews et al., 1990; Nystrom et al., 1992). 
These, therefore, suggest a significant association between the incidence of type I 
diabetes and the average yearly temperature, latitude or hours of sunlight. A consistent 
seasonal pattern being found worldwide with peak incidence in autumn and winter also 
implies the importance of cold weather (Karvonen et al., 1993; Lounamaa, 1996). The 
underlying mechanism is not clear but it may be related with the pattern of viral 
infections or other unknown factors. 
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2.5.4.4 Socio-economic status 
Conflicting results have been reported regarding the influence of socio-economic status 
on risk of developing type 1 diabetes. In the Copenhagen area of Denmark, Christau et 
al. (1977) found a higher incidence of type 1 diabetes in regions with relatively low 
average incomes. In northern England, Crow et al. (1991) found a highly significant 
trend of decreasing incidence with decreasing level of deprivation, whereas Siemiatycki 
et al. ( 1988) found the opposite trend in Montreal, Canada. A Swedish case-control 
study (Blom et al., 1989) found a positive but weak association between type 1 diabetes 
and low educational level and income and a similar result was found in northern 
England showing a highly significant trend of decreasing incidence with decreasing 
level of deprivation (Crow et al., 1991). A study from Scotland showed significantly 
higher rates in the rural compared with urban areas (W augh, 1986). Patterson et al. 
( 1996) from Northern Ireland reported that areas with a high population density and the 
most material deprivation were observed to have the lowest incidence rates. Staines et 
al. ( 1997) also found that incidence rates were significantly lower in areas of high 
population density and with many overcrowded houses in Yorkshire, whilst studies 
from Norway (Joner and Sovik, 1989) and Northern Italy (Bruno et al., 1993) found 
higher incidence rates in urban areas. Overall, studies of the relationship between 
indicators of socio-economic status and type 1 diabetes are difficult to interpret. As 
proposed by Blom et al. (1989), any such associations may be explained by unknown 
events or life style factors that influence both the risk of developing type 1 diabetes and 
socio-economic status, and the "Hygiene hypothesis" may be one of the possible 
explanations (Kolb and Elliott, 1994). 
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2.5.4.5 Stressful life events 
Several studies have discussed the possibility that psychological factors and stressful 
life events contribute to the pathogenesis of type 1 diabetes, and some have provided 
confirmatory evidence, although the link appears rather weak (Robbins and Fuller, 
1985; Siemiatycki et al., 1989; Hagglof et al., 1991 ). It is possible that stressful life 
events and psychological distress may, through elevated stress-hormone levels, increase 
the demand for endogenous insulin production and thereby accelerate the decline 
towards clinical overt diabetes in individuals with ongoing ~ cell destruction. 
2.5.4.6 Other environmental factors 
Apart from the above mentioned risk factors, there are many other environmental 
factors being proposed and studied. Some of them may also play an important role in 
the development of the disease and they are listed in Table 2.5. 
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Table 2.5 Certain proposed environmental risk factors for childhood type 1 
diabetes in literatures 
Risk factors 
I. Maternal-child blood group incompatibility 
2. High growth rate 
3. Excessive weight gain in pregnancy 
4. Amniocentesis 
5. Maternal age (over 35 years) 
6. Short gestational age 
7. Caesarean section 
8. Pre-eclampsia 
9. Heavier birth weight 
I 0. Longer birth length 
II. Large-for-gestational age 
I2. Neonatal jaundice 
I3. Frequent infections 
I4. Vitamin D deficiency 
I5. Zinc deficiency 
I6. Coffee 
I7. Tea 
I8. Fats 
I9. Toxins (alloxan, streptozotocin) 
20. Vacor (rodenticide) 
21. Vaccination 
22. Rainfall 
Reference# 
I,2 
3 
4 
4 
I, 4-9 
IO 
IO 
9,IO 
ll 
I2,I3 
I2,I3 
9,I4 
2,9, I5 
I6 
I7 
I8-20 
20 
2I-23 
24-26 
26,27 
I5,28-3I 
32 
Reference #: I: Dahlquist and Kiillen, I992; 2: The EURODIAB Substudy 2 Study 
Group, 2000; 3: Blom et al., I992; 4: McKinney et al., I997; 5: Blom et al., I989; 6: 
Patterson et al., I994; 7: Soltesz et al., I994; 8: Douek et al., 1999; 9: The EURODIAB 
Substudy 2 Study Group, I999b; IO: Dahlquist, I997; II: Metcalfe and Baum, I992; 
I2: Dahlquist et al., I996; l3:Dahlquist et al., I999; I4: Rami et al., I999; I5: Blom et 
al., I99I; I6: The EURODIAB Substudy 2 Study Group, I999a; I7: Haglund et al., 
I996; I8: Tuomilehto et al., I990; I9: Bain et al., I990; 20: Virtanen et al., I994b; 2I: 
Scott and Marliss, I99I; 22: Issa-Chergui et al., I988; 23: Akerblom and Knip, I998; 
24: Wolff, I993; 25: Like and Rossini, I976; 26: Assan and Larger, I993; 27: Karam et 
al., I980; 28: Ciassen and Classen, I996; 29: Classen, I996; 30: Classen and Classen, 
I997; 3I: Qin and Singh, I997; 32: Lee et al., I993. 
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Environmental risk factors can be classified into the following categories, initiators, 
promotors, precipitators and unclassified. Initiating factors could be defined as factors 
that start the pathogenic process by causing the initial damage of the ~ cell thereby 
causing the release of ~ cell antigens, such as cow milk and viral infections. Promotors 
could then be subsequent exposure(s) that increase the rate of self-perpetuation, for 
example, by increasing cytokine levels (Dahlquist, 1993). A precipitating event would 
in principle be an event that increases the peripheral need for insulin thereby disclosing 
the ~ cell damage and turning the disease into a symptomatic or clinically overt 
condition. Stressful life events, high growth rate and cold environment could be 
classified as promotors and/or precipitators. Finally, some of the non-genetic risk factors 
may play their roles by both of the above-mentioned ways or through some other, as yet, 
unknown mechanisms. Further investigations of these environmental factors' role by 
epidemiological studies are needed. 
2.5.4.7 Protective factors 
There is evidence from animal models (Schwimmbeck et al., 1988; Leiter et al., 1990; 
Wilbertz et al., 1991) and epidemiological case-control studies (Gibbon et al., 1997; 
Mckinney et al., 2000) that exposure to infections in early life protects against the 
development of type I diabetes - the so-called 'hygiene hypothesis' (Kolb and Elliot, 
1994). This hypothesis is consistent with the epidemiological characteristics of the 
disease which implicate infections (Kolb and Elliot, 1994; Gibbon et al., 1997) and 
show a significantly lower incidence in densely populated and deprived areas (Patterson 
et al., 1996; Karvonen et al., 1997; Staines et al., 1997) and a seasonal variation of 
month of birth (Rothwell et al. 1996). Animal studies suggest that chronic exposure to 
infections in early life may modify the lymphocytic response to late immunological 
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challenges (Schwimmbeck et al., 1988) and lead to the stimulation of immunoregulatory 
cytokine production (Bach, 1994) which protects the body against autoimmune 
pathogenesis and hence against the development of type 1 diabetes (Rabinovitch et al., 
1995). 
A recent large European case-control study (The EURODIAB Substudy 2 Study Group, 
1999b) shows that being a firstborn child, having a low birth weight or a short birth 
length are protective factors. Pre-school day-care attendance has also been reported to 
have a protective effect (The EURODIAB Substudy 2 Study Group, 2000). 
2.6 Pathogenetic mechanism of~ cell destruction 
Most of the pathogenetic models proposed for type 1 diabetes are based on an 
autoimmune destructive mechanism. There is a large body of evidence (Patterson et al., 
1988; Tisch and McDevitt, 1996; Gray, 1999) indicating that in most cases of type 1 
diabetes ~ cell destruction began several years before the clinical onset of diabetes. The 
immune markers of humoral or cellular autoimmune activity appear many years before 
disease manifestation (Bingley et al., 1993; Bingley and Gale, 1993; Bonifacio et al., 
1995; 1996; Greenbaum and Palmer, 1996; Christie, 1996; McEvoy et al., 1996; 
Atkinson and Bowman, 1996). Some of the immune markers typically found in pre-
diabetic individuals may also disappear, as shown in prospective identical twin studies 
(Millward et al., 1986; Tun et al., 1994). The initiation of an autoimmune process may 
operate at different levels and affect either the ~ cell antigen itself, the antigen 
presentation process or the regulation of T- and B-cell interactions (Dahlquist, 1998). 
Thus, a risk factor identified through epidemiological studies may induce autoimmunity 
by an antigen mechanism by molecular mimicry, alteration of a ~ cell antigen or 
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exposure of a previously sequestered antigen. 
The model of the pathogenetic mechanism ~ cell destruction proposed by Mandrup-
Poulsen (1996, 1998) is that environmental risk factors (such as viruses, chemicals, and 
nutrition) trigger an inflammatory reaction in the islets of Langerhans in genetically 
susceptible people, which results in ~ cell destruction and eventually the clinical onset 
of type I diabetes. These environmental triggers initiate the process by causing 
restricted and focal damage to ~ cells; this leads to the release of ~ cell antigens that 
were either modified or have previously been 'hidden' from recognition by the immune 
system. These antigens are taken up by macrophages or dendritic cells, or both, or later 
by antigen presenting cells recruited to the islets in which focal ~ cell damage has taken 
place. After processing and presentation of ~ cell antigen, and provision of appropriate 
soluble and surface membrane second signals, specifically reactive T helper cells will be 
activated to transcribe cytokine genes. The synthesised and released cytokines recruit 
both antigen specific and non-specific mononuclear cells to build up the insulin 
infiltrate and activate endothelial cells. Recruited macrophages are stimulated by 
interferon y (IFN y) to produce interleukin (IL) I and tumour necrosis factor (TNF) a, 
which in synergy with IFN y lead to ~ cell destruction via the induction of toxic nitric 
oxide radicals and pathways that activate apoptosis (programmed cell death) specific to 
~cells. 
A recent paper (Gray, 1999) presents a hypothesis called the MIAC theory - 'MHC-
based Inhibition of Autoreactive Cells', regarding the aetiology of type I diabetes. It 
suggests that autoimmunity is normally prevented by an inhibitory or negative signal 
delivered by MHC molecules, and in type I diabetes it is the inability of ~ cells to 
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deliver sufficient negative signal from MHC Class II that drives the intriguing 
underlying autoimmune process. The author of this paper declared that the so called 
MIAC theory appeared to fit the 'facts' of type I diabetes better than other current 
hypothesis, but it still needs to be tested. In Matzinger's view (I998), there may be 
nothing wrong with the immune response in many cases of auto-immune diseases. Her 
"Danger Model" ( I994) has indicated that an immune response is initiated by tissue 
injury rather than by the recognition of non-self. When a cell dies messily, or becomes 
stressed or damaged, an immune response is initiated whatever the damage is caused by 
a pathogen or by an innate defect. Her explanation of the cause of diabetes was that the 
antibodies and cytokines released during an immune response are highly potent 
molecules that can cause enormous cell death in some tissues, which are more sensitive 
to certain cytokines than others. This immune response could be directed against a self 
component, or strictly against a pathogen, or a cross-reaction made by individuals with 
certain MHC haplotypes, but this response could be made by many individuals without 
destroying their islets. However, this response in diabetes may be shifted to a class that 
destroys the islets, which are sensitive to certain cytokines such as TNF and IFNy. 
Another recent paper (Bruining and Batstra, I999) reviews the literature and suggests 
that there is increasing evidence for type I diabetes being a congenital or perinatal 
disease, resulting in autoimmunity. For example, polymorphisms of the promotor region 
of the insulin gene may be correlated to altered insulin content in~ cells early in life. In 
humans the endocrine pancreas is formed from pancreatic ducts in a continuous process 
throughout the second trimester of pregnancy. The extraordinary heterogeneity of adult 
islets is likely to be a reflection of such a repetitive development. Specific 
developmental programming continues until birth and in the first months of life, e.g. 
85 
when many redundant pancreatic islets become apoptotic. After birth these intricate 
processes may easily be perturbed by exogenous conditions, foreign proteins or toxins. 
These might form the basis of type I diabetes being congenital. 
2.7 Summary of the epidemiology of type 1 diabetes 
The characteristics of the epidemiology of type I diabetes can be briefly summarised as 
follows: 
• Very large geographical variations worldwide in incidence with a high incidence in 
Europe and low in Asia. 
• The incidence is increasing in many parts of the world. 
• The incidence has a weak north-south gradient pattern. 
• The clinical manifestation of the disease generally shows a seasonal pattern with 
fewer cases diagnosed in the summer months. 
• A positive family history is a risk factor and the risk is higher if the child's father 
rather than the mother has type I diabetes, but 90% of all newly diagnosed diabetic 
children have no family history of the disease. 
• Both genetic and non-genetic (environmental) factors play important roles in the 
aetiology of the disease. Among the most strongly suspected environmental agents 
are certain viruses, enteroviruses and Coxsackie B viruses in particular, and 
exposure early in life, possibly in utero, may contribute to the aetiology of type I 
diabetes. Some nutritional factors, such as short duration of breast-feeding and early 
exposure to cow's milk protein, appear to be related to an increased risk of type I 
diabetes. 
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SUBJECTS AND METHODS 
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CHAPTER 3. SUBJECTS AND METHODS 
3.1 Cornwall and Plymouth Children's Diabetes Register (CPCDR) 
3.1.1 Diabetes register 
Monitoring diabetes incidence is critical for our understanding of the aetiology and 
natural history of the disease and for evaluating preventive measures (LaPorte et al., 
1993). The standard way of monitoring incidence and prevalence for type 1 diabetes is 
by setting up a registry. Registries require unbiased case ascertainment that is as 
complete as possible in order to determine accurately the number of cases or rate of 
diabetes in the community. Where existing methods are inadequate and are assumed to 
give a point estimate not close enough to the truth, methods such as "capture-recapture" 
can be very helpful and are recommended (LaPorte et al., 1992; 1993; WHO, 1994). 
The registry can be prospective (collecting cases as they occur) or retrospective 
(collecting cases after they have occurred). As a surveillance system, the goal of 
diabetes registries is actively to identify and count as close to 100% of actual cases of 
type 1 diabetes as possible. A secondary source of case ascertainment is needed, which 
should be independent of tbe primary source. It is usually much less costly to employ 
two or more incomplete sources for case ascertainment than to try to count all cases 
from a single source. 
When two sources are available for case ascertainment, the capture-recapture approach 
can be applied (Figure 3.1). The capture-recapture technique was originally developed 
by ecologists studying the sizes of animal populations. In the wild it is not possible to 
conduct a census, except of tbe very large animals. Instead, an area is defined and a 
sample of the species of interest is obtained. Those captured are marked and released. 
Some time later the process is repeated. The proportion of those caught the second time 
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Figure 3.1 The two-source capture-recapture method for case ascertainment 
Sample I Sample 2 
The following equations are used for estimating the number of cases in a defined area 
using two-source capture-recapture method based on the above figure. 
(M+ I)(n+ I) 
N= -I, 
(m+ I) 
N= estimate of number, 
M= number in first sample (those marked), 
n = number in second sample, 
m =number of "marked" items in both samples, 
Var(N) 
(M+ I)( n+I )(M-m)( n-m) 
(m+I)2 (m+2) 
95% confidence interval= N ± 1.96 x )var(N) . 
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who are marked can be used to give an estimate of the entire population. This is only a 
reasonable procedure if the two sweeps can be assumed to be independent, that is if the 
probability of finding an individual animal in a sweep is not affected by finding it, or 
failing to find it, in an earlier sweep. This procedure can be applied to studies in human 
populations where different sources are used to identify cases. 
With this approach the proportion of cases not counted can be estimated and the correct 
frequency of the disease can be calculated (LaPorte et al., 1992; 1993). However, there 
are limitations to the capture-recapture method in situations where the primary and 
secondary sources are strongly interrelated or the quality of the basic data is very poor 
(WHO, 1994). 
The calculations of the two-source capture-recapture method have been programmed in 
an epidemiological software package, Epi Info (Dean et al., 1994). Version 6 of this 
package has been employed in this thesis. An example of the calculations of the method 
was given in Appendix I. 
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3.1.2 Cornwall and Plymouth Children's Diabetes Register (CPCDR) 
3.1.2.1 General description 
There have been several regional diabetes registers established in the UK (for example, 
Bingley and Gale, 1989b; Burden et al., 1989; Staines et al., 1993; and Patterson et al., 
1996). They have provided valuable information allowing the descriptive epidemiology 
of type 1 diabetes in these regions. Until the beginning of this thesis, however, there 
was no such register in Devon and Cornwall, and little detailed epidemiological 
information was, therefore, available about the disease's occurrence in this region. It 
was therefore decided to set up such a register in order to derive accurate 
epidemiological information of the disease in this region. I received my PhD 
studentship in order to set up this database, later to become known as the "Cornwall and 
Plymouth Children's Diabetes Register" - CPCDR. With the help of a part-time research 
nurse, I have collected information on children with type I diabetes from all possible 
sources, diabetic clinics through diabetes specialist nurses (DSN), hospital audit offices, 
local regional health authorities, and GP's surgeries. The detailed methods used for data 
collection and the raw data are described later in this chapter. The objective of the 
CPCDR was to identify all incident cases in the well-defined population, the Cornwall 
& Isles of Scilly and former Plymouth Health Authority region including the whole of 
the South Hams District, thereby providing reliable and standardized estimates of the 
incidence of the disease by area, sex, age, calendar time and by other categories for 
intra- and inter-population comparisons. Map 3.1 shows the position of the study region 
in England & Wales. I have input all the data originally on to an Excel spreadsheet and 
later it was converted into an Access database. Each patient was assigned an 
identification number for data manipulation and management. The register is an on-
going resource for epidemiologists, clinicians and healthcare planners. It has enabled 
analytical studies to be carried out on the aetiology, natural history, long-term 
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Map 3.1 Position of the study region in the map of England & Wales 
London 
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complications of the disease and the provision of health service. The establishment and 
continued operation of the register have obtained ethical approvals from the three Local 
Research Ethics Committees in the region (Cornwall and Isles of Scilly, Plymouth and 
Torbay). 
Population-based registers from across the world are providing epidemiological data for 
a global collaborative project, the World Health Organisation (WHO) Multinational 
Project for Childhood Diabetes (DIAMOND) for studies on possible variations in the 
clinical characteristics of the disease and to examine genetic as well as environmental 
determinants of diabetes in childhood and the complex interactions between genetic and 
environmental factors in the cause and pathogenesis (WHO DIAMOND Project Group, 
1990; Karvonen et al., 1993). More than 180 centres in over 70 countries world wide 
have submitted case registrations to the WHO DIAMOND Project (WHO, 1995; 
Sekikawa and LaPorte, 1997). A recent analysis of the WHO DIAMOND Project 
described the epidemiology of the disease in 19,013 cases reported from 99 centres of 
50 countries (Karvonen et al., 2000) and reported an even larger global variation in 
incidence (365 times difference between Finland and China). A similar network in 
Europe - the EURODIAB-ACE Study has also been set up (Green et al., 1992; The 
EURODIAB Substudy 2 Study Group, 2000). The CPCDR is also part of the WHO 
DIAMOND Project (Karvonen et al., 2000) (our centre code: 184). 
The CPCDR contains details of all children diagnosed in the far South West of England 
with type I diabetes from I 51 January 1975 . .The geographical area of the study was 
defined by the boundaries ofthe Cornwall & Isles of Scilly and former Plymouth Health 
Authorities including the whole South Hams District. Map 3.2 shows the study area by 
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Map 3.2 The local government district boundary of the study region of the CPCDR 
FD 
EX: Caradon 
EY: Carrick 
EZ: Kerrier 
FA: North Cornwall 
FB: Penwith 
FC: Restormel 
GB: South Hams 
GF: West Devon 
I>-- Isles ofScilly 
Plymouih(CA) 
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administrative District, consisting of the administrative counties of The Cornwall & 
Isles of Scilly and part of Devon (Southwest Devon) covering approximately 5,200 km2 
(520,000 hectares) in area and supporting 818,000 people including 158,000 children 
under 16 years of age as of 1991 census (Office Of Population Censuses & Surveys, 
1992a; 1992b ). 
3.1.2.2 Case definition and eligibility 
Newly diagnosed children, satisfying the Diabetes Epidemiology Research International 
(DERI) standard criteria for the diagnosis of childhood diabetes (Rewers et al., 1988), 
which was standardised throughout the global framework by WHO DIAMOND Project 
(WHO DIAMOND Project Group, 1990; WHO, 1995), were recorded retrospectively to 
1975 and prospectively from 1996 onwards. Data analysed for this thesis ran from 
l/1/1975 to 31112/1996, a total of 22 years. The DERI diagnostic criteria are: (a) 
diagnosis of diabetes by a physician; (b) daily insulin injections at the time of 
registration; (c) age at first insulin administration less than 15 years and (d) residence by 
the patient in the area of registration at the time of first insulin administration. In the 
CPCDR, all children diagnosed under 16 years of age and usually resident in the 
Cornwall & Isles of Scilly and former Plymouth Health Authority region including the 
whole South Hams District at the time of diagnosis were eligible. The time of diagnosis 
was taken as the date of the first insulin injection, an objective date sufficiently close to 
the date of onset of symptoms to be used as a global standard (LaPorte et al., 1985; 
WHO, 1995). Children with other kind of diabetes, such as cystic fibrosis, 
pancreatectomy, p Thalassaemia and steroid treatment were excluded, as diabetes in 
these children is a different entity, arising from generalised pancreatic destruction 
(secondary diabetes), rather than a specific auto-immune P-cell destruction. 
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3.1.2.3 Case finding 
Cases were identified from the following sources. Firstly, all of the diabetologists in the 
region were contacted, and all agreed to participate. Subjects were ascertained from 
their clinic records and from the records of Diabetes Specialist Nurses (DSN) attached 
to the clinics. At each clinic a list of patients was drawn up, and their diabetic notes or 
hospital notes were sought. When found they were abstracted on to a standard form 
(Appendix 2). 
Secondly, lists of all admissions to the two main hospitals, Derriford and Treliske, from 
1975 to date, were obtained from the audit offices of the two major hospitals in the 
region, where a discharge diagnosis of diabetes (International ·classification of Disease 
9 code 250) was recorded for a person aged under 16 years. Lists were also obtained of 
all the diabetic children who underwent the retinal screening in Torbay hospital. For 
each new subject identified in this way the diabetic notes or hospital notes were sought. 
Thirdly, all of the lead general practitioners in each community clinic (surgery) in the 
study region were approached with a letter (Appendix 3a) and a form (Appendix 3b), 
with reply-paid envelopes, and asked to provide a list of all patients known to have type 
1 diabetes, diagnosed under the age of 17 years, on their practice lists. Here, the age 
limit was extended to under 17 years just to ensure that all these under 16 years of age 
were obtained. Telephone contact was made with non-respondent surgeries' lead GPs or 
their practice managers after four weeks. Returns were collated and cross-checked with 
the pre-existing register and all potential new cases were followed up in the hospital 
medical records for confirmation of the information. If no match could be made, 
information about the place where the diagnosis was originally made was obtained, and 
the notes located and abstracted. Permission was obtained to check hospital notes held 
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in The Plymouth Medical Records Library (Bush Park, Plymouth), and most notes were 
investigated and abstracted there. Hospital notes held in Treliske Hospital were checked 
in the same way. 
Therefore, the primary source of case ascertainment for the CPCDR was from hospital 
clinic attendance. Diabetologists, paediatricians, and diabetes specialist nurses involved 
in the treatment of diabetes in children were asked to provide cases to the study. The 
secondary source of ascertainment was from general practitioners in all clinics and 
surgeries in the study region. Following a patient's information form (Appendix 3b), 
patient's name, sex, address at diagnosis, postcode at diagnosis, date of diagnosis, date 
of first insulin injection, date of birth, address at birth, postcode at birth and source of 
ascertainment were noted. 
All the patients obtained from all these sources were sent a letter (Appendix 4a) with a 
form (Appendix 4b) and a self-addressed and reply-paid envelope requesting that they 
(or their parents) provide information. about their diabetes. This information was also 
checked against the existing register to ensure that data were as accurate as possible. 
Systematic checks were applied to validate the register, filtering errors and removing 
duplicate registrations. Validation was performed by three researchers, Dr Millward (my 
supervisor), Liz Stenhouse (research nurse) and myself. The patients' postcodes in 
addresses both at diagnosis and birth, were checked against The postal Address Book for 
the South West published by The Royal Mail in 1997. The Patient Administration 
System (PAS) in Derriford hospital was also employed in the process of validation. Any 
ambiguities of eligibility were resolved by direct inspection of the hospital or diabetic 
notes. 
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3.1.2.4 Allocating events to areas 
For this thesis, postcodes were used to link the address of each case at diagnosis and at 
birth to counties, districts, wards and enumeration districts (ED). Postcodes were 
developed by the Royal Mail during the late 1960's as an aid to the delivery of mail. 
Postcodes cover the entire United Kingdom. The PC2ED programme was used to link 
the postcodes to EDs. The PC2ED program is on the Internet of Manchester 
Information & Associated Services at the University of Manchester 
(http://mimas.ac.uklregn.htrnl), can only be used as registered users. It provides a grid 
reference (National Northing and Easting) for each postcode, and a Small Area Statistic 
code (SAS code) when a postcode was put into the programme either by simple or batch 
mode. The SAS code is used as the basic area] unit for the census of England and 
Wales. The code provides a hierarchical summary of the geographical location for each 
spatial unit. The full SAS code refers to the smallest area] unit, an enumeration district 
(ED), which were eo-terminus with and aggregated to form an electoral ward. The 
electoral wards aggregate to form local government districts and finally to one of the 55 
administrative counties in England and Wales. The example in Figure 3.2 shows EDOI 
in St. Germans ward (FZ), Caradon district (EX), Cornwall county (I 6) is assigned a 
SAS code of 16EXFZO I. 
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Figure 3.2 An example of the spatial hierarchy of census based areal units 
Cornwall &Isles of Scilly 
16 
99 
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3.2 Population data 
Population estimates used in this study were the 1981 and 1991 censuses of the UK 
(Office of Population Censuses and Surveys, 1982a; 1982b; 1992a; 1992b ). SASP AC 
software system and the Chadwick Healey 1991 Census CD-ROM were also used to 
retrieve population figures in more detail at ward and ED levels from the 1981 and 1991 
census data. Because the mid-year population figures for the study area were not 
directly available, the mid-year populations for each year of the study period from 1975 
to 1996 were estimated by the linear interpolation method based on the aforementioned 
two decennial census data. This mid-year population was considered as the population 
at risk for each year and the incidence rate for each year was calculated. Census data are 
aggregated to a hierarchy of geographical levels (country, administrative county, local 
government district, electoral ward, enumeration district). Table 3.1 shows the average 
size of each of these for the study area. 
100 
Table 3.1 Average population in census units for the study region 
Population count in 1991 census 
Unit Number Average M in Max 
CPCDR (all ages) 1 818 000 
CPCDR (0-15 years) 158 000 
County 2 409 000 347 000 471 000 
Local Government District 10 82 000 2 900 243 400 
Electoral Ward 202 4 121 1 034 16 210 
Enumeration District 2 071 395 0 I 802 
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For both censuses the 'usually resident population' is used as a base. This refers to those 
people whose pennanent residence is within a census output area, and it excludes 
visitors. The single year population estimates provided in the Local Base Statistics 
(LBS) in census data are for residents in households only. Total population counts are 
available only for five year age bands, 0-4, 5-9 and 10-14 apart from age 15-year which 
is a stand-alone item. To calculate the total population for each single year of age, the 
total population in 5-year age bands were allocated into single years of age using the 
same proportion of single year population within the corresponding five year group of 
the household population. The average population of each single age of year from the 
1981 and 1991 census was taken to calculate the average incidence rate for each 
individual age. 
Population density is the total population of an area [ward, district or Water Supply 
Zone (WSZ)], divided by its area. Childhood population density is the total population 
aged 0-15 years for a region, divided by its area. 
The live birth population in each month during the 1970-95 period in the study area was 
mainly retrieved from the Birth Registration Books held in the Maternity Departments 
of the hospitals (Derriford and Treliske) in the study region in order to compare the 
seasonality of birth pattern in diabetic children with that of the general population. A 
very small number of home deliveries take place making it very unlikely that the overall 
birth pattern is significantly affected. 
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3.3 Measures of incidence 
An incidence rate is defined as the ratio between the number of new cases with the 
disease and the person years at risk over the same time interval. Incidence rate shows 
the frequency or strength of the occurrence of a disease. Incidence can be calculated on 
a basis of a day, a week, a month or a year, but annual incidence rate is used in most 
studies. Statistically valid comparison of incidence rates requires a homogenous 
population structure, mainly for age and sex. For comparison of incidence in several 
populations or in different subgroups of the same population, either standardised rates 
or the log-linear model may be used. 
3.3.1 Standardisation of incidence rate 
There are two ways to standardise incidence rate, i.e. direct and indirect standardisation, 
and they are described below. 
3.3.1.1 Direct standardisation 
The structure of a population varies between countries, and even between regions, and 
thus a method to account for these differences is required. The basic idea of direct 
standardisation is to suppose that both area (a) and area (b) have the age distribution of 
the standard area instead of the age distributions they actually have. Standardised rates 
are then calculated for each area, making use of the standard age distribution. These 
standardised (or adjusted) rates are then compared, and any difference between them 
can no longer be due to differences in age distribution because age has been taken into 
account. The directly standardised incidence rate is based on a theoretical or standard 
population to allow direct comparison between areas of differing population structures. 
Directly standardised incidence rates are a weighted average of age-sex stratum specific 
rates, with weights being the proportion of the standard population in each stratum. 
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Age-sex standardised incidence rates are thus used to correct for age-sex specific 
differences in risk and population structure. The standard population used in this project 
is the common standard population recommended by the WHO DIAMOND Project 
(WHO DIAMOND Project Group, 1990; WHO, 1995), assuming equal numbers of age 
groups (0-4: 1/3; 5-9:1/3 and 10-14 years: l/3) in both genders. 
The directly standardised rate 1 is calculated below (Esteve et al., 1994) 
g 
1 =(liS) Isj{ojlp), 
j=l 
(Note: Oj I pj is the rate in stratum}) 
or 
g 
t= L[(sjS)(ojlp)], 
j=l 
Oj observed number of cases in stratum}, 
pj person years accumulated in stratum}, 
Sj size of the standard population in stratum} (Note I Sj = S), 
S total size of standard population, 
g total number of strata, and 
g 
I(sjS)=I. 
j=J 
The observable incidence rate of a disease is subject to a certain degree of random 
variation. This variability affects the estimate of the rate and can lead to spurious 
conclusion. In order to evaluate the importance of this kind of variation, the incidence 
(crude or standardised) rate should be presented with its standard error or its confidence 
interval. 
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95% confidence intervals for incidence rates can be calculated usmg Byar's 
approximation to the Poisson exact method (Breslow and Day, 1987) because the rates 
of many rare diseases are assumed to follow Poisson distribution, not normal 
distribution. The exact confidence limits for incidence rate are obtained by finding 
lower (L) and upper (V) limits. Byar's approximation is sufficiently accurate that one 
may avoid the interactive calculations needed for the exact results. Thus, for a 95% 
confidence interval, we have the approximate limits, 
L = [l- (l/90)- (1.96/(3 X .JO ))]\ 
u = (l + 1/0)[l- 11(9(0+ 1 )) + 1.96/(3 x .Jo + 1 )]3, 
where L is the lower limit, U the upper limit and 0 the observed number of cases. 
The 95% Cis are therefore 
IIower = l X L, 
I upper = l X U. 
95% confidence interval for an observable incidence rate can also be estimated by using 
Geigy Scientific Tables (Lentner, 1982). If we suppose that the observed case number 0 
is a variable that follows a Poisson distribution, from the Geigy Scientific Tables the 
95% confidence limits of this 0 can be found. Then the exact 95% Cl for this 0 can be 
calculated by dividing these lower and upper limits by the accumulated person-years at 
risk in the study. 
3.3.1.2 Indirect standardisation 
A common method for presenting internal comparisons of rates between geographical 
areas is to calculate Standard Incidence Ratio (SIR). Originally designed for mortality 
studies (Standardised Mortality Ratio or SMR), the method can be applied to the 
incidence of morbidity. The principle is to compare the observed number of cases of the 
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disease in an area with that expected based on rates for the entire area. The expected 
number of cases was calculated from the age-sex stratum specific incidence rates and 
the susceptible population. 
The expected number of case (E) in the population under study is 
g 
E = l"""m·A-
..t:.. ~1· 
j=l 
where A.1 is the incidence rate of stratum j in the standard population; m1 is the number of 
person-years accumulated by stratum j in the population under study and g is the total 
number of strata. The ratio between the total number of cases observed in the population 
under study (0) and the expected number (£) is called the Standard Incidence Ratio 
(SIR) which is a measure of relative risk of the population under study compared with 
the standard population. It is usually expressed as a percentage, SIR= ( 0/E)x I 00, I 00% 
indicating a risk equal to the average risk for the entire study area. An area with SIR 
greater than 100% has an elevated risk for the disease and vice versa (Esteve et al., 
1994). 
Byars calculations described above (Breslow and Day, 1987) were applied to calculate 
95% Cis of SIR as 
SIR1ower = SIR X L, 
SIRupper =SIR X U. 
3.3.2 Poisson regression 
Simple linear regression for the analysis of variation in disease occurrence is not 
appropriate because it gives equal weights to all areas, regardless of populations, and 
because it assumes that errors are normally distributed. This does not apply to studies of 
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most human disease. Case and count data of the kind studied here usually have a 
Poisson distribution (Breslow and Day, 1987). It is possible to use various weighting 
schemes to overcome these objections, but it is usually simpler to use Poisson 
regression to analyse the data (McCullagh and Nelder, 1989). 
Poisson regression is an extension of ordinary (that is least squares or normal theory) 
linear regression, being a member of the class of Generalised Linear Models (GLM's) 
(McCullagh and Nelder, 1989). The analysis based on a model for the number of events 
in an area, first adjusting for different number of person-years at risk, that is the 
population multiplied by the duration of the study, in that area. The logarithm of the 
person-year at risk in each stratum enters the model as an offset. 
Poisson regression models were used here to compare the differences in incidence rate 
between sexes, age groups and local governmental administration districts, i.e. to 
disentangle the contributions of these variables to the observed variation in incidence, 
and to investigate the trends in incidence rate for the whole study area and each district. 
Models with terms for 2 genders, 3 age groups (0-4, 5-9, and 10-14 years), 9 districts 
and 22 calendar years ( 1975-96) were fitted. The data set used for the Poisson 
regression modelling includes 484 cases aged 0-14 years. Four cases from the Isles of 
Scilly (IOS) were excluded because the IOS is far from the mainland and there were 
only 4 cases found during the 22 study-year. These models take account of possible 
differences in age and sex structure in each district's population and permit for any 
linear trend in incidence rate within a district. Further models incorporating interaction 
terms were used to test for differences in the linear trends between districts, between 
sexes, and between age groups. Poisson-regression models were also fitted for each 
district separately to test its linear trend in incidence rate. Likelihood-ratio x! tests were 
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used to provide a test of significance for the last tenn added to the model. Models were 
fitted with the GLIM software package (GLIM 4, 1992 Royal Statistical Society, 
London). 
In these fitted Poisson-regression models, the risk of developing type I diabetes before 
the age of 15 years was modelled as a function of age group, sex, geographical location, 
calendar year and the interactions between these factors. The significance of the main 
effects and their interactions was assessed using maximum likelihood ratio statistics. 
The number (Y) of incident cases was assumed to have a Poisson distribution with 
mean Nr, where N is the population at risk and r is the risk of developing type I 
diabetes. The risk r is modelled as a multiplicative function of the explanatory variables, 
or, equivalently, the logarithm of the risk can be modelled as an additive function of the 
predictors. A multiplicative model focuses the analysis on the ratio of incidence rates 
rather than on absolute differences between the rates. 
Age group, sex and location were fitted into a model which allowed a direct comparison 
of the variations of incidence rates within each tenn. Similarly, a test for trend in the 
incidence rate for overall data, gender, age group and location was perfonned by fitting 
in models with age group, sex, location and calendar year, and interaction tenns 
between age group and calendar year, between sex and calendar year, and between 
location and calendar year. 
The Poisson-regression described above was run with an entry for every combination of 
age group, sex, district and calendar yaar. This gives rise to a model with 3 strata for age 
group, 2 for sex, 9 for district and 22 for calendar year, giving I, 188 strata in total. With 
only 484 cases included in the analysis, more than half of the strata contain no cases. 
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Therefore, there are lots of 0 counts in the Poisson regression. Thus, the residual 
deviance cannot be assumed to be ·l distributed and cannot be used as a basis for 
testing goodness of fit ofthese models. But the likelihood ratio tests of individual model 
terms based on differences in residual deviance are still valid. 
3.3.3 Seasonality analysis 
3.3.3.1 Seasonality at onset of the disease 
To evaluate the seasonal pattern of this disease at diagnosis, a parametric test, Roger's 
method (Roger, 1977), for cyclic trends in incidence data was used, which performs 
well for small sample size and is recommended by the WHO DIAMOND Project 
(WHO, 1995). Its statistic can be written in the following form, which is approximately 
chi-squared with two degree of freedom under the null hypothesis of that the individuals 
are equally likely to be allocated to each of the categories (months), 
R = 2[(1}1;sin(2mlk)i + (IN;cos(2mlk))2]/n, 
R, the statistic, 
N;, the number of events (case) in ith category (month), 
i = 1,2,3 ... k (here, k = 12), 
n, sample size (i.e. total number of cases), 
The seasonality at diagnosis of the disease was analysed for the whole dataset, each age 
group and gender, respectively. 
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3.3.3.2 Seasonality at birth 
Tests for seasonal variation in birth pattern were carried out using the method of Waiter 
and Elwood (Waiter and Elwood, 1975), which has been widely used in publications 
(Rothwell et al., 1996; 1999; Jongbloet et al., 1998; Mutoni et al., 1999; Zhao et a!, 
2000). This method assumes as a null distribution a uniform distribution on a circle, 
representing the twelve months of the year. It also allows for differences in month 
lengths. Briefly, those cases born in each month are represented as a weight on the rim 
of a disc. Ifthere is no seasonal variation, thenthe centre of gravity ofthe disc will be at 
the centre. If there is seasonal variation, the centre of gravity will be displaced. The 
direction of this displacement is towards the peak of the seasonal variation. When 
investigating seasonal variation in the birth of cases, the underlying variation in the 
seasonality of birth must be accounted for (Russell et al., 1993). What is required are 
the numbers of births in each month from the earliest year of birth in the study to the 
most recent. The total number of births for each month during 1970-95 were obtained 
from the two major hospitals, Derriford and Treliske in the study area; there were 417 
diabetic children born between 1970-95. Sex-specific live birth figures in the population 
were not available, so this analysis could not be done separately by gender. A BASIC 
programme of this method produced by Dr Yi Wang was used for this analysis. 
3.4 Mapping of the incidence 
Mapping software is the MAP91 held in the Department of Geographical Sciences at 
University of Plymouth. The SIRs were mapped according to the Local Government 
District boundaries. 
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3.5 Space-time clustering 
In a defined geographical area over a fixed length of time, the place and time of onset of 
all cases of any disease, three distinct forms of clustering may be observed. The cases 
may show space clustering, time clustering, or space-time clustering (Pike and Smith, 
1968). Space clustering is a non-uniform distribution of the cases over the area to the 
underlying population. Time clustering is a non-uniform distribution of the cases over 
the duration of the study. Space-time clustering is the phenomenon in which there is a 
tendency for groups of cases which occur close together in space also to be close in time 
(Armitage and Beny, 1994). If a relatively rare condition was in part caused by an 
infectious agent one would expect to find a space-time interaction; this would be 
regarded as evidence for contagion or infection of the disease. 
3.5.1 Knox test 
Knox was the first to distinguish clearly between space-time clustering and the other 
two forms of clustering and to suggest the first statistical test for it (Knox, 1963; 1964). 
Knox tabulated all possible pairs of cases in space and time (Knox, 1963), and his test 
has been the most widely employed, analysed and modified procedure used in this field 
(Alexander and Boyle, 1996). The Knox test measures distances in both space and time 
between all possible pairs of cases. The expected number of pairs of cases can be 
calculated and tested against the chi-squared distribution. 
To conduct the Knox procedure, the measurement of a spatial and temporal distance 
must be taken between all possible pairs of cases in the study region. The spatial 
measurement in the present study was between the postcodes of the residential home 
(address at diagnosis) of every patient both at the time of their diagnosis and at the time 
of birth. The postcode has been georeferenced and the distance is measured in 
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kilometres. The temporal parameter was an absolute measure in days between either the 
dates of diagnosis or the dates of birth of each patient. 
The full set of measurements generates a symmetrical matrix of distances in both time 
and space between all possible pairs of cases. There are n(n-1 )/2 unique measurements 
for each parameter where n is the number of cases. Then the Knox test requires to 
classify each measured distance as either "adjacent" or "not adjacent", by selecting 
thresholds for both the temporal and spatial parameter. The selection of thresholds 
needs both knowledge of the dataset, possible aetiological factors, the biology of the 
disease and results from other similar studies in publications. The limitation of multiple 
testing directed the number of thresholds to a minimum while still allowing a wide 
range of conditions to be tested. It is not illuminating to test thresholds too large to 
interpret in relation to potential environmental factors or too short to discern a pattern. 
The diabetes dataset was georeferenced through postcode via PC2ED program, a dataset 
at a resolution of 10 metres. The shortest spatial distance was chosen as I km, and the 
longest distance 50 km. Greater distances were considered to be uninterpretable. The 
same criteria were applied to the dates, with the shortest time distance as 7 days and the 
longest as 360 days. The observed measurements were categorised as either "adjacent" 
or "not adjacent" for each threshold in space and time, and a 2 by 2 table of the pairs can 
be tabulated in Table 3.2. 
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Table 3.2 The 2x2 table generated for the Knox test 
Spatial threshold Time threshold 
<= > 
<= a b pairs adjacent in space 
"clustered pairs" 
> c d n(n-1)/2 
pairs adjacent in time number of pairs 
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The observed measurements were categorised as "clustered", Oc, when a pair of patients 
are both "adjacent" in time and space. The expected numbers of pairs can be calculated 
from the marginal totals and tested against the chi-squared distribution. The expected 
number of "clustered" pairs, E( Oc), assuming chance alone was calculated as 
E(Oc) = [(a+b)(a+c)] I [n(n-1)/2]. 
The significance of the departure of the observed number of clustered pairs from those 
expected was tested against the chi-squared distribution with I degree of freedom. 
X= [(Oc- E(Oc))2]/E(Oc). 
3.5.2 Knox-Mantei test 
Nathan Mantel in I967 argued that the Poisson distribution is an unfair assumption and 
he developed a conceptual generalisation of the Knox procedure (Mantel, I967), 
referred to as the Knox-Mantel test. The Knox-Mantel test relies on a permutational 
variance to allow the calculation of a standard normal deviate. The resultant z score can 
be tested for significance against the standard normal distribution. 
3.5.2.1 Permutaionai variance 
Let X ij be the spatial measure and Yii be the temporal measure. The Knox-Mantel test 
assigns I to X ii and Yii when the measure between the pair is "adjacent" or within the 
set thresholds. The observed number of clustered pairs is calculated as 
Oc = L: L: X ij Yij . 
i<j 
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Mantel stated that if the null distribution of Oc (that is when there is no clustering) can 
be determined, the significance of the deviation of Oc from E( Oc) can be calculated. 
Various methods have been suggested, such as a Monte Carlo analysis simulating 
random data using the X u and Y,1 matrices (David and Barton, \966). An alternative 
method only applicable to very small datasets is to actually calculate Oc for each 
permutation of then! possible combinations and the mean and standard deviation can be 
known exactly. Both methods are computationally intensive, Mantel derived a 
permutational variance of Oc based on the assumption that Oc follows a normal 
distribution. The permutations are derived from theJ·oint matrix X,; I Y. .. 
. !I u 
The following equations allow the computation of the permutational variance. 
a row sum of Xu 
b row sum of X~ 
c row sum of YY 
d row sum of Yu2 
e row sum of xij yij 
Ax=Z:a 
Bx=Z:b 
Oc=Z:e 
Hx = Dx- Bx 
Kx = Gx - 2Bx - 4Hx 
L = 2BxBy 
0 = 2MI(n-2) 
Ay=l:c 
By=l:d 
Dy =Z:c2 
Gy=A/ 
Hy = Dy- By 
Ky = Gy - 2By - 4Hy 
M= 2HxHy 
P = Kx.Ky/[(n-2)(n-3)] 
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Q=GxGy/[n(n-1)] R=L+O+P-Q 
resultant perrnutational variance Var( Oc) = R/[(n(n-1 )]. 
3.5.2.2 z score and significance test 
The z score is derived 
z = [Oc- E(Oc)] I ~Var(Oc), 
where Oc, E(Oc) and Var(Oc) are calculated from the above Knox equations, z is tested 
against a standard normal distribution (one-sided). 
3.5.2.3 Multiple testing 
Multiple testing exists when repeatedly testing a series of inclusive thresholds in the 
Knox-Mantel tests. Multiple testing significantly increases the rate of Type I error 
(false positives) because for every 20 tests of significance on average one test will be 
significant by chance alone at a = 0.05. 
In order to reduce the Type 1 error while retaining the power (reduction of false 
negatives), a modification of the Bonferroni procedure (Simes, 1986) was used in the 
thesis. Simes procedure is based on ordered P values for each test. It is considerably less 
conservative than the classical Bonferroni procedure and significantly reduces the Type 
2 error rate (false negatives). 
3.5.2.4 Implementation of the Simes procedure (modified Bonferroni procedure) 
Let Po; ... PrnJ be the ordered P values (from the smallest to the biggest P values) for 
testing the hypotheses Ho= {Hr I) ... Hrn;}. Then Ho is rejected when Pw 5.ja/n for any j 
=I ... n. 
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3.5.3 Testing of subgroups 
The Knox-Mantel test is also used in this thesis to determine whether specified 
subgroups of the data display clustering. The patients are divided into the following 
subgroups, (a) age group: 0-4, 5-9, and 10-15 years; (b) sex: male and female; (c) time 
period: 1975-84 and 1985-96; (d) county of residence: Devon and Cornwall; and (e) 
type of residence: urban (Plymouth) and rural area (the rest of the study area). An S-
Pius program constructed by Dr Rana Moyeed was used to carry out the intensive 
computation of the Knox-Mantel method. 
3.6 Measures of the association of the disease and water quality 
Patients were located into their Enumeration Districts (ED), the smallest area unit of the 
UK 1991 census using the PC2ED program held on the Mimas ser-Vice of the University 
of Manchester (http://mimas.ac.uk!regn.html), as described before. 
Domestic drinking water for all residents in this study area is supplied by the South 
West Water company. Our study area covers 40 water supply zones (WSZ), which were 
created by the water company according to the law (Great Britain, 1989) which requires 
that each WSZ must have a population not exceeding 50,000. The water quality data for 
nitrate, nitrite, copper (Cu), magnesium (Mg), manganese (Mn), zinc (Zn), iron (Fe), 
aluminium (AI) and calcium (Ca) concentrations were provided by South West Water 
company. The water data supplied were complete from 1993 onwards and therefore the 
full water dataset between 1993 and 1997 was used in the analysis. Water samples are 
taken from the distribution network at customers' taps and indicate the water quality 
across the zone at that time. The average values of the monthly means of these water 
chemicals were taken to estimate the average exposures of the chemicals to account for 
short-term seasonal variation in each WSZ. The trend analysis for these chemicals 
117 
during the sampling period, I993-97 showed that AI, Ca, Cu, Fe, Mg, nitrate, and Zn 
levels significantly increased with time in 4, 7, 2, 10, 3, 3 and 3 out of 40 WSZs, 
respectively, whilst AI, Fe, Mn and nitrate levels significantly decreased in I9, I, 23 and 
4 out of 40 WSZs, respectively. Overall, in this whole study area, Ca and Fe showed 
increased trends while AI and Mn showed decreased trends, and others remained 
unchanged during 1993-97. 
The digitised WSZ boundary data (Map 3.3) were provided by the South West Water. 
WSZs covered in this study are on the left-hand side of the dotted line on the map. The 
digitised ED boundary data of the UK l99I census were obtained through the Mimas 
service on the Internet as described above. EDs were assigned to 40 WSZs by 
superimposing the two sets of digitised maps (EDs and WSZs maps) using GIS-
ArcView version 3. In a situation where an ED was divided by one or more WSZ 
boundaries, it was assigned to the WSZ which contained the largest part of its area. In 
this way, 517 children with type I diabetes were assigned to 40 WSZs. Four cases from 
the Isles of Scilly and I case from North Cornwall District were not included because 
their water data were not available. 
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Map 3.3 Water Supply Zones in Devon and Cornwall 
302 
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The UK 1991 census data were used to obtain the demographic data. Standardized 
incidence ratios (SIRs) of type I diabetes were calculated for each WSZ as the ratio of 
observed to expected cases multiplied by 100. The expected number of cases of each 
WSZ was estimated by using age-sex stratum specific rates and census population totals 
in that WSZ. 95% confidence intervals for the SIRs were calculated using Byar's 
approximation to the Poisson exact method (Breslow and Day, 1987). Children's 
population density (0-15 years old) in each WSZ was derived by dividing the children's 
population in each WSZ by its area. in hectares. Simple correlation was estimated using 
Spearman's rank test between SIR and children's population density and all other water 
chemicals. SIRs and x! tests for trend were also calculated based on tertiles of all 
variables by dividing them into three strata, all with approximately equal children's 
populations. Nitrite was excluded from the analysis because 95.1% nitrite samples 
(2895/3043) had only one value (0.01 mg!L). The incidence of type 1 diabetes was 
assumed to be Poisson distributed and therefore Poisson regression analysis was used to 
assess the significance of each variable on SIR after adjusting other variables' effects. 
The number of cases in each WSZ was used as the dependent variable and the log of the 
expected number of cases used as the offset. All variables were analysed in tertiles (3 
categories) by Poisson regression which was done by using ST AT A (StataCorp, 1997). 
3. 7 Measures of the association of the disease and birth weight 
Heavier birth weight has been suggested as a risk factor of developing childhood onset 
type 1 diabetes in several studies (Metcalfe and Baum, 1992; Dahlquist et al., 1996) but 
this has not yet been confirmed (Lawler-Heavner et al., 1994; McKinney et al., 1997). A 
pilot case-control study was carried out aiming to investigate the relationship between 
birth weight and childhood diabetes and test this hypothesis in our cohort. 
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3.7.1 Selection of cases and controls 
Since 1975, children diagnosed with type I diabetes under the age of 16 years in this 
study area have been registered on the CPCDR. Birth weight data are recorded on the 
Plymouth Child Health Database (PCHDB) since 1980. Birth weight infonnation have 
been retrieved from PCHDB on 56 type I diabetic patients in the CPCDR and 224 non-
diabetic controls matched (I :4) by date of birth and gender. All subjects were singleton 
pregnancies. Birth weight >= 4000g was defined as exposure according to literature 
(Metcalfe and Baum, 1992). 
3.7.2 Statistical analysis 
The Mantel-Haenszel !:M matched case-control analysis method (Rothman, 1986) was 
employed. The data collection and arrangement table is listed in Table 3.3. 
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Table 3.3 Data coUection of 1 :M matched case-control study 
No. of cases 
Exposure 
Unexposure 
0 
Ilo.o 
No. of exposed controls 
2 ... m ... M 
... nl,m ... 
Ilo.l Ilo,l ... no.m ... Ilo,M 
122 
3.7.2.1 Calculation of x1 value 
M M 
[ L (M-m+ I )nl,m-1 - L milo.m) f 
m= I m= I 
x2= __________________________ _ 
M 
LT m m (M-m+ I) 
m= I 
where Tm = n1.m-l + no,m-
3.7.2.2 Calculation of odds ratio (OR) 
M 
I (M-m+l)nl.m-1 
m= I 
M 
I milo,m 
m= I 
3.7.2.3 Calculation of95% confidence intervals of OR 
Lower limit of OR, ORL = OR1'-'-'".fV>, 
Upper limit of OR, ORu = OR1'''-..;.r;r,. 
The significance of difference in birth weight between the patients and controls was also 
examined by the student's t-test and -/ test by dividing the subjects into exposed (birth 
weight>= 4000g or >=3000g) and unexposed groups. 
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3.8 Measures of the association of the disease and serum elements 
With the available serum samples in the lab of our department, a pilot study was also 
conducted to try to explore the relationships in serum levels of Cu, selenium (Se), Mg, 
sodium (Na), potassium (K), chloride (Cl) and Ca between type 1 diabetic patients and 
normal subjects. 
3.8.1 Subjects 
3.8.1.1 Patients 
54 patients (27 males, 27 females; mean age, 14.8 years old; median age, 14.5 years; 
age range: 8-30 years) with average duration of disease of 4 years (Range: 0-16 years 
and there were no evident complications) were included in this pilot study. Patients 
were diagnosed with type I diabetes between 1978 to 1995. Serum samples of patients 
were collected between 1993 and 1996 for the genetic study of various diseases. All 
serum samples were stored at -80 degree Celsius until tested. 
3.8.1.2 Controls 
68 normal controls (33 males, 35 females; mean age, 13.9 years; median age, 13.5 
years; age range, 9 - 29 years old) were randomly selected and their blood samples were 
taken between 1994 and 1995, and similarly, the serum were kept in -80 degree Celsius, 
too. 
3.8.2 Methods of the measurement 
0.5 ml of patient's serum was digested in lml of Aristar grade concentrated nitric acid & 
I ml spectrosol grade sulphuric acid, overnight at room temperature. Raw digests were 
diluted to 5ml (xlO dilution) with deionized water. 100 times dilutions were prepared by 
1 :9 dilution of the 10 times diluted sample. Zn and Cu were analysed on the raw digests, 
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Ca, Mg, Na and K on the lOO times dilutions. All metals except Na and K were 
analysed using graphite furnace. The settings ofgraphite furnace is listed in Table 3.4. 
Na and K were analysed by usmg flame automic absorption spectrophotomentry 
(FAAS, Coming flame photometer, Varian SpectrAA 600). Cl was determined from 
whole serum using automated titration against a I OOmM NaCI standard. 
Data are corrected for atomic absorption blanks, all calibrations and blanks were matrix 
matched to human serum. Procedural blanks containing deionized water, and treated as 
serum samples served to account for contamination in the tubes and reagents. 
Contamination was negligible for all metals except Cu where data have been corrected. 
Contamination from Zn invalidates the Zn analysis, the Zn contamination might either 
come from the sample tubes themselves or from the deionized water. The acid reagents 
used here were high quality and would show contamination in general if it was the Zn 
source. 
3.8.3 Statistical analysis 
Normality tests were carried out for each serum chemical in patient and control groups, 
separately. If they are normally distributed data in both groups, student's t-test was used 
to test the significance of difference in serum concentrations between patients and 
controls. If not, Mann-Whitney (Wilcox) W test was applied to compare their medians. 
Analyses were done by using the computing software - Statgraphics Plus for Windows. 
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Table 3.4 The settings of graphite furnace 
Lamp current (mA) Slit width (mm) Wavelenth (nm) Mode 
Ca 10 0.5 422.7 Flame N20/acetylene 
Mg 4.0 0.5 285.2 Flame air/ acetylene 
Cu 2.6 0.5 324.8 Flame air/ acetylene 
Zn 5.0 1.0 213.9 Flame air/ acetylene 
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CHAPTER 4. RESULTS 
4.1 Number of cases and completeness of ascertainment 
During the 22-year study period from 01/01/1975 to 31/1211996, 522 children (244 boys 
and 278 girls), aged 15 years and under, were diagnosed as having type 1 diabetes in the 
study region of Cornwall and Plymouth area. All these 522 study subjects were detailed 
in Table 4.1.1 by year at diagnosis, gender and age groups. Of these, 502 were 
identified through the primary source, hospital records (clinic records from 
diabetologists and diabetic specialists nurses and audit offices of hospitals), 216 through 
the secondary source, a postal survey of all local general practice surgeries through all 
lead general practitioners in the study region. Sixty-nine per cent (99/144) replied with 
patient lists enclosed. A total of 196 subjects were identified by both of the two sources 
(Table 4.1.2). In addition, 96% of the patients (503/522) were approached by a letter 
from their consultant doctors to ask them and their parents to provide information about 
their diabetes. The response rate to the postal survey was 58% (291/503). The 
completeness of the ascertainment for the whole database was estimated as 94.4% (95% 
Cl, 91.4% to 97.6%). The method used to estimate the case ascertainment was described 
in detail in Chapter 3 (3.1.1) and the example of the actual calculation is given in 
Appendix I. The completeness of the ascertainment for those children aged 0-14 years 
old was estimated as 95.3% (95% Cl, 92.5% to 98.3%, Table 4.1.3). The detailed case 
ascertainment, crude and ascertainment-corrected incidence rates in three age groups (0-
4, 5-9 and 10-14 years) during different time periods were listed in Table 4.1.4. Two 
cases were excluded (one with cystic fibrosis and the other with maturity onset diabetes 
of the young). One patient died of a myocardial infarction after having had type 
diabetes for 22 years, diagnosed in 1976 when she was 14 years old. 
128 
Table 4.1.1 Number of cases by year at diagnosis, gender and age groups in the study 
Girls Girls' Total Boys Boys' Total Grand Total 
Year at diagnsis 0-4 yr 5-9 yr 10-14 yr 15 yr 0-4 yr 5-9 yr 10-14 yr 15 yr 
1975 0 2 5 1 8 0 1 2 0 3 11 
1976 2 5 6 0 13 0 6 3 0 9 22 
1977 7 8 0 16 3 0 10 0 13 29 
1978 2 1 2 1 6 2 4 6 0 12 18 
1979 0 5 5 1 11 1 5 2 9 20 
1980 0 2 6 1 9 2 3 4 0 9 18 
1981 1 1 6 9 3 2 4 0 9 18 
1982 1 3 9 1 14 1 5 2 1 9 23 
1983 3 8 7 0 18 2 6 4 2 14 32 
1984 0 4 5 0 9 0 2 6 2 10 19 
1985 2 4 3 2 11 3 3 5 1 12 23 
1986 2 5 3 0 10 0 3 3 0 6 16 
1987 0 7 5 1 13 4 5 3 1 13 26 
1988 5 6 7 1 19 3 4 6 1 14 33 
1989 2 2 5 2 11 6 5 0 12 23 
1990 4 7 8 2 21 5 2 2 2 11 32 
1991 1 2 0 0 3 0 3 9 1 13 16 
1992 0 5 5 2 12 4 5 3 0 12 24 
1993 6 3 6 0 15 7 4 5 3 19 34 
1994 4 6 8 0 18 4 7 3 0 14 32 
1995 4 5 8 0 17 2 1 4 0 7 24 
1996 4 5 4 2 15 5 2 7 0 14 29 
1975-96 44 95 121 18 278 52 75 101 16 244 522 
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Table 4.1.2 Number of all cases identified through the two sources from 1975-96 
Total 
Hospital' 
Yes No Total 
Yes 196 20 216 
No 306 ? 
502 522 
I Hospital means cases identified from the primary source 
2 GP means cases identified through the secondary source 
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Table 4.1.3 Number of cases aged 0-14 years identified through the two sources 
Total 
from 1975-96 
Hospital 1 
Yes No Total 
Yes 188 16 204 
No 284 ? 
472 488 
I Hospital means cases identified from the primary source 
2 GP means cases identified through the secondary source 
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Table 4.1.4 Case ascertainment level, crude and ascertainment corrected incidence rate in 3 age groups during 
different time periods (cases/100,000/year) 
Age group Rate or ratio 
0-4 years Crude rate 
Ascertainment(%) 
Corrected rate 
5-9 years Crude rate 
Ascertainment(%) 
Corrected rate 
1 0 - 14 years Crude rate 
Ascertainment(%) 
Corrected rate 
0 - 14 years Crude rate 
Ascertainment(%) 
Corrected rate 
1975-79 
5.15 
91.70 
6.07 
13.23 
80.00 
15.60 
17.92 
92.90 
21.13 
12.70 
84.80 
14.98 
1980-84 
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6.09 
100 
6.80 
14.89 
90.00 
16.64 
18.62 
84.10 
20.80 
14.20 
89.50 
15.87 
Time period 
1985-89 
8.73 
100 
8.89 
17.91 
97.80 
18.24 
18.50 
100 
18.84 
14.98 
98.20 
15.25 
1990-96 
14.17 
100 
14.33 
16.28 
98.30 
16.46 
20.85 
98.60 
21.08 
17.06 
98.90 
17.25 
1975-96 
9.35 
98.00 
9.81 
15.81 
95.00 
16.59 
19.02 
94.50 
19.96 
14.93 
95.30 
15.67 
4.2 Incidence of type 1 diabetes 
The overall average incidence rate for children aged 0-15 years was 14.9/100,000/year 
(95% Cl, 13.6 to 16.2/100,000/year). The average annual incidence rates for boys and 
girls were 13.6 (95% Cl, 12.0 to 15.5/100,000/year) and 16.2 (95% Cl, 14.5 to 
18.4/l 00,000/year), respectively. The male to female ratio was 1: 1.19. 
4.2.1 Age- and sex-specific incidence 
Figure 4.1 shows the age-specific incidence rate for the entire study area during the 
study period. Children in their first year of life (0 year old) have the lowest incidence. 
The rate gradually increased until a peak incidence at 10 years of age and then it 
levelled off and fell down afterwards. Figure 4.2 shows the age- and sex-specified 
incidence rate for the whole dataset. From this figure, it can be seen that girls' rate 
increases with ageuntil 12 years of age, and then starts to fall. There are some random 
variations along with the increase trend of the rate. Boys generally have lower rates than 
girls but have the similar increase trend as girls until 14 years of age also with some 
random fluctuations in rate. The maximum peak rate appeared two years later in boys 
than that happened in girls. 
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Figure 4.1 Incidence rate by individual age at onset in the far South West of England, 1975-96 
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Figure 4.2 Incidence rate by sex and age at onset in the far Southwest England, 1975-96 
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4.2.2 Incidence by study period 
Figure 4.3 shows that the distribution of incidence rates over the 22 study years for the 
entire database (0-15 years). It demonstrates a slow general increasing trend with 
random variations of peak incidence rates in certain years, e.g. 1977, 1983, 1988, 1990 
and 1993. When the study period was divided into 4 periods, 1975-79, 1980-84, 1985-
89 and 1990-96, the increase trend is even more clear (Figure 4.4). Figure 4.5 shows 
that the incidence also changes over the 22-year study period for each sex. From this 
figure it can be seen that girls' rate has a greater increase and greater random variations 
than the boys'. A more steady increase trend with less random fluctuations for boys can 
be seen from Figure 4.5. 
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Figure 4.3 Incidence rate of type 1 diabetes in children aged 0-15 years by calendar year at diagnosis in the far SouthWest of 
England, 1975-96 
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F~me 4.4 Temporal trend of incidence of type 1 diabetes in children aged 0.15 years by time period in tbe far SouthWest of E~Iand, 1975-96 
Incidence (case/1 00,000/year) 
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Figure 4.5 Incidence rate of type 1 diabetes in children aged 0-15 years by sex and calendar year in the far South West of England, 
1975-96 
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4.2.3 Incidence by local government district 
The incidence of type 1 diabetes in each local government district is shown in Table 
4.2.1 presented as standardised incidence ratios and crude incidence rates. The Isles of 
Scilly and Penwith in Cornwall, and the West Devon district in Devon had the lowest 
observed number of cases (4, 25 and 22, respectively) and Plymouth (169 cases) the 
highest. The lowest incidence was found in the Penwith District (10.6 cases/lOO, 
000/year) in Cornwall and the South Hams District (12.4 cases/100,000/year) in Devon. 
The departure of the observed from the expected number of patients was measured by 
the SIR and tested against a chi-square distribution with 1 degree of freedom (df). The P 
value is presented for each district and remains significant at the 1% level only for the 
Isles of Scilly. 
To visualise the SIR in the study region, the SIRs were divided into 3 levels, low, 
SIR<90, medium, SIR, 91-110 and high level with SIR >110, plotted in Figure 4.6. 
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Table 4.2.1 Childhood (0-15 years) onset type 1 diabetes by local government district in 
the far Southwest of England, 1975-96 
SIR (95% Cl) 
Crude 
Districts Population n SIR Low Upper p Incidence Rate 
Penwith (FB) 10721 25 71 46 105 >0.05 10.6 
South Hams (GB) 13519 37 84 59 116 >0.05 12.4 
Carrick (EY) 14971 47 96 71 128 >0.05 14.3 
Restormel (FC) 16335 52 98 73 129 >0.05 14.5 
Kerrier ( EZ) 17353 57 100 76 130 >0.05 14.9 
Plymouth (GA) 51514 169 100 86 116 >0.05 14.9 
Noth Cornwall (FA) 14049 48 104 77 138 >0.05 15.5 
West Devon (GF) 5576 22 122 76 185 >0.05 17.9 
Caradon (EX) 14995 61 124 95 159 >0.05 18.5 
Isles of Scilly (FD) 398 4 400 108 1024 <0.01 45.7 
Grand Total 159431 522 14.9 
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Figure 4 .6 Standardised incidence ratios in 10 local administration districts 
in the far South West of England, 1975-96 
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4.2.4 Mean age-at-onset 
All of these 522 type I diabetic children (244 boys and 278 girls) aged 0-15 years were 
analysed. The average age at onset for each year of the 22-year study period was 
calculated. The Spearrnan rank test was used to examine the changing pattern of the age 
at onset in children with type I diabetes. Each year during the 22-year study period, 
approximately 24 children were diagnosed with this disease (range from 11-34 cases) in 
the population-based study area. The average age at onset was 8.80 years for the whole 
dataset, 8.59 years for boys and 8.98 years for girls. The average age at onset for all 
patients dropped 2.79 years from 10.82 years in 1975 to 8.03 years in 1996. The results 
of the Spearrnan rank analyses indicated that there were significant decreasing trends of 
mean age at onset and the Spearrnan's correlation coefficients were - 0.5822, P = 0.0045 
for all patients, -0.5264, P = 0.0118 for boys and -0.4805, P = 0.0236 for girls. The 
results show that the children residing in the area have been diagnosed with type 1 
diabetes at younger age stage as the time goes by. The changing pattern is plotted in the 
figure with a linear trend superimposed in it (Figure 4.7). 
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Figure 4. 7 Trend of the mean age at onset for children aged 0-15 year-old diagnosed with type 1 diabetes in 
the far South West of England, 1975-96 
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4.2.5 Analysis of the incidence in children aged 0-14 years old 
In order to make the results comparable with other published data, the following results 
were based on the analysis for children aged 0-14 years old only. 
Of the total 522 cases, 93% (488/522) of them were aged 0-14 years with 228 boys and 
260 girls. For this group the case ascertainment was 95.3% (95% Cl, 92.5-98.3%). The 
observed average incidence rate in these children was the same as in those diagnosed at 
ages 0-15 years (14.9/100,000/year, 95% Cl, 13.6-16.2/100,000/year). The 
ascertainment-corrected incidence was 15.66/100,000/year with the ascertainment-
corrected case number of 512 (488/0.953). The age- and sex- standardised incidence 
rate was 14.8/100,000/year (Table 4.2.2). In order to demonstrate the temporal trend 
clearly, the semi-logarithmic plots of the incidence rates in the three age groups were 
used in Figures. 4.8A-C. These show that the fastest increase in trend was found in the 
youngest age group whilst the other two age-groups showed no significant increase. 
These figures show that the incidence rate in the 0 - 4 years age-group has almost 
reached the incidence levels of the two older age-groups towards the end of the study 
period. Table 4.1.4 shows the details of case ascertainment and, crude and 
ascertainment-corrected incidence rates in the three age groups during the different time 
periods. These data also clearly demonstrate a significant increase in incidence m 
children diagnosed under 5 years even after adjusting for case ascertainment. 
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Table 4.2.2 Number of cases of childhood onset Type 1 diabetes, population and average 
incidence rate per 100,000/year by age-group and sex in the far South West of England, 
1975-96 
Age Groups Age- and sex-
0-4 yr. 5-9yr 10-14yr Crude Incidence Adjusted Incidence 
Male 
n 52 75 101 228 
Population 23924 25047 27092 76063 
Rate 9.88 13.61 16.95 13.63 13.48 
95%CI 7.38-12.96 10.71-17.06 13.80-20.59 12.00-15.47 11.90-15.47 
Female 
n 44 95 121 260 
Population 22749 23836 25958 72543 
Rate 8.79 18.12 21.19 16.29 16.03 
95%CI 6.39-11.80 14.66-22.15 17.58-25.32 14.49-18.38 14.14-18.10 
Total 
n 96 170 222 488 
Population 46673 48883 53049 148605 
Rate 9.35 15.81 19.02 14.93 14.76 
95%CI 7.57-11.42 13.52-18.37 16.44-21.51 13.58-16.16 13.54-16.19 
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Figures 4.8A · C. Semi-logarithmic plot of annual incidence rates of childhood onset Type 1 diabetes and 
their linear trends in 3 age-groups, A: 10-14 years ( ~ ); B: 5-9 years ( -tr) and C: 0-4 
years old children ( *) in the counties of Devon and Cornwall, England, 1975 - 1996 
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4.2.6 Poisson-regression modelling 
4.2.6.1 Comparisons of incidence rates by age group, sex and district 
484 cases aged 0-14 years were included in the Poisson-regression analyses, excluding 
4 cases from the IOS. The likelihood-ratio x} tests from fitting the Poisson regression 
models to the data from all districts are summarised in Table 4.2.3. Differences in 
incidence rates between the three age-groups (0-4 years, 9.35, 5-9 years, 15.81 and I 0-
14 years, 19.02/100,000/year) were highly significant (P < 0.001) either before (Model 
1.1) or after (Models 1.4, 1.10 and 1.14 in Table 4.2.3) adjusting for the effects of sex 
and district. Differences in incidence rates between genders (males, 13.6, females, 16.3 
cases/100,000/year) were also statistically significant (P < 0.05) either before (Model 
1.2) or after adjusting for other factors (Models 1.5, 1.8 and 1.14a). However, there 
were no statistically significant district-to-district variations in incidence rate of the 
disease for children living in different districts in the study population (P > 0.3) either 
before (Model 1.3) or after adjusting for other factors (Models 1.7, 1.11 and 1.13), 
although children living in Penwith district had only half of the risk of developing the 
disease compared to those living in Caradon district. There were no significant 
interactions between age group, sex and district in this study population (Models 1.6, 
1.9, 1.12, 1.15, 1.16, 1.17 and 1.18 in Table 4.2.3). Table 4.2.4 shows the relative risk 
ratio estimates based on the Model 1.13 in Table 4.2.3, indicating that in this study 
population, boys have a significantly lower risk of developing type I diabetes than girls; 
children diagnosed between 5-9 and 10-14 years of age have a 1.7 and 2 times higher 
risk relative to children of0-4 years of age, respectively. 
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Table 4.2.3 Variable selection in sex, age and district models of type 1 diabetes 
in children aged 0-14 years from the far Southwest of England, 1975-96 
(n=484) 
Likelihood ratio 
Model statistic for last df ?value 
term 
1.1 age 34.51 2 <0.0001 
1.2 sex 3.89 1 0.0486 
1.3 district 8.728 8 0.3658 
1.4 sex, age 34.47 2 <0.0001 
1.5 age, sex 3.849 1 0.0498 
1.6 age, sex, age*sex 2.685 2 0.2612 
1.7 sex, district 8.723 8 0.3662 
1.8 district, sex 3.884 1 0.0487 
1.9 district, sex, district*sex 7.247 8 0.5102 
1.10 district, age 34.70 2 <0.0001 
1.11 age, district 8.917 8 0.3493 
1.12 age, district. age*district 22.23 16 0.1359 
1.13 sex, age, district 8.911 8 0.3499 
1.14 sex, district, age 34.65 2 <0.0001 
1.14a district. age, sex 3.843 1 0.0499 
1.15 sex, age, district, age*sex 2.271 2 0.2582 
1.16 sex, age, district. sex*district 7.315 8 0.5031 
1.17 sex, age, district, age*district 22.17 16 0.1378 
1.18 sex, age, district, 50.30 42 0.1778 
sex*age*district 
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Table 4.2.4 Risk ratio estimates based on model1.13 in Table 4.2.3 
Risk ratio 95%CI 
estimate 
Variable Lower Upper 
Gender 
Girl 1.00 Reference group 
Boy 0.84 0.70 1.00 
Age Group (years) 
0-4 1.00 Reference group 
5-9 1.66 1.29 2.13 
10-14 1.99 1.56 2.52 
District (census code) 
Caradon (EX) 1.00 Reference group 
Carrick (EY) 0.79 0.53 1.16 
Kerrier (EZ) 0.80 0.55 1.17 
North Cornwall (FA) 0.88 0.60 1.29 
Penwith (FB) 0.54 0.33 0.88 
Restorrnel (FC) 0.72 0.49 1.07 
Plymouth (GA) 0.82 0.61 1.11 
South Hams (GB) 0.68 0.45 1.04 
West Devon (GF) 0.93 0.56 1.55 
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4.2.6.2 Comparisons of incidence trends 
Previous model fitting confirmed that there were significant differences in incidence 
rates between age groups and sexes. In order to allow for the differences in age and sex 
specific rates from district to district in estimating linear trends, a base model (Model 
1.13 in Table 4.2.3) including terms for age, sex and district was used. Models that 
specified different patterns of linear trend were obtained by adding terms to the base 
model. The results are shown in Table 4.2.5. The test of the overall trend in incidence 
rate was obtained by adding a trend term, the calendar year, shown in Model 2.1 in 
Table 4.2.5. A statistically significant overall increased rate was found, shown in the 
Model 2.1 (2.49% per year, 95%Cl, 1.04-3.95%). This increase was mainly due to the 
marked increase in those diagnosed under 5 years of age (6.32% per year, 95%CI, 2.81 -
9.94%), compared with 5-9 years (1.46%, 95% Cl, -0.93 - 3.92%) and 10-14 years 
(1.76%, -0.34- 3.9%). However, the differences in trends between age groups did not 
quite reach the statistically significant level at 5% (Model 2.2, Poisson regression x.2 = 
5.809, df = 2, P = 0.0548). Plot of fitted incidence rate for the 3 age groups based on 
Poisson regression are given in Appendix 5, which clearly show the fastest increase rate 
in the youngest age group. 
The significant increase in incidence was also found in both genders with 2.56% per 
year (95% Cl, 0.60 - 4.57%) for girls and 2.40% per year (95% Cl, 0.30 - 4.54%) for 
boys. Again, no evidence of a statistically significant difference in trends between boys 
and girls has been detected (Model 2.3, Poisson regression x.2 = 0.0127, df = 1, P = 
0.91). 
However, Model 2.4 in Table 4.2.5 indicates that a significant difference in trends exists 
between different districts (Poisson regression x.2 = 27.18, df= 8, P = 0.0007). 
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Table 4.2.5 Summary of Poisson-regression models for incidence trends for children with 
type 1 diabetes, aged 0-14 years from the far Southwest of England, 1975-96 (n=484) 
Model Likelihood 
ratio statistic df Pvalue 
for last term 
2.1 Base model + year 11.59 1 0.0007 
2.2 Base model + year + age*year 5.809 2 0.0548 
2.3 Base model + year + age*year 0.0127 1 0.9101 
+ sex*year 
2.4 Base model + year + age*year 27.18 8 0.0007 
+ sex*year + district*year 
2.5 Base model + year + age*year 2.119 2 0.3466 
+ sex*year + district*year 
+ age*sex*year 
Note: Base model = constant+ age + sex + district. 
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Model 2.5 gives no evidence that the difference in trends between age groups varied 
between boys and girls (Poisson regression x2 = 2.119, df = 2, P = 0.35). Because the 
incidence trends varied significantly between districts, therefore, the trends in the 9 
districts were modelled separately with a model incorporating terms of age group, sex, 
age/sex interaction and the trend term, calendar year. The results are shown in Table 
4.2.6. This table shows that the significant trends of incidence were detected in Carrick, 
North Cornwall and Penwith districts whilst the incidence trends in other districts 
remained random variations during the 22-year study period. 
4.2.6.3 Comparisons of incidence rates by time periods 
In order to compare the differences in incidences in different time periods, the data were 
grouped into 4 time periods, 1975-79, 1980-84, 1985-89 and 1990-96. Poisson 
regression was run with an entry of combinations of 3 age groups, 2 sexes, 9 districts 
and 4 periods. This gives rise to a model with 216 strata in total. A significant 
difference in incidence rate of 4 different study periods was found allowing for the 
effects of sex and age distribution (P = 0.043, Model 3.6 in Table 4.2.7). Moreover, a 
significant interaction has been detected between time period and district, indicating that 
the pattern of incidence across the 9 districts differed between the 4 time periods (Model 
3.11 in Table 4.2.7). Further investigation revealed that the Carrick District (EY, see 
Map 4.6 in Page 142) was an area with significantly higher risk of developing childhood 
diabetes during the most recent time period, 1990-96. This district lies in the rriiddle of 
the county of Cornwall. No other interactions were found to be significant between age 
groups, sexes, time periods and districts. Other results of the analyses in Table 4.2.7 are 
similar as those described before. 
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Table 4.2.6 Summary of Poisson-regression analyses showing the incidence trend 
in each local government district during 1975-96 
District Increase rate (%) 95%CI p 
per year 
Caradon (EX) 0.49 -3.54-4.70 0.81 
Carrick (EY) 9.08 3.78-14.66 <0.001 
Kerrier (EZ) 2.58 -1.71 - 7.05 0.24 
N. Cornwall (FA) 5.25 0.44-10.29 0.029 
Penwith (FB) 17.92 8.12-28.60 <0.001 
Restormel (FC) 3.10 -1.60- 8.02 0.20 
Plymouth (GA) 0.17 -2.26-2.66 0.89 
S. Hams (GB) -1.31 -6.34- 3.99 0.62 
W. Devon (GF) -0.22 -6.89-6.92 0.95 
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Table 4.2.7 Variable selection in sex, age, time period and location models of type 1 diabetes in children aged 0-
14 years from the far Southwest of England, 1975-96 (n=484) 
Likelihood 
ratio statistic 
for last term 
Model df Deviance (df) P value 
3.1 sex 214 304.4 4.05 (1) 0.044 
3.2 age 213 270.56 37.90 (2) < 0.001 
3.3 period 212 302.46 6.26 (3) 0.1 
3.4 district 207 299.38 9.08 (8) 0.34 
3.5 sex, age 212 266.5 37.90 (2) < 0.001 
3.6 sex, age, period 209 258.37 8.13(3) 0.043 
3.7 sex, age, period, district 201 248.94 9.43 (8) 0.31 
3.8 sex, age, period, district, sex*age 199 246.12 2.82 (2) 0.24 
3.9 sex, age, period, district, sex*period 198 248.68 0.26 (3) 0.97 
3.10 sex, age, period, district, age*period 195 239.04 9.90 (6) 0.13 
3.11 sex, age, period, district, period*district 177 207.64 41.30 (24) 0.015 
3.12 sex, age, period, district, age*district 185 226.8 22.14 (16) 0.14 
3.13 sex, age, period, district, sex*district 193 241.79 7.157(8) 0.52 
3.14 sex, age, period, district, period*district, sex*period*district 142 169.59 38.06 (35) 0.33 
3.15 sex, age, period, district, period*district, sex*period*age 160 190.48 17.16(17) 0.44 
3.16 sex, age, period, district, period*district, sex*age*district 135 157.68 49.97 (42) 0.19 
3.17 sex, age, period, district, period*district, age*period*district 107 127.32 80.32 (70) 0.19 
!55 
4.2. 7 Seasonality 
4.2.7.1 Seasonal variation at diagnosis 
There was considerable variation in the numbers of cases diagnosed each month with a 
peak occurrence in fall (October) and winter (January and February) and lowest in 
summer time (June) (x2= 22.19, df= 2, P = 0.000015). There was no seasonal variation 
among children in the 0-4 year age group (X2 = 0.97, df= 2, P = 0.62), some seasonal 
variation in children of the 5 - 9 year age group (x2=6.29, df = 2, P = 0.043) and very 
marked variation in incidence in the oldest children, 10 to 14 years old (X2 = 19.07, df= 
2, P = 0.000072) or 10 to 15 (x2 =16.98, df= 2, P = 0.000206) (Fig 4.9). There was also 
a significant variation in the pattern of seasonal onset in both boys and girls (x2 = 22.67, 
df= 2, P = 0.000012 for boys; x2 = 4.96 df= 2, P = 0.08 for girls, Fig 4.10). 
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Figure 4.9 Seasonal variation at diagnosis of type 1 diabetes by age group in children aged 0-15 
years in the far South West of England, 1975-96 
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Figure 4.10 Seasonal variation at diagnosis of type 1 diabetes by sex in children aged 0-15 years in 
the far South West of England, 1975-96 
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4.2.7.2 Seasonal variation at birth 
The numbers of total live births in the study region were retrieved from Derriford and 
Treliske hospitals. Only the birth figures between 1970 to 1995 from both hospitals 
were available for use, therefore only those patients born in this time period were used 
in this analysis (n=417). The seasonal pattern of birth of diabetic children from this 
study did not statistically significantly differ from that of the general population in this 
study region (r}= 4.05, df=2, P = 0.13, Fig 4.11 ), although more patients were found to 
be born in February and May, and fewer in August compared with the pattern in the 
general population. 
4.2.8 Population density and incidence 
Spearman rank test was used to examine the relation between population density and 
incidence rate of childhood diabetes. No significant correlation was detected between 
either total population density (all age residents in the study region by district, n = 10, 
Rs = -0.18, P = 0.61) or childhood population density (aged 0-15 years, n = 10, Rs = 
-0.34, P = 0.34) and the incidence rate among the 10 studied districts. 
This relationship was also investigated in the same way when the study region was 
divided into 40 Water Supply Zones (WSZ), which will be described later in section 4.4 
of this chapter. Likewise, no significant correlation was found either between the total 
population density and the SIR of the disease (n = 40, Rs = -0.008, P = 0.96), or 
between childhood population and the SIR of the. disease (n = 40, Rs = -0.002, P = 0.99) 
among those 40 WSZs. Similar non-significant relationship between childhood 
population and the SIR of the disease was obtained when Poisson regression model was 
employed. 
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Figure 4.11 Observed divided by expected number of births each month in the population 
with diabete (for cases born between 1970-95, o=417) 
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4.3 Results of space-time clustering 
The Knox-Mantel test was applied to the CPCDR to detect space-time clustering both at 
the time of diagnosis of the disease and at the date of birth of the patients. The analysis 
used consistent spatial and temporal thresholds throughout to allow direct comparison 
between subgroups. The thresholds selected were: time in days, 7, 28, 90, 180, 270 and 
360; and space in kilometres, l, 5 15, 25, 35 and 50. 
The series of thresholds allowed a combination of 36 separate tests to be applied to the 
datasets. The tables present the observed number of "clustered" pairs of cases (Oc) 
located within each combination of thresholds, the expected number of clustered pairs 
and the z score from the Knox-Mantel test. The level of significance of z is shown as a 
one-tailed P value calculated from a standardised normal distribution. If z ~ 1.6449, P s; 
0.05; z ~ 2.3263, P s; O.Ol. If the Simes adjustment P value is less than 0.05, the z score 
is labelled with S in the result tables. 
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4.3.1 Space-time clustering in the full register 
The CPCDR contained 522 patients. Of them, four cases from Isles of Scilly (lOS) were 
not eligible for the test of space-time clustering because the lOS are not adjacent to the 
rest of the study region geographically. Therefore they were excluded from the cluster 
analyses. The results from applying the Knox-Mantel test to the register (n=518) are 
shown in Table 4.3.1. The results provide evidence for space-time clustering of 
childhood diabetes in the Cornwall and Plymouth area. The clustering occurred at the 
spatial distances of 25, 35 and 50 km over the time of 90 to 360 days. The most 
significant degree of clustering was seen in pairs of children living within 35km and 
diagnosed within 360 days of each other. After accounting for multiple testing, there 
was still a clear significance for clustering at thresholds of 35 and 50 km in space, and 
270 and 360 days in time. At shorter spatial temporal distances no space-time clustering 
was detected, with the cases occurring randomly in time and space. 
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Table 4.3.1 Comparison of observed and expected numbers of pairs of cases adjacent 
in both space and time at diagnosis (n = 518) in the CPCDR 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 4 7 24 48 63 87 
EXPECTED 2.0 7.9 24.3 46.8 68.5 92.1 
z 1.37 -0.31 -0.07 0.17 -0.68 -0.55 
5 OBSERVED 26 96 307 563 812 1086 
EXPECTED 23.9 91.7 283.8 546.1 798.2 1073.4 
z 0.46 0.45 1.35 0.72 0.48 0.38 
15 OBSERVED 53 236 730 1404 2073 2770 
EXPECTED 60.3 231.6 716.5 1378.7 2015.2 2710.2 
z -1.07 0.31 0.53 0.72 1.34 1.20 
25 OBSERVED 90 370 1129 2165 3211 4324 
EXPECTED 93.35 358.78 1110.12 2135.94 3122.05 4198.73 
z -0.43 0.70 0.66 0.74 1.85" 2.26" 
35 OBSERVED 114 475 1466 2814 4178 5609 
EXPECTED 120.8 464.2 1436.4 2763.6 4039.6 5432.6 
z -0.84 0.65 1.01 1.25 2.82 .. 5 3.12 .. 5 
50 OBSERVED 154 630 1944 3704 5476 7334 
EXPECTED 159.2 611.8 1892.9 3642.2 5323.7 7159.6 
z -0.65 1.11 1.74" 1.54 3.10 .. 5 3.08 .. 5 
•: P < 0.05; **: P < 0.01; S: P < 0.05 with Simes adjustment. 
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Of the total 518 cases in the register (excluding 4 cases from IOS), it was possible to 
trace the postcodes at birth of 426 (82%) cases including 46 patients born outside the 
study area but within the UK. Six of the untracked cases were known to have been born 
abroad and the other 86 cases have no record of their postcodes at birth or detailed birth 
address traceable. So there were 380 patients, born in the period 1960-94, included in 
the cluster analyses at their birth addresses. Table 4.3.2 shows that the various 
combinations of space and time thresholds have not reached the statistical significance 
of space-time clustering at birth, indicating no evidence of space-time clustering 
happened at the time of birth. 
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Table 4.3.2 Comparison of observed and expected numbers of pairs of cases adjacent 
in both space and time at birth (n = 380) in the CPCDR 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 2 4 8 24 31 45 
EXPECTED 0.9 3.8 12.6 24.5 37.4 49.8 
z 1.21 0.10 -1.31 -0.09 -1.05 -0.69 
5 OBSERVED 13 40 118 225 324 450 
EXPECTED 8.9 38.8 128.6 249.5 381.0 508.4 
z 1.46 0.21 -0.97 -1.49 -2.64 -2.26 
15 OBSERVED 24 84 290 559 814 1117 
EXPECTED 20.0 87.0 288.5 559.6 854.7 1140.3 
z 1.04 -0.37 0.10 -0.02 -1.35 -0.64 
25 OBSERVED 30 119 419 818 1226 1661 
EXPECTED 28.9 126.0 417.9 810.7 1238.2 1652.0 
z 0.25 -0.78 0.06 0.30 -0.38 0.24 
35 OBSERVED 37 152 516 1017 1537 2076 
EXPECTED 36.5 159.1 527.6 1023.5 1563.3 2085.7 
z 0.11 -0.75 -0.67 -0.26 -0.83 -0.26 
50 OBSERVED 50 208 716 1404 2142 2853 
EXPECTED 50.0 217.7 722.1 1400.7 2139.5 2854.4 
z 0.01 -1.04 -0.35 0.13 0.08 -0.04 
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4.3.2 Clustering in age groups 
The results of the Knox-Mantel test applied separately to age groups 0-4, 5-9 and 10-I5 
years of age at diagnosis are shown in Tables 4.3.3, 4.3.4, 4.3.5, respectively. The 
youngest age group, 0-4 years old at diagnosis, displays an excess of observed numbers 
of clustered pairs compared to those expected with a random distribution. The most 
significant space-time clustering was observed at long spatial distances (I5, 25, 35 and 
50 km) over one month to a year time thresholds. Four combinations remained 
significant after the Simes adjustment. Three of them were at 90 days and at distances of 
I5, 25 and 35 km, and one was at 270 days and 50 km. The Knox-Mantel test applied to 
the middle age group, 5-9 years old at diagnosis, also provided evidence for space-time 
clustering with clustering mainly at long spatial distances of 35 and 50 km, and longer 
time thresholds at 3 months to a year apart. Whilst the most significant clustering was 
observed in pairs of cases diagnosed living within I km and diagnosed 7 days apart 
even after the Simes' correction for multiple testing. The I O-I5 year olds provided little 
evidence for clustering. There were significant excesses of observed cases mostly within 
thresholds of 5 km over 28 to I80 days. 
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Table 4.3.3 Knox-Mantel test results for 0-4 years olds at diagnosis 
(n=95) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 
7 28 90 180 270 360 
OBSERVED 0 1 4 9 33 15 
EXPECTED 0.3 1.2 4.3 8.4 34.8 15.0 
z -0.54 -0.19 -0.13 0.21 -0.32 -0.01 
5 OBSERVED 7 24 42 388 69 
EXPECTED 1.2 4.9 17.6 34.6 369.2 61.9 
z -0.17 1.01 1.64 1.31 1.00 0.86 
15 OBSERVED 3 16 49 86 1098 141 
EXPECTED 2.3 9.7 34.4 67.7 1078.3 121.2 
z 0.55 2.39~ 2.88~s 2.49~ 0.66 1.86' 
25 OBSERVED 4 19 64 109 1854 180 
EXPECTED 3.17 13.40 47.59 93.77 1794.33 167.80 
z 0.58 1.93' 2.96~s 1.90' 1.70' 1.06 
35 OBSERVED 4 20 71 127 2464 208 
EXPECTED 3.8 16.2 57.4 113.2 2393.0 202.6 
z 0.12 1.27 2.37~s 1.69' 2.46~ 0.47 
50 OBSERVED 5 22 83 158 3412 263 
EXPECTED 4.8 20.2 71.9 141.7 3305.6 253.6 
z 0.14 0.58 1.92' 1.98' 2.8o~s 0.82 
*: P < 0.05; **: P < 0.01; S: P < 0.05 with Sirnes adjustment. 
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Table 4.3.4 Knox-Mantel test results for 5-9 years olds at diagnosis (n=l68) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 2 2 4 8 10 15 
EXPECTED 0.3 0.9 2.9 5.3 7.6 9.9 
z 3.27-s 1.15 0.65 1.20 0.90 1.69* 
5 OBSERVED 6 12 34 61 94 119 
EXPECTED 3.6 11.8 37.7 68.7 98.7 128.7 
z 1.34 0.06 -0.62 -0.98 -0.49 -0.89 
15 OBSERVED 14 30 97 162 241 304 
EXPECTED 8.7 28.3 90.5 165.1 237.1 309.2 
z 2.12* 0.36 0.78 -0.27 0.28 -0.33 
25 OBSERVED 16 44 147 244 369 470 
EXPECTED 12.8 41.6 132.8 242.3 348.1 454.0 
z 1.15 0.47 1.53 0.14 1.39 0.93 
35 OBSERVED 18 56 179 306 457 585 
EXPECTED 15.6 50.8 162.3 296.1 425.5 554.8 
z 0.82 0.97 1.75* 0.78 2.06* 1.73' 
50 OBSERVED 21 71 223 388 569 730 
EXPECTED 19.7 64.2 204.9 373.7 536.9 700.1 
z 0.45 1.29 1.91' 1.13 2.10' 1.71' 
•: P < 0.05; ••: P < 0.01; S: P < 0.05 with Simes adjustment. 
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Table 4.3.5 Knox-Mantel test results for 10-15 years olds at diagnosis 
(n=255) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 3 6 10 14 20 
EXPECTED 0.5 1.9 5.5 10.4 14.9 20.3 
z 0.66 0.80 0.23 -0.11 -0.25 -0.07 
5 OBSERVED 7 30 71 126 175 228 
EXPECTED 5.5 20.0 57.4 108.7 156.9 213.4 
z 0.66 2.32* 1.86* 1.80* 1.58 1.14 
15 OBSERVED 12 55 149 293 419 573 
EXPECTED 14.7 53.2 152.9 289.5 417.7 568.1 
z -0.78 0.27 -0.35 0.24 0.08 0.25 
25 OBSERVED 23 91 246 485 705 966 
EXPECTED 24.54 89.18 256.13 484.95 699.60 951.59 
z -0.38 0.24 -0.78 0.00 0.26 0.63 
35 OBSERVED 32 120 335 648 936 1275 
EXPECTED 32.5 118.0 338.9 641.7 925.8 1259.2 
z -0.11 0.25 -0.29 0.35 0.48 0.65 
50 OBSERVED 46 164 453 859 1237 1700 
EXPECTED 42.5 154.6 444.0 840.6 1212.7 1649.5 
z 0.84 1.19 0.68 1.04 1.15 2.13* 
*: p <0.05; **: p < 0.01. 
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4.3.3 Clustering within time periods 
The results of the Knox-Mantel test applied separately to the two study periods of 1975-
84 and 1985-96 are shown in Tables 4.3.6 and 4.3.7, respectively. The results provided 
very little evidence for space-time clustering during the first time period I 975-84. There 
was only one combination of thresholds displaying space-time clustering, those children 
diagnosed within l km and 7 days of each other. However, during the time period 1985-
96, type l diabetes in the study area displayed a significant degree of space-time 
clustering at biggest combinations of thresholds similar to the results from the entire 
dataset shown in Table 4.3.1. 
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Table 4.3.6 Knox-Mantel test results at diagnosis for children diagnosed 
during 1975-1984 (n=209) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 
OBSERVED 3 4 10 19 29 
EXPECTED 0.9 3.8 11.5 22.3 33.1 
z 2.34- 0.12 -0.47 -0.74 -0.77 
5 OBSERVED 13 52 156 275 411 
EXPECTED 10.8 47.5 145.8 281.7 418.3 
z 0.75 0.67 0.87 -0.41 -0.35 
15 OBSERVED 26 105 329 626 942 
EXPECTED 23.7 104.6 321.1 620.3 921.2 
z 0.58 0.04 0.50 0.25 0.71 
25 OBSERVED 32 146 458 878 1319 
EXPECTED 33.42 147.28 452.15 873.35 1297.03 
z -0.33 -0.13 0.35 0.20 0.71 
35 OBSERVED 40 182 565 1095 1648 
EXPECTED 41.9 184.5 566.5 1094.2 1625.1 
z -0.43 -0.26 -0.09 0.03 0.75 
50 OBSERVED 51 231 701 1350 2003 
EXPECTED 51.0 225.0 690.7 1334.1 1981.3 
z -0.01 0.63 0.63 0.69 0.73 
•: p < 0.05; **: p < 0.01. 
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Table 4.3.7 Knox-Mantel test results at diagnosis for children diagnosed 
during 1985-96 (n=309) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 3 14 28 33 46 
EXPECTED 1.1 4.1 12.6 24.1 34.7 46.4 
z -0.12 -0.53 0.41 0.83 -0.31 -0.06 
5 OBSERVED 13 44 149 283 388 525 
EXPECTED 12.0 43.3 134.1 256.6 370.0 493.8 
z 0.29 0.11 1.28 1.69* 0.96 1.43 
15 OBSERVED 27 130 395 758 1098 1476 
EXPECTED 35.1 126.4 391.7 749.6 1080.9 1442.5 
z -1.53 0.34 0.18 0.34 0.57 0.96 
25 OBSERVED 58 222 664 1265 1854 2490 
EXPECTED 58.49 210.39 651.92 1247.56 1798.84 2400.77 
z -0.08 0.94 0.56 0.60 1.58 2.21* 
35 OBSERVED 74 291 892 1692 2484 3317 
EXPECTED 78.0 280.7 869.7 1664.3 2399.7 3202.7 
z -0.60 0.80 0.98 0.90 2.31* 2.73 .. 
50 OBSERVED 102 395 1228 2318 3412 4542 
EXPECTED 107.8 387.6 1201.0 2298.3 3313.9 4422.8 
z -0.86 0.56 1.16 0.63 2.63 .. 2.75 .. 
*; p < 0.05; **; p <0.01. 
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4.3.4 Clustering in counties 
Tables 4.3.8 and 4.3.9 give the results of the Knox-Mantel test applied separately to two 
counties in the study area, Devon and Cornwall. The analyses at a county level provided 
no evidence for space-time clustering. 
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Table 4.3.8 Knox-Mantel test results for children diagnosed in Devon 
(n=228) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 3 4 21 37 49 65 
EXPECTED 1.3 6.1 18.3 35.5 51.7 70.0 
z 1.54 -0.87 0.65 0.26 -0.40 -0.63 
5 OBSERVED 20 81 247 458 658 872 
EXPECTED 16.4 78.4 234.3 454.4 662.6 896.2 
z 1.14 0.36 1.01 0.21 -0.22 -1.01 
15 OBSERVED 33 145 446 840 1238 1650 
EXPECTED 30.9 147.4 440.7 854.8 1246.4 1685.7 
z 0.72 -0.33 0.44 -0.92 -0.41 -1.53 
25 OBSERVED 41 184 557 1057 1547 2083 
EXPECTED 38.62 184.32 551.22 1069.08 1558.86 2108.32 
z 1.13 -0.06 0.67 -1.05 -0.83 -1.52 
35 OBSERVED 44 207 615 1192 1740 2347 
EXPECTED 43.0 205.3 614.1 1191.0 1736.6 2348.7 
z 1.02 0.74 0.24 0.20 0.54 -0.24 
50 OBSERVED 44 210 627 1217 1774 2400 
EXPECTED 44.0 209.9 627.6 1217.2 1774.8 2400.4 
z 0.17 0.37 -0.92 -0.23 -0.80 -0.35 
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Table 4.3.9 Knox-Mantel test results for children diagnosed in Cornwall 
(n=290) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 1 3 3 10 13 21 
EXPECTED 0.6 2.2 6.7 13.1 18.9 25.2 
z 0.45 0.52 -1.45 -0.87 -1.40 -0.87 
5 OBSERVED 6 14 37 66 96 144 
EXPECTED 3.6 12.5 37.7 73.5 106.2 141.7 
z 1.28 0.42 -0.11 -0.90 -1.02 0.20 
15 OBSERVED 17 64 170 328 470 641 
EXPECTED 16.2 56.4 169.4 330.7 477.5 637.5 
z 0.21 1.10 0.05 -0.16 -0.37 0.15 
25 OBSERVED 32 119 334 661 971 1321 
EXPECTED 32.91 114.18 343.20 669.95 967.42 1291.54 
z -0.19 0.54 -0.60 -0.42 0.14 0.98 
35 OBSERVED 43 168 494 971 1417 1906 
EXPECTED 47.9 166.2 499.6 975.3 1408.4 1880.2 
z -0.98 0.19 -0.34 -0.19 0.31 0.79 
50 OBSERVED 61 237 718 1378 1989 2665 
EXPECTED 67.3 233.5 702.0 1370.3 1978.7 2641.6 
z -1.34 0.38 1.02 0.35 0.38 0.73 
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4.3.5 Clustering in genders 
The CPCDR was divided into boys and girls both at diagnosis and at birth, and the 
Knox-Mantel test applied separately to the four datasets. Analysis of the datasets at 
diagnosis shows that male patients have ony three significant combinations scattered at 
spatial distances of 1, 5 and 50 km over 7, 90 and 270 days (Tables 4.3.10); female 
patients shows two significant combinations at long distance of 50 km over 28 and 360 
days (Table 4.3.11). However, The analysis of datasets at birth shows very little 
evidence for space-time clustering either in boys (Table 4.3.12) or girls (Table 4.3.13). 
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Table 4.3.10 Knox-Mantel test results for boys at diagnosis (n=242) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 2 3 8 14 18 27 
EXPECTED 0.5 2.0 6.0 11.2 16.0 22.2 
z 2.12' 0.75 0.82 0.87 0.52 1.08 
5 OBSERVED 7 25 79 137 192 261 
EXPECTED 5.5 21.4 66.0 122.4 175.2 242.4 
z 0.68 0.78 1.65' 1.44 1.40 1.31 
15 OBSERVED 12 48 159 300 444 609 
EXPECTED 13.4 51.9 159.5 296.0 423.7 586.3 
z -0.44 -0.59 -0.05 0.27 1.18 1.12 
25 OBSERVED 20 72 238 452 661 921 
EXPECTED 20.82 80.76 248.39 460.88 659.73 912.78 
z -0.23 -1.18 -0.80 -0.54 0.06 0.36 
35 OBSERVED 28 108 333 621 915 1262 
EXPECTED 27.9 108.3 333.2 618.2 884.9 1224.3 
z 0.02 -0.04 -0.01 0.16 1.47 1.57 
50 OBSERVED 35 147 437 807 1196 1643 
EXPECTED 36.7 142.2 437.3 811.4 1161.4 1606.9 
z -0.46 0.65 -0.02 -0.26 1.75' 1.55 
•: P< 0.05; ••: P < 0.01. 
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Table 4.3.11 Knox-Mantel test results for girls at diagnosis (n=276) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 0 1 5 11 14 17 
EXPECTED 0.5 1.9 5.9 11.7 17.5 23.4 
z -0.70 -0.66 -0.39 -0.21 -0.87 -1.39 
5 OBSERVED 5 25 79 152 221 286 
EXPECTED 6.0 23.4 73.1 144.1 215.5 288.1 
z -0.42 0.34 0.72 0.67 0.38 -0.13 
15 OBSERVED 11 67 193 394 588 784 
EXPECTED 16.0 62.6 195.7 385.8 576.8 771.2 
z -1.43 0.62 -0.22 0.46 0.51 0.52 
25 OBSERVED 19 101 299 594 897 1214 
EXPECTED 24.51 96.00 299.91 591.31 884.07 1181.94 
z -1.38 0.62 -0.06 0.13 0.53 1.15 
35 OBSERVED 27 132 383 751 1132 1523 
EXPECTED 30.7 120.4 376.2 741.7 1108.9 1482.6 
z -0.90 1.39 0.47 0.45 0.92 1.41 
50 OBSERVED 43 173 506 1004 1499 2012 
EXPECTED 40.6 159.0 496.7 979.4 1464.2 1957.6 
z 0.57 1.67. 0.63 1.18 1.36 1.ss• 
*: P< 0.05; ••: P< 0.01. 
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Table 4.3.12 Knox-Mantel test results for boys at birth (n=l72) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 1 4 9 10 13 
EXPECTED 0.2 1.1 3.0 5.5 8.4 11.1 
z 1.58 -0.07 0.57 1.53 0.55 0.57 
5 OBSERVED 6 13 35 58 82 118 
EXPECTED 2.5 11.4 32.0 57.9 89.3 118.1 
z 2.37- 0.52 0.57 0.01 -0.72 -0.01 
15 OBSERVED 8 21 66 116 169 239 
EXPECTED 5.1 23.0 64.4 116.7 179.9 238.0 
z 1.52 -0.49 0.22 -0.07 -0.82 0.06 
25 OBSERVED 9 31 96 171 253 348 
EXPECTED 7.1 32.2 90.2 163.5 252.0 333.3 
z 0.90 -0.27 0.75 0.68 0.07 0.90 
35 OBSERVED 12 45 120 213 314 430 
EXPECTED 9.1 41.4 116.1 210.3 324.1 428.8 
z 1.30 0.76 0.49 0.24 -0.71 0.07 
50 OBSERVED 16 57 169 301 457 600 
EXPECTED 12.7 57.7 161.6 292.8 451.2 597.0 
z 1.55 -0.15 0.96 0.74 0.40 0.18 
•: p < 0.05; ••: p < 0.01. 
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Table 4.3.13 Knox-Mantel test results for girls at birth (n=208) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 1 2 2 6 9 15 
EXPECTED 0.2 0.9 3.4 6.3 9.4 12.3 
z 1.88· 1.10 -0.77 -0.13 -0.15 0.80 
5 OBSERVED 2 10 28 58 82 115 
EXPECTED 2.0 10.0 36.2 67.1 100.1 130.2 
z 0.00 0.01 -1.39 -1.12 -1.81 -1.34 
15 OBSERVED 4 25 92 171 232 312 
EXPECTED 5.1 25.3 91.7 170.1 253.8 330.3 
z -0.53 -0.07 0.03 0.07 -1.48 -1.10 
25 OBSERVED 5 38 136 257 364 477 
EXPECTED 7.5 37.5 136.2 252.5 376.7 490.3 
z -1.13 0.09 -0.02 0.34 -0.79 -0.73 
35 OBSERVED 7 50 166 326 467 605 
EXPECTED 9.3 46.4 168.4 312.4 466.0 606.6 
z -0.99 0.69 -0.24 1.01 0.06 -0.08 
50 OBSERVED 10 65 226 433 639 825 
EXPECTED 12.5 62.4 226.3 419.6 626.1 814.9 
z -1.06 0.51 -0.03 0.98 0.77 0.53 
•: p < 0.05; ••: p < 0.01. 
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4.3.6 Clustering in urban and rural areas 
The results of the Knox-Mantel test applied separately to patients living in urban 
(Plymouth) and rural area (the rest of the study area) and diagnosed during 1975-96 are 
shown in Tables 4.3.14 and 4.3.15, respectively. There was some evidence of space-
time clustering in the rural area at the combinations of distances of 5, 35, and 50 km and 
7, 270 and 360 days (Table 4.3.15). There was no evidence of space-time clustering in 
densely populated urban area (Table 4.3.14). 
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Table 4.3.14 Knox-Mantel test results at diagnosis for children living in urban 
area and diagnosed during 1975-96 (n=169) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 2 3 19 33 45 61 
EXPECTED 1.3 5.4 16.8 32.4 47.1 62.3 
z 0.67 -1.08 0.55 0.11 -0.33 -0.18 
3 OBSERVED 5 40 116 213 299 401 
EXPECTED 8.0 34.5 106.7 205.7 299.1 395.4 
z -1.30 1.12 1.09 0.63 -0.01 0.36 
5 OBSERVED 18 77 234 437 626 835 
EXPECTED 16.8 72.5 224.1 432.0 628.2 830.3 
z 0.49 0.88 1.11 0.42 -0.15 0.29 
7 OBSERVED 23 102 304 581 846 1122 
EXPECTED 22.67 97.65 301.67 581.53 845.71 1117.73 
z 0.20 1.23 0.37 -0.06 0.03 0.37 
9 OBSERVED 26 109 341 652 945 1244 
EXPECTED 25.3 108.9 336.3 648.3 942.8 1246.1 
z 0.88 0.08 1.53 0.89 0.44 -0.36 
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Table 4.3.15 Knox-Mantel test results at diagnosis for children living in rural 
area and diagnosed during 1975-96 (n=349) 
SPACE TIME INTERVAL (DAYS) 
INTERVAL (KM) 7 28 90 180 270 360 
OBSERVED 2 4 4 12 15 23 
EXPECTED 0.7 2.5 7.7 14.9 21.5 28.8 
z 1.61 0.97 -1.36 -0.77 -1.44 -1.13 
5 OBSERVED 7 15 41 75 108 158 
EXPECTED 3.6 13.2 41.2 79.2 114.2 153.4 
z 1.81* 0.50 -0.04 -0.49 -0.60 0.39 
15 OBSERVED 19 71 194 372 532 727 
EXPECTED 17.2 62.7 195.9 376.4 542.7 728.6 
z 0.47 1.12 -0.14 -0.25 -0.49 -0.06 
25 OBSERVED 39 139 403 789 1160 1573 
EXPECTED 35.91 131.03 409.53 786.99 1134.57 1523.27 
z 0.61 0.81 -0.38 0.08 0.89 1.50 
35 OBSERVED 54 203 603 1162 1701 2302 
EXPECTED 52.6 192.0 600.0 1152.9 1662.1 2231.5 
z 0.25 1.03 0.16 0.35 1.23 1.92* 
50 OBSERVED 76 281 895 1696 2455 3290 
EXPECTED 75.6 275.8 862.0 1656.5 2388.1 3206.2 
z 0.07 0.48 1.69* 1.47 2.05* 2.19* 
•: p < 0.05; ••: p < 0.01. 
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4.4 Results of drinking water quality and type 1 diabetes 
4.4.1 Preliminary analysis 
The demographic data of the 40 WSZs are shown in Table 4.4.1. Plots of the 
standardised incidence ratios (SIRs) of the disease in relation to the mean values of the 
water quality indicator concentration and childhood population density among the 40 
WSZs are shown in Appendices 6a - 6i. No apparent pattern appears in these plots. The 
sampling frequency of water quality indicators and other characteristics of the dataset 
and the results of Spearman's rank test of the correlations between SIR and all other 
variables are listed in Table 4.4.2. The numbers of samples taken for any water quality 
indicator varied from a minimum of 40 (for example Ca and Mg) to a maximum of 
1899 (for example Fe, AI and Mn) in any one year over this 5 year period. Table 4.4.2 
shows that only copper has a significant negative correlation with SIR (Rs = - 0.396, P 
= 0.013). Analysis on tertiles of the dataset with SIR and x.2 tests for linear trend are 
detailed in Table 4.4.3. This table tells us that children living in areas with higher 
copper concentrations had a significant decrease in risk of developing type 1 diabetes in 
term of SIR (X.2 test for trend = 6.58, df = 1, P = 0.01 ). Significant decreases in SIR were 
also observed with an increase in the concentration of magnesium (x.2 test for trend = 
6.39, df = 1, P = 0.011 ), with a significantly decreased risk at the highest tertile (2.61-
8.42 mg!L, SIR = 80.2, 95%CI, 67-95). The mean nitrate levels also showed a 
borderline significantly decreased trend (x.2 test for trend = 3.899, df = 1, P = 0.048), 
which suggest that, like copper and magnesium, nitrate might also have some protective 
effects. 
184 
Table 4.4.1 Demographic data for the 40 Water Supply Zones studied in 
Devon and Cornwall 
Mean Minimum Maximum Total 
Area (hectares) 13519 84 42761 540755 
Total Population 20727 1303 44506 829093 
Population aged 0-15 years 3932 254 8655 157275 
No. of cases 13 35 517 
Incidence (/100,000/year) 14.94 3.85 24.85 
Standardised Incidence Ratio 99.6 25.6 166.7 100 
(%) 
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Table 4.4.2 The characteristics of variable samples, national standards and results of Spearman's rank test of SIR to 
chemicals in domestic water in Devon and Cornwall, UK, 1993-97 
National 
standards 
Variables n Mean (SO) Median Minimum Maximum (Maximum)" Rsb p value 
Children Popuation Density 
(0-15 years lhectare) 40 2.77 (4.22) 0.3S 0.0 1S.9 -0.002 0.990 
Nitrate (mgll) 3049 6.02 (S.02) 4.6 0.487 31.9 so -0.266 0.098 
Copper (IJ.gll) 934 22.48 (19.37) 20 10 310 3000 -0.396 0.0133 
Zinc (1-Lgfl) 838 28.19 (32.68) 20 9.4 420 sooo -0.019 0.909 
Magnesium (mgtl) 2S6 3.04 (2.S1) 2.2 O.S9 13.4 so -0.29S 0.064S 
Calcium (mgll) 2S6 10.94 (6.09) 11.4 1.1 31 2SO 0.023 0.887 
Manganese (IJ.gll) 6841 10.1S (10.83) 10 1.0 440 so -0.013 0.93S 
Aluminium (IJ.gll) 6841 36.41 (22.97) 32 10.0 430 200 0.06S 0.690 
Iron (IJ.gll) 6841 S3.26 (102.73) 27 10 3060 200 -0.008 0.961 
a from Water Supply (Water Quality) Regulations 1989 (Great Britain, 1989) 
b Rs, correlation coefficient of Spearrnan's rank test 
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Table4.4.3 The results of analyses of relationship between tertiles of water chemical levels and SIR of childhood type 1 diabetes 
95% Cl of SIR 
Variables Range NoofWSZs 0 E SIR Lower Upper 0·15 population 
Children population density 0.01 0.21 17 173 176 98.3 84 114 53473 
(0-15 years/ hectare) 0.22 1.62 10 179 176 101.7 87 118 53583 
Chi2 = 0.02, p=0.88 1.63 15.92 13 165 165 100 85 116 50219 
Nitrate (mg!L} 1 3.65 13 180 161 111.8 96 129 48987 
Chi2 = 3.899 3.66 7.83 16 172 173 99.4 85 115 52763 
p =·0.048 7.84 16.58 11 165 183 90.2 77 105 55525 
Cu (pg/L} 16.62 19.44 11 200 169 118.3 102 136 51377 
Chi2 = 6.58 19.45 22.52 17 161 176 91.5 78 107 53520 
p = 0.01 22.53 44.79 12 156 172 90.7 77 106 52378 
Zn (11g/L) 15.06 22.26 14 175 167 104.8 90 122 50702 
Chi2 = 0.19 22.27 27 11 164 173 94.6 81 110 52502 
p = 0.66 27.1 58.09 15 178 178 100 86 116 54071 
AI (f!g/L) 22.59 33.2 14 165 161 102.5 87 119 49050 
Chi2 = 0.26 33.21 39.52 13 181 179 101.1 87 117 54500 
p = 0.61 39.53 104.61 13 171 177 96.6 83 112 53725 
Fe (11g/L) 22.97 38.25 12 177 166 106.6 91 124 50429 
Chi2 = 0.59 38.26 56.62 11 178 187 95.2 82 110 56736 
p = 0.44 56.63 111.22 17 162 165 98.2 84 115 50110 
Mg(mg/L} 0.71 1.9 14 197 183 107.7 93 124 55731 
Chi2 = 6.39 1.91 2.6 11 182 162 112.3 97 130 49301 
p = 0.011 2.61 6.42 15 138 172 80.2 67 95 52243 
Mn (11g/L) 6.57 9.26 16 175 175 100 66 116 53203 
Chi2 = 0.013 9.27 10.59 11 176 174 101.1 87 117 52963 
p = 0.908 10.6 18.78 13 166 168 98.8 84 115 51109 
Ca (mg/L) 1.48 11.75 19 165 170 97.1 83 113 51656 
Chi2 = 0.00 11.76 14.19 11 187 176 106.3 92 123 53455 
p = 0.98 14.2 20.22 10 165 171 96.5 82 112 51964 
Note: 0, observed number of cases; E, expected number of cases; SIR, standardised incidence ratio; Cl, confidence interval 
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4.4.2 Poisson regression analysis 
Poisson regression analyses were made by using tertiles of all the variables: children's 
population density, nitrate, Zn, Mg, Cu, Fe, Mn, AI and Ca. Table 4.4.4 gives the results 
of fitting all possible models including the combinations of Zn, Mg and Cu. For models 
including just one variable at a time, Cu (P = 0.016) and Mg (P = 0.005) are 
significantly associated with the risk of diabetes. However, in Model 1, which includes 
all three variables (Zn, Mg and Cu), Zn (P = 0.025) and Mg (P = 0.005) are significant 
but allowing for the effects of Zn and Mg, Cu is not significant (P = 0.156). Eliminating 
Cu from the model gives Model 2 for which both Zn (P = 0.046) and Mg (P = 0.004) 
are significant. Addition of any other variables did not make any significant 
contribution to the model. Therefore the final model is Zn + Mg (Model 2). The model 
incidence rates and their 95% Cl of Zn and Mg indicate that the ranges of zinc 
concentration (22.27-27.00 pg!L) and magnesium (~.61 mg!L), relative to the base 
levels of Zn and Mg in domestic drinking water, significantly decrease the risk of 
childhood diabetes by 24% and 28%, respectively. Table 4.4.4 also shows that allowing 
for the effect of Zn, Mg is significant (P = 0.004). Similarly, allowing for the effect of 
Mg, Zn is significant (P = 0.046). The goodness-of-fit x2 tests for all of these models 
indicated that the data fit these Poisson models very well (all P values> 0.2). 
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Table 4.4.4. Calculated incidence relative ratios (95%CI) for childhood diabetes by exposure 
to different levels of chemical compositions in drinking water with different Poisson 
regression models 
Goodness~f-fit Variable 
Model Incidence rate Model Chl2(df) Chl2 test (df) chl2(df) 
Range ratios (95% Cl) z p > IZI p p p 
Model1 20.407(6) 23.934 (33) 
Zn 15.06 - 22.26 1 (p=0.0023) (p=0.8758) 7.377(2) 
(~Jg/L) 22.27 - 27.00 0.73 (0.56, 0.95) -2.330 0.020 (p=0.025) 
27.01 - 58.09 1.01 (0.81, 1.25) 0.056 0.956 
Mg 0.71 - 1.90 1 10.57(2) 
(mg/L) 1.91 - 2.60 1.26 (0.99, 1.62) 1.875 0.061 (p=0.005) 
2.61 - 80.42 0.78 (0.61, 1.02) -1.842 0.066 
Cu 16.62 - 19.44 1 3.717(2) 
(~Jg/L) 19.45 - 22.52 0.80 (0.64, 1.01) -1.913 0.056 (p=0.156) 
22.53 - 44.79 0.89 (0.69, 1.14) -0.928 0.353 
Model 2 (Final) 16.690(4) 27.652(35) 
Zn 15.06 - 22.26 1 (p=0.0022) (p=0.8071) 6.168(2) 
(~Jg/L) 22.27 - 27.00 0.76 (0.59, 0.97) -2.216 0.027 (p=0.046) 
27.01 - 58.09 0.99 (0.80, 1.23) -0.070 0.944 
Mg 0.71 - 1.90 1 15.847(2) 
(mg/L) 1.91 - 2.60 1.19 (0.95, 1.50) 1.510 0.131 (p=0.004) 
2.61 - 80.42 0.72 (0.58, 0.91) -2.828 0.005 
Model3 9.835(4) 34.506(35) 
Zn 15.06 - 22.26 1 (p=0.0433) (p=0.4918) 1.611(2) 
(~>g/L) 22.27 - 27.00 0.90(0.73, 1.12) -0.942 0.346 (p=0.447) 
27.01 - 58.09 1.03(0.83, 1.28) 0.278 0.781 
Cu 16.62 - 19.44 1 8.992(2) 
(~Jg/L) 19.45 - 22.52 0.79(0.61, 0.94) -2.581 0.010 (p=0.011) 
22.53 - 44.79 0.75(0.60, 0.93) -2.595 0.009 
Model4 13.03(4) 31.311(35) 
Mg 0.71 - 1.90 1 (p=0.0111) (p=0.6469) 4.806(2) 
(mg/L) 1.91 - 2.60 1.07(0.87, 1.31) 0.613 0.540 (p=0.091) 
2.61 - 80.42 0.81(0.63, 1.04) -1.643 0.102 
Cu 16.62 - 19.44 1 2.508(2) 
(~Jg/L) 19.45 - 22.52 0.84(0.67, 1.05) -1.550 0.121 (p=0.287) 
22.53 - 44.79 0.87(0.69, 1.11) -1.093 0.274 
ModelS 0.843(2) 43.499(37) 
Zn 15.06 - 22.26 1 (p=0.6561) (p=0.2142) 0.843(2) 
(~Jg/L) 22.27 - 27.00 0.91(0.73, 1.12) -0.917 0.359 (p=0.6561) 
27.01 - 58.09 0.95(0.77,1.18) -0.441 0.660 
Model6 10.522(2) 33.819(37) 
Mg 0.71 - 1.90 1 (p=0.0052) (p=0.6190) 10.522(2) 
(mg/L) 1.91 - 2.60 1.04 (0.85, 1.28) 0.426 0.670 (p=0.0052) 
2.61 - 80.42 0.75 (0.60, 0.93) -2.628 0.009 
Model7 8.224(2) 36.118(37) 
Cu 16.62 - 19.44 1 (p=0.0164) (p=0.5102) 8.224(2) 
(~Jg/L) 19.45 - 22.52 0.77(0.63, 0.95) -2.421 0.015 (p=0.0164) 
22.53 - 44.79 0.77(0.62, 0.94) -2.502 0.012 
ModelS Constant 44.342 (39) 
Note: z = estimate/s.e.; df, degree of freedom; p, p value; the statistics in the final column test the significance of the model term(s) 
allowing the other model terms. 
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4.5 Birth weight and type 1 diabetes 
All subjects were singleton pregnancies. Birth weight ;;: 4000g was defined as exposure. 
Results of the present analysis show that a heavier birth weight does not increase the 
risk of developing diabetes (ORMH = 0.84, 95% Cl, 2.35-0.36, x2=0.11, p = 0.74). No 
significant difference has been detected between mean birth weights of patients and 
controls (Table 4.5.1) 
When comparing the two groups, patients and normal controls, with the :x,2 test by 
defining exposure as birth weight >= 4000g or >=3000g, no significant difference in 
percentage of exposure was found between patients and controls either (Tables 4.5.2a 
and 4.5.2b). 
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Table 4.5.1 Mean birth weight of patients with type 1 diabetes and normal controls 
Case 
Control 
n 
56 
224 
Note: t = 0.5936, P = 0.55 
Mean +/- SD (g) 
3395 +/- 495 
3354 +/- 459 
191 
Median (g) 
3430 
3310 
Ranges (g) 
2510-4750 
2100-4840 
Table 4.5.2 x2 tests of birth weight of patients and controls 
a. If birth weight >= 4000g is defined as exposure, then, 
Birth weight Case Control Total 
>=4000g 4 19 23 
<4000g 52 205 257 
Total 56 224 280 
The proportion of exposure is 7.14% among cases (4/56) and 8.48% in controls 
(19/224). Fisher exact P value is 1.00. 
b. If birth weight>= 3000g is defined as exposure, then, 
Birth weight Case Control Total 
>=3000g 44 175 219 
<3000g 12 49 61 
Total 56 224 280 
The proportion of exposure is 78.57% among cases ( 44/56) and 78.13% in controls 
( 175/224). x2 =o.o 1, P = 0.94. 
192 
4.6 Serum chemical elements and type 1 diabetes 
Table 4.6.1 gives the results of comparisons of serum chemical elements between 
patients with type 1 diabetes and normal controls. The results of examination of Zn 
levels could not be analysed because of the contamination from unknown source(s). 
These results showed that the serum levels of Ca, Na and Cl in patients were 
statistically significantly lower than those in controls but these differences are of no 
clinical significance because most of them fell into the normal clinical ranges. The 
concentration changes of these serum microelements may be due to the effects of the 
disease or its treatment. The levels of other elements showed no statistically significant 
differences between patients and controls. 
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Table 4.6.1 Comparisons of serum elements between patients with type 1 diabetes and normal controls 
Patients (n=54) Controls (n=68) 
Indicators (Mean +/- SO) Median Ranges (Mean +/- SO) Median Ranges P-value 
Sex (M/F) 27/27 33/35 
Age (yr) 14.8 +/- 4.3 14.5 8-30 13.9 +/- 4.7 13.5 9-29 0.33* 
K (mmoi/L) 5.32 +/- 1.61 4.78 3.45-27.05 4.65 +/- 0.53 4.6 3.85-19.25 0.113* 
Mg (mmoi/L) 0.75 +/- 0.10 0.74 0.59-0.96 0.77 +/- 0.12 0.76 0.56-1.18 0.47 
Ca (mmoi/L) 1.94 +/- 0.12 1.97 1.5-2.13 2.00 +/- 0.13 2.01 1.69-2.39 0.007* 
Na (mmoi/L) 133.56 +/- 6.39 133.92 110.19-148.59 137.56 +/- 6.76 136.42 124.80-165.86 0.001 
Cu (IJmoi/L) 11.29 +/- 3.09 10.64 6.12-24.85 10.95 +/- 1.97 10.6 7.46-16.9 o.85* 
Cl (mmoi/L) 95.72 +/- 4.36 96.62 83.09-104.35 102.42 +/- 2.93 102.42 96.62-110.15 <0.05* 
Se (IJg/L) 35.54 +/- 21.55 27.67 1.67-83.87 35.49 +/- 16.16 35.43 2.80-83.17 0.68* 
(n=29, M/F: 15/14) (n=37, MIF:20/17) 
•: Mann-Wbitney (Wilcox) W test was used to compare medians for those non-normally distributed data. 
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CHAPTERS: 
DISCUSSION 
195 
5.1 Data quality 
5.1.1 Case data 
CHAPTER 5. DISCUSSION 
An extensive search for the newly diagnosed diabetic children in the present research 
has achieved a very high level of ascertainment. No cases were accepted without direct 
confirmation of their diagnosis, from hospital notes, and great care was taken to exclude 
children who had other diseases leading to pancreatic dysfunction. The ancillary data is 
also complete. All of the cases could be allocated to a district (later they were allocated 
to a ward), and basic demographic details were complete for all cases. 
5.1.2 Population data 
The population at risk for the present research was derived from the 1981 and 1991 UK 
census data, which are the most reliable available population data. They were used here 
to analyse the 1975-96 data. More than 99% of residents in the study area are White 
Caucasian, so the ethnic difference in any aspects of the disease cannot be addressed in 
the present research. 
5.2 Incidence study 
The incidence of type I diabetes mellitus in children has seen a steady increase, not only 
in Europe, but also in most parts of the world (Bingley and Gale, 1989a; Diabetes 
Epidemiology Research International Group, 1990; Lounamaa, 1996; The EURODIAB 
TIGER Study Group, 1998; Vaananen et al., 1998; EURODIAB ACE Study Group, 
2000). In the UK, many registers have been set up and generally report rates that put the 
UK in the middle to upper ranks of risk in the world (Barclay et al., 1988; Bingley and 
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Gale, 1989b; Burden et al., 1989; Green et al., 1992; Staines et al., 1993; Patterson et 
al., 1988; 1996; Gardner et al., 1997; Rangasami et al., 1997). No detailed reports have 
appeared so far regarding the epidemiology in the far South West of England. This is the 
first detailed and well-validated epidemiological study of type 1 diabetes in Devon and 
Cornwall in the far South West of England in children under 16 years of age from 1975-
96. The case ascertainment is high in this register over the 22-year period, so reliable 
conclusions can be drawn from it. The finding in this project of a standardized annual 
incidence rate of 14.8 per 100,000 per year for children aged 0-14 years in the period 
1975-96, suggests that the overall incidence in the far South West of England falls in the 
middle to low range of risk within the UK, compared with other studies, such as 18.6 in 
the Bart's Oxford study (1985-95) (Gardner et al., 1997), 13.5 in Yorkshire (1978-90) 
(Staines et al., 1993), 19.6 in Northern Ireland (1989-94) (Patterson et al., 1996), 23.9 in 
Scotland (1984-93) (Rangasami et al., 1997) and 13.51100,000/year in the British Isles 
in the "snapshot" study in 1988 (Metcalfe and Baum, 1991 ). European studies report a 
wide range of rates, with high rates generally in northern Europe, lower rates in Mid and 
Southern Europe and the lowest rates of all in Eastern Europe and Israel (Green et al., 
1992; Karvonen et al., 1993; Schober et al., 1995; Sebastiani et al., 1996; Tuomilehto et 
al., 1992; 1999; EURODIAB ACE Study Group, 2000). 
However, the most striking finding from the present study is that the incidence in 
children diagnosed under the age of 5 years shows a highly significant and very fast 
temporal increased trend. The increased trend in the 0-4 years of age group in the 
present study is similar to that seen in the Finland during 1975-92 (Tuomilehto et al., 
1995a) and Europe as a whole during 1989-94 (EURODIAB ACE Study Group. 2000), 
but only about half of that seen in Oxford between 1985-95 (Gardner et al., 1997). 
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However, in the present study, the increase in this age group (0- 4 years) has been more 
apparent since 1985. Therefore, if the change of incidence only in the recent decade 
were considered, the increase in rate would be higher than that across the whole 22-year 
period. The difference in incidence rates among the three age groups (0-4, 5-9 and I 0-14 
year olds) has almost disappeared during recent years because of the doubling of 
incidence in the 0-4 year old children during the last 7 years. 
An overall steady significant increase in incidence (2.49% per year) has also been 
described in this study, as seen around the world (Diabetes Epidemiology Research 
International Group, 1990; Karvonen et al., 1993; Tuomilehto et al., 1995a; Lounamaa, 
1996; Vaananen et al., 1998; The EURODIAB TIGER Study Group, 1998). Clearly, it 
is those children diagnosed under the age of 5 years who have contributed most to the 
increase in trend (6.32% per year). Because the increase trends in boys and girls were 
similar (boys: 2.40%, girls: 2.56%), the factor(s) may have a similar influence in both 
genders. Although the reason or factors contributing to the increase, especially the rapid 
increase in incidence in the youngest age group, is still unknown, it has been suggested 
that this may have resulted from improved hygiene (Kolb and Elliott, 1994), reduced 
chance of exposure to infections in early life (McKinney et al., 2000), lower degree of 
population mixing (Parslow et al., 1999) or increased maternal age at delivery (Douek et 
al., 1999). Although an increase of the pool of genes conferring susceptibility to type I 
diabetes has been suggested as an alternative explanation (Tuomilehto et al., 1995a), the 
rapid increase is unlikely to be caused by shifts in the population gene pool due to 
improved survival of people with type I diabetes, and it is, therefore, usually attributed 
to a change in the environment. A newly suggested hypothesis is that the increased 
incidence of type I diabetes in Finland could be caused by the decreased incidence of 
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enterovirus meningitis infections (Viskari et al., 2000). 
The increase in the number of children diagnosed under the age of 5 years is of 
particular concern clinically. These very young children become sick very quickly and it 
is very difficult to achieve good diabetic control in children of this age, and this is 
necessary to reduce the risk of microvascular complications (The Diabetes Control and 
Complications Trial Research Group, 1993). Children who later develop proteinuria are 
at high risk of later morbidity and mortality. 
The present finding of a rapid increase in incidence in the under 5's is unlikely to be due 
to ascertainment bias. The case ascertainment for this age group was I 00% in all time 
periods except for 1975-79, when it was still greater than 91%. This small difference in 
ascertainment is unlikely to account for the remarkable rise in incidence. Moreover, 
even after adjustment for the underestimated cases, the incidence between 1990-96 was 
still more than twice as high as that between 1975-79. The relatively low ascertainment 
levels in 5-9 years age-group during 1975-79 (80%) and 10-14 years age-group during 
1980-84 (84%) certainly made some contributions to the increase trends for both their 
own age-groups and the overall increased trend. However, because the rates of increase 
in these two groups were not statistically significant (5-9 years, 1.52%; 95% Cl, -0.87 -
3.91%) and 10-14 years, 1.76%; 95% Cl, -0.33- 3.85%), their contributions had no 
statistical significance at all. Therefore, the overall increase trend would be less likely 
to be affected significantly by these slightly underestimated case numbers. 
The girls' incidence was higher than that of boys in this study, and this is similar to the 
results of a I 0-year study conducted in the north of England (Crow et al., 1991 ). Other 
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studies from the UK usually report that boys have a higher incidence than girls (Bloom 
et al., 1975; Bingley and Gale, 1989b; Metcalfe and Baum, 1991; Staines et al., 1993; 
Patterson et al., 1996; Gardner et al., 1997; Rangasami et al., 1997). However, the rates 
of increase in boys and girls were similar, which means that both genders have a parallel 
increase in incidence with time. With the significant increase trend in incidence, 
especially in the youngest age group, we can expect a decreasing trend with time in 
average age at onset. The mean age at onset calculated from the entire 522 patients 
showed a statistically significant drop of 2.79 years from 10.82 years in 1975 to 8.03 
years in 1996. The results show that as time has gone on children residing in the study 
area have been diagnosed with type I diabetes at an ever younger age. 
By the Poisson regression, no significant geographical variation m incidence was 
detected according to the local administration district boundaries, although the cases 
were not evenly distributed in the study region where more cases were found around the 
Tamar valley. However, there was an interaction between district and time period, 
demonstrating that children in Carrick district in the middle of the Cornwall had a 
higher risk of developing type 1 diabetes during the most recent time period, 1990-96. 
The reason for this is not clear, and further investigation is required. 
Poisson regression is a commonly used method in analyzing this kind of data in practice 
because incidence and count data of this kind are considered to be Poisson-distributed. 
Therefore, it has been employed in the thesis to compare the differences in incidence 
between genders, age groups, districts and time periods, and to estimate the secular 
trends in incidence for the overall data and for different age groups, genders and districts 
as used in many other similar epidemiological studies of diabetes (Rosenbauer et al., 
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2000; EURODIAB ACE Study Group, 2000; Gardner et al., 1997; Ragasammi et al., 
1996; Staines et al., 1993; Green et al., 1992). 
When estimating the trends in incidence in the present research, the data were divided 
into 3 strata for age group, 2 for sex, 9 for district and 22 for calendar year, giving I, 188 
strata in total. With only 484 cases included in the analysis, more than half of the strata 
contained no cases. Thus, the residual deviance of a Poisson model cannot be assumed 
to be x_2 distributed and cannot be used as a basis for testing goodness-of-fit of these 
models to the data. However, when the 22-year study period was grouped into 4 time 
periods, 1975-79, 1980-84, 1985-89 and 1990-96, to compare the differences in 
incidence between genders, age groups, districts and time periods, there were 216 strata 
with 484 cases as described on page !53 of the thesis. This time, the x_2 test can be used 
to check the goodness-of-fit of the model. The final model (Model 3.11 in Table 4.2.7 
on page 155), which includes all significant single and interaction terms, shows a non-
significant model residual deviance (x_2 = 207.64, df=!77, P=0.057). This means that the 
model just fits the data at a borderline significance, indicating some extra-Poisson 
variation in the data. However, when the seasonal term, which has been found to be 
significant in this data, has been added into the model, the goodness-of-fit shows a great 
improvement (x_2 = 413.93, d.f=388, P=O.I75). Therefore, this data set can be described 
by an appropriate Poisson model. Although the finding of space-time clustering in the 
study region may not be consistent with the assumption of Poisson distribution of the 
data, since the space-time clustering in these data mainly occurred at thresholds far apart 
both in space and time, the general Poisson distribution of the data has, therefore, not 
been influenced significantly. The effect of significant seasonality of the data should be 
accounted for and the term of seasonality should be included in the model. 
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The seasonal analysis at the time of diagnosis also confirmed the worldwide 
phenomenon (Lounamaa, 1996), of a peak incidence found in autumn and winter, and a 
trough in summer time. The significant seasonal variation at onset is generally 
considered to be related to infection (especially virus). However, the data did not show 
any statistically significant difference in the birth pattern of children with diabetes 
compared to that in the background population, although more patients were born in 
May and fewer patients in August. Studies of this kind (birth seasonality) report 
inconsistent results, with some significant differences found in Scotland, Yorkshire, and 
England and Wales (Rothwell et al., 1996), in south east Sweden (Samuelsson et al., 
1999), in Shanghai, China (Ye et al., 1998) and in Israel (Laron et al., 1999); and some 
non-significant difference in the far South West of England (Zhao et al., 2000), in Japan 
(Kida et al., 2000) and in many European regions (Rothwell et al., 1999). Jongbloet and 
colleagues ( 1988) reported a significantly different pattern of month-of-birth between 
patients with type 2 diabetes and the standard birth curve with an excess of patients born 
in the first quarter of the year and fewest during the last quarter. This was not true for 
patients with type I diabetes except in the older aged patients, although the total number 
of patients with type 1 diabetes displayed similar birth peaks and troughs. In a recent 
report, Jongbloet and colleagues ( 1998) found that the monthly pattern of births differed 
from that in the general population only in boys with peaks in April, May and 
November. These various results represent the complex aetiology of the disease and 
imply that different maternal, paternal or perinatal risk factors may be present in early 
life in relation to the development of this disease in different populations or regions. The 
significant seasonal variation at diagnosis along with the evidence of space-time 
clustering at the time of diagnosis (which will be discussed later) and the ever increasing 
trend in incidence may therefore reflect the involvement of virus infections, which have 
202 
long been considered as potential inducers of p cell damage (V aarala et al. 1999), in the 
aetiology of the disease. 
An association between a lower incidence of type I diabetes and high population 
density or urban/rural status has been reported (Barclay et al., 1988; Patterson et al., 
1988; 1996). However, in the present research, no significant associations were found 
between the incidence of the disease and either the whole population density or the 
childhood population density based on the 10 administrative districts. When analysing 
the data based on the 40 Water Supply Zones, no significant association was found 
either between the SIR and childhood population density. This result is in agreement 
with the finding from a German study (Neu et al., 1997) which provided no evidence for 
supporting the hygiene hypothesis proposed by Kolb and Elliot ( 1994 ). These non-
significant results are unlikely to be due to a small sample size or Jack of power of the 
study in that 40 pairs (based on 40 WSZs) of data for correlation statistics should be 
powerful enough to describe a relation between two variables if the sample size of 10 
pairs (based on 10 governmental districts) of data is not big enough. 
These data, therefore, have confirmed the rising incidence of childhood onset type I 
diabetes mellitus in children aged 14 years or under. This effect was most apparent in 
those children in the 0-4 years of age group. Continuation of the register and further 
studies are needed to monitor the development of the significant trend and to explore the 
possible causes of such a rapid increase of incidence in these children, especially in the 
very young age group. 
In the space-time clustering analysis the results were adjusted for multiple testing as has 
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been done in other similar studies (Samuelsson et al., 1994) because it is important to 
take account of multiple testing in space-time clustering (Kulldorff and Hjalmars, 1999). 
However, other findings from this thesis, such as the disease incidence analyses and 
water data analyses, have not been adjusted for multiple comparisons because these data 
were analyzed by fitting Poisson regression models and these models are not completely 
independent of each other, so they should not be adjusted for multiple comparisons 
(Rothman, 1990). This also conforms with other such publications, for example, in 
incidence analyses (Rosenbauer et al., 2000; EURODIAB ACE Study Group, 2000; 
Gardner et al., 1997; Ragasammi et al., 1996; Staines et al., 1993; Green et al., 1992; 
Rewers et al., 1989) or analyses of water composition (Pars low et al., 1997; Foster et al., 
1997), in which the authors have not adjusted for multiple comparisons. Furthermore, 
whether or not multiple comparisons need to be adjusted for in any data analysis is still 
under debate. Some people advocate adjustment for multiple testing (Bland and Altman, 
1995; Bender, 1999) whilst others advise against it (Pemeger, 1995; Savitz and Olshan, 
1995; Rothman, 1990). Therefore, the other findings from this thesis have been 
presented here without adjusting for multiple comparisons. Serum trace element 
analyses in this thesis could be adjusted for multiple comparison, but considering that 
there were no meaningful significant results found there appears to be no further need 
for the adjustment of multiple testing. 
5.3 Clustering of the disease 
Recent publications (Samuelsson et al., 1994; Dahlquist and Kiillen, 1996; Law et al., 
1997; Joner et al., 1998;) have shown positive space-time clustering and have therefore 
provided evidence to support the idea that environmental factors, such as viral 
infections, may play a role in the development of this disease; whilst several other 
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similar studies have not supported this idea (Mann et al., 1978; Hours et al., 1990; 
Patterson and Waugh, 1992; Patterson et al., 1996). With the establishment of the 
present diabetes register, CPCDR, as part of the WHO DIAMOND Project (Marjatta et 
al., 2000), there is the opportunity to check this database for evidence of clustering both 
at birth and at time of diagnosis in this disease in the counties of Devon and Cornwall. 
The database on which this study is based is a high quality population-based register 
known as the CPCDR. The ascertainment level is high (94.4%). Therefore, almost all 
newly diagnosed diabetic children living within this study region were included in this 
register. 
The application of the Knox-Mantel test to the same data set repeatedly gave levels of 
significance potentially increasing the risk of deriving false positive results, known as 
multiple testing. To compensate for this effect, a less conservative adjustment, the 
Simes correction (Simes, 1986), was therefore used in the study. After adjusting for 
multiple testing, clustering remained evident on the CPCDR and was, therefore, not 
considered to cast doubt on the conclusion. 
The Knox-Mantel test makes no allowance for population size changes over time or 
population shifts between different sub-areas in the region studied, otherwise the test is 
biased (Mantel, 1967; Kulldorff and Hjalmars, 1999). The change of childhood 
population size between the 1981 and 1991 censuses was very small in the study region. 
The overall increase rate of the childhood population for the study region was -1.43% 
between 1981 and 1991. For the 9 districts included in the clustering analyses, the 
increase rates mostly ranged from -8% to 6%, except in Plymouth (-12%). In addition, 
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from the 1991 census data of the study region, a migration rate of 11% was estimated in 
the childhood population (0-15 years). About one third of them moved within the 
electoral wards and more than two thirds (69%) of the total migration happened within 
district. Therefore, only about 3.4% of the migration occurred between districts, regions, 
or from other regions inside or outside the UK. Therefore, it appears that these 
population changes are unlikely to have systematically affected the results of the space-
time clustering test. 
Another potential source of bias was described by Roberson and Fisher ( 1983). 
Simulation studies discovered spurious clustering when the diagnosis rates varied in 
space and time. This circumstance is common in diseases with difficult and differential 
diagnosis. However, it is not applicable to the disease studied here. The diagnosis of 
childhood onset type I diabetes is rarely in doubt as clinical symptoms, signs and lab 
investigations of children with the disease are conclusive. In the CPCDR, great efforts 
were made to validate the diagnosis for every case using their medical records. 
In order to control for the confounding effect of the genetic susceptibility, which is a 
prerequisite in the occurrence of the disease, the data were re-analysed after excluding 5 
sib pairs (no twin-patients were found in the CPCDR), but the results were unaffected. 
This means that the familial aggregation has not accounted for these results. 
The non-significant results of clustering at birth are in agreement with the results from 
Northern Ireland (Patterson et al., 1996) and Yorkshire (Law et al., 2000) but 
inconsistent with the results of the Swedish study (Dahlquist and Kiillen, 1996), which 
may be due to either the fact that a different method was used in the Swedish study, or 
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could be a genuine difference in the UK compared to Sweden. The non-significant 
space-time clustering at birth is indirect evidence suggesting that infections are unlikely 
aetiological factors acting in utero or early life. However, it does not rule out the 
possibility of other environmental risk factors being involved ;1round the time of birth 
(Law et al., 2000). The most significant thresholds at the time of diagnosis in this study 
were 35 km and 360 days, which are in line with the findings from the Swedish study 
(Samuelsson et al., 1994) but appeared further apart in space compared to the Yorkshire 
study (Law et al., 1997). This may be because the current study area is a mainly rural 
area and a longer spatial distance would naturally be expected. The present data also 
show more significant clustering in younger children (0-4 years) and during the recent 
period (1985-96) when the incidence was higher. Furthermore, when the data from only 
Plymouth were analysed, no significant space-time clustering was detected. Plymouth is 
the main town in the study area with a population density of 561/km2 for children aged 
0-15 years according to 1991 UK census (Office Of Population Censuses & Surveys, 
1994). However, the data from the rest of the region, where the children's population 
density was much less than 35/km2 according to 1991 UK census (Office Of Population 
Censuses & Surveys, 1993; 1994), did demonstrate the presence of the clustering at 
combinations of 5, 35 and 50 km and 7, 90, 270 and 360 days (all P values< 0.05). This 
suggests that the space-time interaction in these data is confined only to the rural area, 
unlike the other reports (Samuelsson et al., 1994; Patterson et al., 1996; Law et al., 
1997; Joner et al., 1998) which did not differentiate between the rural and urban areas. 
The evidence of clustering around the time of diagnosis, along with other 
epidemiological characteristics of the disease, suggests an involvement of infections in 
the onset of the disease. Although there is no readily available explanation for the 
clustering phenomenon at the time of diagnosis in this area, various unknown, localised 
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environmental factors, such as viral infections, toxic substances (for example, 
agrochemicals which are used mainly in rural areas, radon exposure), dietary habit, 
infant feeding pattern or social status, could all possibly be implicated. If infections play 
a role in the onset of the disease, they are probably not transmitted via the person-to-
person mode, which might be expected to occur relatively more frequently in places 
with high population density, such as in urban areas. Having said that, however, we 
should also bear in mind that this study region is mainly a rural area with small towns 
and villages where children within an area of 20-40 km often share the same school, 
school buses, sports facilities etc. Therefore, maybe this type of close contact makes it 
easier for an environment factor to influence genetically predisposed individuals. When 
considered together with viral infections, such as congenital rubella syndrome, which 
has long been suspected as risk factors in the development of type I diabetes (Hytity et 
. al., 1995; Yoon, 1996; Dahlquist, 1998; Akerblom and Knip, I998), hypothesized 
protective effects of infections in early life, and clustering of the disease, which usually 
occurs in areas where the incidence is high, further investigations of this complex 
relationship are required. In addition, the current results on the relation of drinking 
water quality to childhood onset type I diabetes have shown that low levels of Mg, Zn 
or Cu in drinking water might have caused the increase in the disease incidence, which 
in turn might be responsible for disease clustering within the same water supply .zones. 
However, because of the much smaller size of the area of the water supply zone (WSZ, 
on average, I 0 by I 0 km) or population within it, the number of cases may not be large 
enough to be detected as a significant cluster within a single WSZ. Furthermore, WSZs 
with similar levels of chemicals in the water (e.g. Mg, Zn or Cu) were not necessarily 
located adjacently or even closely together; instead, they seemed to be randomly 
situated across the entire study region. Therefore, it is possible that the deficiency of 
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these trace elements in drinking water may contribute to some extent to the space-time 
clustering at large space-time thresholds found in this study region. Hence, the 
relationship between chemicals in drinking water and the clustering of the disease may 
be worth further investigation. 
Seasonal variation reflects the change of incidence of the disease in time scale, while 
space-time clustering describes cases occurring closely both in time and in space. These 
two different approaches carried out in this thesis, therefore investigate the possible 
causes of a disease from different angles, providing complementary data. However, the 
findings of a significant seasonality and of a space-time clustering may both indicate 
that an infectious agent (probably viral infection) may be involved in the pathogenesis 
of the disease. Significant space-time clustering could also result from some other type 
of agent that may appear locally at specific times, such as food poisoning (Kulldorff and 
Hjalmars, 1999). Because the observations of space-time clustering presented in this 
thesis were mainly seen over large space and time thresholds, the evidence of a real 
clustering of the disease in this region was not very strong in reality. This could be 
caused by an uneven distribution of some water compositions. Since seasonal variation 
in incidence may, to some extent, contribute to the appearance of space-time clustering, 
the disease clustering found from this thesis might partly be explained by the seasonal 
variability of the disease in this region. 
After finding an overall significant space-time clustering at larger space and time 
thresholds at the diagnosis of the disease, the next step, as in any investigation, would 
naturally be to try to look further at what causes the clustering, or where the clustering 
comes from. Therefore, the data set was arbitrarily divided into subgroups in order to 
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conduct the further analysis. However, the division of the data in this way may 
obliterate the natural connections between these subgroups, thus losing some 
information. Therefore, the main conclusion should be based on the overall results on 
the entire data. However, the results from subgroup analyses, after adjusting for multiple 
testing, show that the 0-4 year-old children still mainly demonstrate significant 
clustering. This result might well be true because younger children are indeed more 
sensitive and vulnerable to the environmental challenges or insults such as viral 
infections or the effects of certain chemicals i.e. toxins, or deficiency of Mg, Zn or Cu. 
Thus, from this data set, it is relatively safe to say that a weak, but statistically 
significant space-time clustering of the disease at large combinations of space and time 
thresholds has been found, and this could be caused by infections (viral) or deficiency of 
certain chemical compositions (Mg, Zn and Cu) in drinking water. Hence, these results 
further confirm the findings from other studies (Samuelsson et al., 1994; Law et al., 
1997; loner et al., 1998) and lend some support to the hypothesis that infections, or 
some unknown localised environmental risk factors, may have a role to play in the 
development of childhood onset type 1 diabetes. 
5.4 Water quality and the disease 
Several studies have previously examined the relationship between the risk of diabetes 
and contaminants in drinking water (Kostraba et al., 1992; Lai et al., 1994; Virtanen et 
al., 1994a; Haglund et al., 1996; Parslow et al., 1997). Nitrate, mercury and arsenic in 
potable water have all been been suggested to be associated with an increased risk of 
developing diabetes (Kostraba et al., 1992; Lai et al., 1994; Haglund et al., 1996; 
Parslow et al., 1997), and Zn (Haglund et al., 1996) and Mg (Mahaba, 1998) has been 
suggested to have some protective effect. Other studies have found that there were no 
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significant associations between levels of nitrate, nitrite, chromium and vanadium in 
drinking water and the risk of type 1 diabetes (Virtanen et al., 1994a; Haglund et al., 
1996; van Maanen et al., 1999; 2000; Casu et al., 2000). 
The present study, for the first time, shows that children living in areas with Mg levels 
greater than 2.61 mg!L in their drinking water are probably at significantly reduced 
(28% less) risk of developing type 1 diabetes compared with children in areas with Mg 
< 1.90 mg/L in the water, suggesting a preventative effect of Mg on this disease. 
Although a report from Saudi Arabia (Mahaba, 1998) did show a statistically significant 
negative correlation between levels of Mg in drinking water and the prevalence of 
diabetes mellitus at all ages, suggesting a prophylactic role for magnesiun against 
diabetes, the authors did not differentiate between the types of diabetes and most of 
patients included in their study were likely to have type 2 diabetes. The current results 
lend some support to the hypothesis that Zn deficiency may increase the risk of diabetes. 
This is the so-called zinc theory, which was proposed by Okamoto (1949) and supported 
by a Swedish human case-control study (Haglund et al., 1996) and an recent animal 
study from Germany (Ohly et al., 2000). 
The accurate estimation of the exposure to any of these chemical compositions would be 
the estimation of the exposure at an individual level, which has not been possible in the 
present study because no data on dietary intake and the amount of drinking water 
consumed by each individual were available. The exposure estimation of the study was 
crude, but the chemical contents in drinking water are still good indices for intake of 
chemicals due to its daily use in drinking and food preparation. Although drinking tap 
water is less popular than it was (for example, tap water is filtered in some families 
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before use and people buy bottled water to drink), a national survey estimated that tap 
water still accounts for most (67% and 58%) ofthe total liquid consumption of children 
aged 0-5 and 6-15 years old in England and Wales (M.E.L. Research, 1996). The 
exposure of a population in the current study would suitably represent the individual 
exposure in that the potable water is distributed to relatively small populations and the 
drinking water quality within each WSZ is homogeneous. Thus each household within a 
WSZ will receive water of comparable quality. Although there are only accurate data of 
drinking water quality available from 1993 to 1997, it is likely that these measurements 
represent the exposure over the longer period of this study, 1975-96, because the 
significant temporal trends in these indicators' concentrations were absent in the most 
recent time period of 1993-1997 in most of the WSZs for Cu (38/40, 95%), Mg (37/40, 
92.5%), Zn (37/40, 92.5%), nitrate (33/40, 82.5%), Ca (33/40, 82.5%) and Fe (29/40, 
72.5%). Only AI and Mn levels in 19/40 (47.5%) and 23/40 (57.5%) WSZs show 
obviously decreased trends, which lead to general decreasing temporal trends for all 
WSZs as a whole in these two chemical contents. The geochemistry and climate 
situations in this area have not seen a significant change over the past few decades. 
Therefore, the water quality data systematically collected during 1993-97 should 
adequately represent the long-term water quality for the period of case collection (1975-
96), especially for the chemicals, such as Cu, Mg and Zn, which have not shown any 
significant temporal increase or decrease trends during the water sampling period (1993-
97). 
Exposure levels will change as people move to a different WSZ. However, using the UK 
1991 census data, we have estimated that only about 11% of children aged 0-15 years in 
this area changed address during the previous year. Amongst these migrations, 
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approximately one third of them moved within the same Electoral Ward, which is a 
much smaller unit of area on average than a WSZ. Therefore, the child population in 
this area is basically stable and the migration variations should not have biased the 
results significantly. 
Zn and Mg may exert their protective effects through different complex ways although 
the mechanisms can not be elucidated by an epidemiological study such as this one. 
However, from the literature, we know that Zn, Mg and Cu are essential elements 
required by the human body and all living organisms (Robinson and Lawler, 1982; 
Samman, 1998; Robinson, I998). Zn is an important constituent in a number of major 
metabolic processes including protein and nucleic acid synthesis and it is essential for 
the synthesis and action of insulin (Samman, I998). In the human body, Zn may exert 
its role through Cu/Zn superoxide dismutase which could protect pancreatic beta cells 
from destruction by toxic oxygen free radicals (Kubisch et al., I994). Zn deficiency 
could also increase the risk of the disease occurrence by the Zn-theory (Okamoto, I949), 
through the impact on immune function, or by the increased susceptibility to specific 
infections such as Coxsackie B viruses. The hypothesis that cytokines and free radicals 
are important effector molecules in the destruction of pancreatic beta cells (Oberley, 
I988; Mandrup-Poulsen et al., I990) is also compatible with the above-mentioned 
possible mechanisms. Many studies have shown that serum, plasma or intracellular Zn 
levels are significantly lower in type I diabetic patients than in controls (HagglOf et al., 
1983; Raz and Havivi, I989; Waiter Jr. et al., I99I; Isbir et al., I994; Bailey, I997). 
Mg deficiency is evident in type I di&betic patients (Gebre-Medhin et al., I985; Elamin 
and Tuvemo, 1990; Waiter Jr. et al., I99I; American Diabetes Association, I992; Isbir 
et al., I994; Lai et al., 1994; Garber, 1996; Bailey, 1997), although it is not known 
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whether these changes are the causes, consequences or simply associations with diabetes 
mellitus. Studies on Mg metabolism in human body (Robinson and Lawler, 1982) reveal 
that Mg may have a role in the neutralisation of sulphuric acid which is formed inside 
the pancreatic islet cells as a result of sulphur metabolism, a structurally important 
constituent of insulin. So Mg deficiency may be responsible for damage of the islet cells 
by the harmful effect of sulphuric acid (Mahaba, 1998). In addition, Mg is an activator 
for the enzymes involved in the oxidative phosphorylation of adenosinediphosphate 
(ADP) to adenosine triphosphate (ATP), and for all enzymes that bring about the 
conversion of ATP to cyclic adenosine monophosphate (cAMP) (Robinson and Lawler, 
1982). Therefore, Mg deficiency may affect synthesis and release of insulin from islet 
cells (Mahaba, 1998). A review paper also concludes that insulin secretion requires Mg, 
and Mg deficiency results in impaired insulin secretion (Lefebvre et al., 1994). All these 
lines of evidence demonstrate the importance of Mg in the development of diabetes. 
These results offer a possible explanation, viz., that a causal relationship might exist 
between these chemicals' deficiency and the occurrence of the disease, or that the 
deficiency of these chemicals (Mg and Zn) may act as precipitators or promoters of the 
diabetogenic process, at least in certain patients with this disease. These results may also 
partly explain the disease clustering found in this area as discussed before. 
Although an increased nitrate content in drinking water has been hypothesized as a 
promoter or precipitator of type I diabetes in other ecological studies (Kostraba et al., 
1992; Parslow et al., 1997), the present research has shown the contra-indicated result. 
The results from the Poisson regression analysis in the present study has failed to 
provide support for this hypothesis and the preliminary analysis has even suggested that 
nitrate might have a weakly protective effect (P = 0.048). This nitrate-promoter 
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hypothesis does not find support from other studies either in the Netherlands (van 
Maanen et al., 1999; 2000) or in Sardinia, Italy (Casu et al., 2000). Hence, the relation 
between nitrate and type I diabetes still remains to be clarified. The significant finding 
from this thesis proposes that long-term exposure of Mg deficiency through drinking 
water might be one of the potential triggers that cause the increase of the disease in this 
region. 
As for the effects of Cu, the statistically significant results in the univariate analysis 
shown in Tables 4.4.2 and 4.4.3 do imply that it has a protective effect although it was 
subsequently ruled out from multiple Poisson regression which may be because of its 
strong linear correlation with Mg (r=0.42, ?=0.006). Therefore, its influence on the 
development of childhood diabetes is still worth the further attention. 
5.5 Birth weight and type 1 diabetes 
Low birth weight has been linked with the development of type 2 diabetes in adulthood 
(Hales et al., 1991; Phillips, 1998), whilst results from studies on the association 
between birth weight and risk of childhood onset of type I diabetes are not consistent. A 
Swedish study showed that babies large for gestational age have an increased risk of 
developing this disease, whilst poor intrauterine growth decreases the risk (Dahlquist et 
al., 1996). A UK study also demonstrated that children who developed diabetes were 
significantly more likely to be heavier at birth (Metcalfe and Baum, 1992). A recent 
large European case-control study (The EURODIAB Substudy 2 Study Group, 1999b) 
shows that low birth weight is a protective factor. However, another UK study weakly 
points towards poor fetal development being associated with increased risk (McKinney 
et al., 1997). Other studies found no association between birth weight and development 
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of type 1 diabetes (Blom et al., 1992; Kyvik et al., 1992; Lawler-Heavner et al., 1994; 
Stenhouse et al., 2000). Therefore the relation between birth. weight and childhood 
diabetes is still ambiguous and more research is needed. The results presented here 
showed no statistically significant difference in the distribution of birth weight between 
patients and normal controls, which do not support a link between the birth weight and 
later risk of childhood onset type 1 diabetes. However, because this was only a pilot 
study involving 56 patients and it had not taken account of some other important 
confounding factors, such as birth order, maternal age at delivery, perinatal infections 
and maternal smoking that are known to effect intrauterine conditions, the results may 
only be considered suggestive. More patients and information would be needed to 
address this issue thoroughly. 
5.6 Serum trace elements and type 1 diabetes 
The differences between type 1 diabetic patients and normal subjects have been 
examined in serum levels of Cu, Se, Mg, Na, K, Cl and Ca. 54 patients (27 males, 27 
females, mean age: 14.8 years old) with average duration of disease of 4 years (Range: 
0-16 years and there were no evident complications) and 68 normal controls (33 males, 
35 females, mean age: 13.9 years) were included. Serum samples were collected 
between June 1993 and February 1996 and stored at -80 oc from all subjects. 
The results showed that the serum levels of Ca, Na and Cl in patients were statistically 
significantly lower than those in controls but were of no clinical importance because 
most of these values fell in the normal clinical ranges of these parameters and their 
levels may also have been very much influenced by the patients' treatment. The changes 
in concentration of these elements may be due to the effects of the disease and its 
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treatment. The levels of other elements showed no statistically significant differences 
between patients and controls. This does not provide any evidence for an association 
between serum concentrations of Cu, Se and Mg and the development of type 1 
diabetes. Numerous studies have evaluated the mineral status in patients with type 1 
diabetes, but these studies yielded inconsistent results. For example, normal (Ewald et 
al., 1983) and increased (Raz and Havivi, 1989; Waiter Jr. et al., 1991; lsbir et al., 1994) 
serum or plasma levels of Cu have been found in patients with the disease. Low 
(HagglOf et al., 1983; Raz and Havivi, 1989; Waiter Jr. et al., 1991; lsbir et al., 1994) 
and high (Martin Mateo et al., 1975) concentrations of plasma Zn have been reported in 
diabetic patients. A significantly higher mean Se level in patients with type I diabetes 
was found in a Swedish study (Gebre-Medhin et al., 1985). Se is an essential trace metal 
with a protective capacity against cell membrane damage caused by peroxides generated 
from lipids metabolism (El-Yazigi and Legayada, 1996) and there is growing, but 
conflicting, evidence of an association between Se status and diabetes mellitus (El-
y azigi and Legayada, 1996). Whilst no difference of plasma Se level between patients 
and controls was found in a recent Austrian study (Osterode et al., 1996). Urinary Se 
had been examined in a population from Saudi Arabia and no significant difference was 
found (El-Yazigi and Legayada, 1996). Therefore, the roles of Zn, Cu and Se in the 
development of the disease are still unclear and controversial. As for Mg, 
hypomagnesemia has been generally demonstrated in patients with either type 1 or type 
2 diabetes (Gebre-Medhin et al., 1985; Elamin and Tuvemo, 1990; American Diabetes 
Association, 1992;) but an appropriate explanation of the mechanism is still elusive. 
Prospective or ecological studies are needed to determine if the decreased Mg levels are 
a marker or epiphenomenon, or a consequence, or a cause of the disease or simply a 
companion phenomenon. The aforementioned ecological study suggested that decreased 
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Mg intake might precipitate or promote the development of the disease. 
5. 7 General discussion 
Through an extensive search and effort, a high quality of population-based register, The 
Cornwall and Plymouth Children's Diabetes Register (CPCDR), has been successfully 
established in the far South West of England. Children with newly diagnosed type I 
diabetes have been systematically registered in the database since 0110111975 and 
further children, when they are diagnosed with the disease, are being registered. This 
register serves, and will carry on serving as the foundation for analytic investigations of 
risk factors including genetic, immunologic and environmental factors for the 
development of the disease and its complications. 
Childhood onset type I diabetes is one of the most common chronic diseases in 
childhood (LaPorte et al., 1995), the cause of substantial morbidity and mortality and 
forms a serious global health problem (Karvonen et al., 1993). Acute onset of the 
disease can be fatal by hypoglycaemia, ketoacidosis or cerebral edema, while treatment 
and poor control both lead to long-term complications including microvascular (i.e. 
retinophathy, nephropathy, and neuropathy) and macrovascular (i.e. cardiovascular, 
cerebrovascular, and peripheral vascular) disorders. All possible steps are being taken to 
reduce the burden for the individual, family and society. Its incidence rates appear to be 
increasing in countries around the world (Diabetes Epidemiology Research International 
Group, 1990; Onkamo et al., 1999) and the extraordinary geographic differences in its 
incidence have been well documented (Karvonen et al., 1993; Sekikawa and LaPorte, 
1997; Onkamo et al., 1999;). The aetiology of the disease is as yet unknown and a 
multifactorial environmental aetiology for the disease is likely (Haverkos, 1997). 
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Research is targeted at elucidating the causes of the disease with the ultimate aim at 
primary prevention of childhood onset type I diabetes. The CPCDR forms a first step 
towards this goal by describing the full extent of childhood onset type I diabetes in the 
far Southwest England, via data collection, validation and descriptive epidemiological 
analysis. 
Genetic researches, identical twin studies, familial studies, clinical reports, 
immunological and epidemiological studies all point out that this disease is mainly 
caused by unknown environmental factors although genetic susceptibility is necessary 
for the development of the disease. 
The incidence of type I diabetes in the study area increases significantly, especially in 
children aged under 5 years. This result confirms the findings from Oxford (Gardner et 
al., 1997), Finland (Tuomilehto et al., 1995a) and the global increasing trend (Onkamo 
et al., 1999). Age distribution of the disease in this region shows a common pattern of 
most comparable studies (Lounamaa, 1996) with a gradual increased risk with age, with 
peak age at 12 years old in girls and 14 in boys. Common seasonal variation at diagnosis 
has also been detected in this area with the peak in the cold season and nadir in warm 
months. There were some significant increased incidences in 1977, 83, 88-90 and 93-96. 
These peaks appear to be epidemics of the disease but it may also be just random 
fluctuations of the disease and the reason for this needs further investigation. Average 
age at onset has seen a significant drop of nearly 3 years from I 0.82 years in 1975 to 
8.03 years in 1996 because of the significant increased incidence in the under 5's. This 
trend is certainly worth more attention and investigation. 
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Space-time clustering of the disease in this area was examined by applying the Knox-
Mantel test. A tendency for the disease to cluster spatio-temporally in the CPCDR study 
area was found. Significantly more cases occurred in the same area at the same time of 
diagnosis than would be expected by chance alone, suggesting a localised or infectious 
aetiology in the development of type I diabetes. 
An ecological study for exploring the association between chemical composition of 
drinking water and the risk of childhood diabetes has also been done in this area. Mg, 
Zn and Cu have been found to be of some protective effects against the disease. This is 
the first time, as far as I am aware, that an association between Mg and protection 
against childhood onset type I diabetes has ever been reported. Although this study 
failed to detect any differences between serum Mg levels in patients with type I diabetes 
and controls in the pilot study, many other studies generally report significantly lower 
serum Mg in patients than in normal controls (Elamin and Tuvemo, I990). Therefore, a 
decreased intake due to a low concentration in drinking water and food may be one of 
the reasons of the complex aetiology of hypomagnesemia in patients with type I 
diabetes. Zn's protection effect against childhood onset type I diabetes has been 
suggested before in a Swedish study (Haglund et al., 1996). Therefore the present study 
generally confirmed this finding. Cu also has certain suggestive protective effects 
against the disease suggested by the preliminary analysis. The adverse effect of nitrate 
on the risk of type I diabetes could not be confirmed in this study as some other studies 
have shown before (Kostraba et al., 1992; Parslow et al., I997;). In contrast, the 
preliminary analysis even suggested that nitrate had a protective effect. Future research 
will need to confirm these observations on independent datasets. 
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In short, these results are of great importance in public health in terms of prevention of 
the disease. Keeping the contents of Mg Zn and Cu in drinking water at a relatively 
higher level (for Mg, >=2.61 mg!L; Zn, 22.27-27.00 pg/L and Cu, >=19.45 pg!L) would 
significantly reduce the occurrence of the disease in the community, if the findings can 
be replicated in other communities' independent investigations of different nationalities. 
The relation between Mg, Zn, Cu and risk of type I diabetes needs to be closely 
monitored and large-scale population-based follow-up studies could be set up to further 
clarify these associations. 
No significant results have been found between patients with type I diabetes and normal 
controls in serum minerals or birth weight, suggesting no obvious associations between 
serum minerals or birth weight and the disease in these pilot studies. 
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5.8 Summary 
The major findings from this thesis are: 
1. A high quality children's type 1 diabetes register has been set up in the far South 
West of England. 
2. The overall incidence of the disease was 14.9 cases per 100,000 per year in children 
under 16 years of age residing in this region during 1975-96. 
3. The incidence of childhood onset type 1 diabetes has seen a significant increase, 
especially in the under 5's in the far South West of England during 1975-96. 
4. There has been an almost 3-year fall in mean age at onset between 1975 and 1996 in 
patients with type 1 diabetes under the age of 16 years in this study region. 
5. Girls are prone to the disease more than boys in this region. 
6. Significant seasonal variations of onset of the disease have been found with peak 
times in the fall and winter and a nadir in summer. 
7. Space-time clustering has been demonstrated, especially in the younger age group 
(0-4 years). 
8. Mg, Zn and Cu in drinking water might have a protective role. 
9. No statistically significant geographical difference in incidence of the disease has 
been detected in this study area based on the local governmental district boundaries. 
10. No associations were detected between birth weight and serum chemical 
compositions and the disease. 
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Appendix 1. An example of calculations of two-source capture-recapture method 
(M+I)(n+1) 
N= -1 
(m+ I) 
N = estimate of number 
M= number in first sample (those marked) 
n =number in second sample 
m =number of "marked" items in both samples 
Var(N) = [(M+I)(n+l)(M-m)(n-m)] I [(m+1)2 (m+2)] 
95% confidence interval= N ± 1.96* ~Var(N) 
If M= 502, n = 216, m = I 96 (as listed in Table 4.1.2), then, 
N= 
( 502+ I )(2I6+ I) 
(I96 + I ) 
-I = 553 
Var(N) = [(502+ I)(2I6+ I)(502-I96)(216-I96)] I [(196+ I )2 (I96+2)] = 86.93 
Lower limit of N 's 95% Cl= 553- 1.96x9.32 = 534.73 
Upper limit of N's 95% Cl= 553 + 1.96x9.32 = 571.27 
Case ascertainment(%)= IOO% x(5221553) = 94.4% 
Lower limit of 95% Cl of case ascertainment= I 00% x (5221571.27) = 91.4% 
Upper limit of 95% Cl of case ascertainment= I 00% x (5221534. 73) = 97.6% 
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Appendix 2: 
Abstraction form of hospital notes for CPCDR 
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Diabetes Mellitus - Data Source - Hospital Case Notes 
Hospital No: 
Surname: 
Sex: M IF 
Address: 
Post Code: 
Information at Birth 
Address: 
Post Code: 
Presenting Symptoms: 
Thirst 
Polyuria 
Weight Loss 
Hyperglycaemic Coma 
Diabetic Ketoacidosis 
Other 
Forename(s): 
Date of Birth: 
Information at Diagnosis 
Address: 
Post Code: 
General Information 
Y/N 
Family History 
Y IN Not Known 
If Yes, list which family members 
I. 
2. 
3. 
4. 
Type of Diabetes: Type 1/ Type 2 
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Appendix Ja: 
GP approach letter 
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Our ref: BAM/eeb/57/am 471 
Date as postmark 
Letter to the GP 
Dear 
Rcf: 
Derriford Hospital 
Plymouth 
PL6 8DH 
Telephone: 01752 777111 
Fax:01752 768976 
B. Ann Millward MA MSc MD MRCP 
Senior Lecturer/Hon. Consultant Diabetologist 
Hospital Tel: 01752 792256 
University Tel: 01752 232969 
Incidence of Childhood Diabetes in the Under 17's in Devon and Cornwall. 01.01.75- to present day 
Over the last two years I have been investigating the changes in incidence in childhood diabetes in Devon 
and Cornwall. The preliminary data acquired from hospital sources show two interesting points. Firstly, the 
incidence of IDDM in the under 5's has doubled over the two decades, which points to environmental 
changes causing the disease, and secondly, there is an exceptionally high incidence ( 25/100,000) in East and 
Nonh Cornwall. 
To ensure complete ascenainment of all cases in this time period, and in order to verify the first data source 
(and as many of those diagnosed in the first decade are now young adults and may not frequently seen at the 
hospital), it is imponant to have a second data source from general practice. 
I enclose a proforma that I would be most grateful if you could complete. My research assistants, Dr. 
Hongxin Zhao and Mrs. Elizabeth Stenhouse will contact you in the near future in order to answer any 
questions and to help with the data collection if necessary. 
Many thanks. 
Yours sincerely, 
Dr. B. Ann Millward 
Senior Lccturer/Hon. Consultant Diabetologist 
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Chairman: Sir Vernon Seccombe Chief Execulive: Arlhur A. Wilson 
Appendix 3b: 
GP approach form 
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CHILDHOOD DIABETES STUDY 
INCIDENCE OF IDDM IN THE UNDER 17'S IN DEVON AND CORNWALL FROM 01.01.1975 TO PRESENT DATE 
' Please include aU patients with insulin dependent diabetes diagnosed before tbeir 17th birthday from 01.01.1975 to present date. 
Name of practice: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tel No.: ........................................ . 
DATE 
SEX D.O.B. DATE OF STARTED ADDRESS & POSTCODE ADDRESS & POSTCODE 
SURNAME FIRST NAME (FIM) (DDfMMIYY) DIAGNOSIS INSULIN AT DIAGNOSIS AT BIRTH 
(DDfMMIYY) (DD/MM/I I) 
I 
2 
3 
~ 
5 
6 
. 
7 
8 
9 
10 
11 
12 
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Appendix 4a: 
Patients approach letter 
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Our ref: BAM/eeb/58/am481 p 
Date as postmark 
Letter to Patient 
Dear 
Rd: 
Derriford Hospital 
Plymouth 
PL6 8DH 
Telephone: 01752 777111 
Fax: 01752 768976 
Dr. B. Ann Millward, MSc, MD, MRCP 
Senior Lecturer/Hen. Consultant Dlabetologlst 
Hospital Tel: 01752 792256 
University Tel: 01752 232969 
Incidence of Childhood Diabetes in the Under 17's in Devon and Cornwall, 01.01.75 to Present Day 
Our records show that you have insulin dependent diabetes diagnosed between 01.01.75 and up-to-date. 
Over the last two years we have been investigating the changes of incidence of childhood diabetes in 
Devon and Cornwall, and our preliminary information shows two interesting points over the last twenty 
two years. 
Firstly, the number of children under the age of five years getting diabetes has more 
than doubled. 
The incidence of childhood diabetes is exceptionally high around the Tamar valley. 
These are very exciting pieces of information which suggest that there may be environmental (nurture) as 
well as genetic (nature) factors which cause this disease and we will investigate in further studies. 
In order that we can make sure that our records are complete, I wonder if you would complete the 
enclosed form and return it in the stamped addressed envelope provided. All the information collected 
will be dealt with in the strictest confidence. 
Dr. B. Ann Millward, MSc, MD, MRCP 
Senior Lecturer/Hen. Consultant Diabetologist 
Chairman: Sir Vernon Seccombe 
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Chief Executive: Arthur A. Wilson 
Appendix 4b: 
Patients approach form 
233 
PROFORMA FOR PATIENTS 
Incidence of Childhood Diabetes in the Under ITs in Devon and Cornwall. 01.01. 75. -present day 
Surname .. 
Forename(s) .. 
Maiden name (if different) ........................................................... .. 
Sex: MfF Date of Binh 
Present Address 
Post Code 
Address at Diagnosis Address at Birth 
Post Code Post Code 
Date of Diagnosis of Diahetes (Date, Month & Year) 
Date Started on Insulin (Date, Month & Year) 
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Appendix 5. Plot of fitted incidence rate in three age groups ·during the 22-
year study period based on the Poisson-regression model 2.2 in Table 4.2.5 
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Appendix 6a. Plot of SIR of childhood onset type 1 diabetes in 
relation to childhood population density 
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Appendix 6b. Plot of SIR of childhood onset type 1 diabetes in 
relation to nitrate concentration in drinking water 
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Appendix 6c. Plot of SIR of childhood onset type 1 diabetes in 
relation to copper concentration in drinking water 
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Appendix 6d. Plot of SIR of childhood onset Type 1 diabetes in 
relation to zinc concentration in drinking water 
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Appendix 6e. Plot of SIR of childhood onset type 1 diabetes in 
relation to magnesium concentration in drinking water 
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Appendix 6f. Plot of Sffi of childhood onset type 1 diabetes in 
relation to calcium concentration in drinking water 
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Appendix 6g. Plot of SIR of childhood onset type 1 diabetes in 
relation to mangnese concentration in drinking water 
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Appendix 6h. Plot of SIR of childhood onset type 1 diabetes in 
relation to aluminium concentration in drinking water 
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Appendix 6i. Plot of sm of childhood onset type 1 diabetes in 
relation to iron concentration in drinking water 
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Abstract 
Aims To determine the incidence of Type 1 di abetes mellitus (OM) in children 
aged 0-15 yea rs in the far sou th-west of England between 1975 and 1996. 
Methods Patient information was collected to set up the Cornwall and 
Plymouth Children's Diabetes Register (CPCDR) through two main data 
sources; hospitals and the general practitioners in all surgeries in the study 
region. All children under 16 years living within Cornwall and the Isles of 
Scilly, and the former Plymouth Hea lth Authorities and diagnosed as having 
Type 1 OM during the study period were included. The case ascertainment 
was estimated by a capture- recapture method. Trends and differences in 
incidence of sex, age, time period and district of diagnosis were analysed by 
Poisson regression analysis. Roger's method was used to estimate the seasonal 
variations. 
Results A total of 522 subjects aged between 0 and 15 years were identified 
from 01/01/1975 to 31/12/1996, giving an overall crude incidence of 14.9/ 
100 000 population/year. The case ascertainment was 94.4% (95% confidence 
interval (Cl) 9 1.4- 97.6%) for the whole register. Poisson regression analysis 
showed that a significant increase of incidence (2.49% per year) was observed 
throughout the 22-year study period, which was mainly a result of the 
significant increase in the 0-4 year age-group (6.29% per year). The incidence 
significantly differed among the 22-years (P = 0.007), the three age groups (0-
4 , 5-9 and 10-14years, P<0.001) and different sexes (P=0.049). The 
significant seasonal variations were detected with peak incidence appearing in 
autumn and winter. 
Conclusions The first validated childhood-onset diabetes register has been set 
up in the far south-west of England. The incidence of childhood Type 1 OM in 
this region has increased significantly over the past two decades, especially in 
children under 5 years. 
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Introduction 
The incidence of Type I diabetes mellitus (DM) in children 
has seen a steady increase in most parts of the world [1-5] . 
In the UK, many diabetes registers generally report rates 
that pur rhe UK in the middle tO upper ranks of risk in the 
world [6-14[ . No derailed reports have appeared so far 
regarding the epidemiology in the far south-west of 
England. The aim of this paper is tO present rhe main 
results of the descriptive epidemiology for childhood-onset 
T ype 1 OM in the far south-west peninsula of England. 
Patients and methods 
Ethical approval for this population-based study, known as the 
Cornwall and Plymouth Children's Diabetes Register (CPCDR), 
was obtained from the local ethics committees of the South and 
West Devon, and the Cornwall and Isles of Scilly Health 
Authorities. 
CPCDR covers the Cornwall and Isles of Scilly and the former 
Plymouth Health Authority regions including the whole of the 
South Hams District. The population in the CPCDR catchment 
area was 818 117 of whom 158 279 were children aged 0-15 
years (as of 1991 UK census data). The CPCDR catchment area 
was 5153 km2 (515 300 hectares). All children aged under 
16 years residing in this region with suspected diabetes are 
referred to and treated at one of the three main hospitals; 
Treliske (Cornwall), Derriford (Plymouth) and Torbay. 
Children diagnosed as having diabetes (!CD 9:250) between 
01/01/1975 and 31/1211996, placed on daily insulin injections 
before their 16th birthday, and residents of this study area were 
eligible for inclusion. The date of diagnosis of diabetes was 
defined as the dare of the first insulin injection as recommended 
by the WHO DIAMOND Project [15,16] . 
Completeness of ascertainment was assessed using the 
capture-recapture method [17]. The primary data source came 
from the audit offices, diaberologists and diabetes nurse 
specialists in the three hospitals and rhe two Health 
Authorities (Cornwall and Isles of Scilly, and South and West 
Devon). The secondary data source was derived as follows: a 
lener was sent ro all local community clinics (surgeries) asking 
their practice managers to provide a list of children with Type 
1 DM diagnosed by all general practitioners in their daily 
practice. Sixty-nine per cent (99/144) replied with patient lists 
enclosed. Details provided from all sources were verified by 
inspection of the hospital notes. In addition, 96% of the patients 
(503/522) were approached by a letter from their consultant 
docrors ro ask them and their parents to confirm the information 
held on the CPCDR database. Their response rate was 58% 
(291/503). 
The population at risk, used to calculate the incidence rates, 
were the 1981 and 199 1 UK census data. Because the mid-)•ear 
population figures for the study area were not available, the mid-
year populations for each year of the study period were 
estimated by the linear interpolation method based on the 
aforementioned two decennial census data. Ninety-five per cent 
confidence intervals (Cl) of incidence rates were estimated 
assuming a Poisson distribution. Direcr age and sex·standar· 
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dized inctdence rates and their 95% Cl were calculated for the 
children aged between 0 and 14 years according to a common 
standard population, assuming equal numbers of age groups 0-
4, 5-9 and 10-14years for boys and girls. The trends and the 
differences of incidence among the three age groups (0-4, 5-9, 
and I 0-14 ), two sexes, 22 yea rs, nine local administration 
districts and the interactions between these variables were 
analysed with Poisson regression models using GUM 4 (release 
4, 1992 Royal Statistical Society, London). Seasonal variation 
w~s examined by Roger's method [18]. 
Results 
The tOtal number of validated cases of children with Type I 
OM between 0 and 15 years old at diagnosis in the far 
south-west of England during 1975-1996 was 522 (244 
boys, 278 girls). Two cases were excluded (one with cystic 
fibrosis and the other with maturity onset diabetes of the 
young). One patient died of a myocardial infarction after 
having had Type 1 DM for 22 years, diagnosed in 1976 
when she was 14-years-old. 
The ascertainment level was 94.4% (95% Cl91.4-97.6) 
for the whole database. The overall average incidence rare 
for children aged 0-15 years was 14.9/100 000 population/ 
year (95% Cl 13.6-16.2). The average annual incidence 
ra tes for boys and girls were 13.6 (95% Cl 12.0-15.5) and 
16.2 (95% Cl 14.5-18.4), respectively. The male ro female 
ratio was 1:1.19. 
In order tO make our results comparable with other 
published data, the following results were based on 
analysis for children aged 0-14 years only. 
Of the tOtal 522 cases, 93% (488/522) were aged 0-
14 years. The case ascertainment was 95.3% (95% Cl 
92.5-98.3). The observed average incidence rare in 
these children was the same as in those diagnosed at 
ages 0-15 years. The ascertainment-corrected incidence 
was 15.66/100 000 population/year with the ascertain· 
ment-corrected case number of 512 (488/0.953). The 
age and sex-standardized incidence rate was 14.8/ 
100 000 population/year (Table 1). In order tO demon· 
strate the temporal trend clearly, semi-logarithmic 
plots of the incidence rates in three age groups were 
used in Fig. 1; these show rh at the fastest increase in 
trend was found in the youngest age group whilst the 
other two age groups showed no significant increase. 
These figures show that the incidence rate in the 0-
4 year age group had almost reached the incidence 
levels of rhe two older age groups towards the end of 
the study period. Table 2 shows the details of case 
ascertainment and crude and ascertainment-corrected 
incidence rates in the three age groups during the 
different rime periods. These data also clearly demon· 
strate a significant increase in incidence in children 
diagnosed under 5 years of age even after adjusting for 
case ascertainment. 
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Table 1 Number of cases of chi ldhood onset T ype I diabetes mellitus, population and average incidence rate per I 00 000 population/year by age 
group and sex in the far somh-west England, 197 5-1996 
Age g roup 
0-4 year 5-9 yea r I 0-14 year Crude incidence 
Age and sex-adjusted 
incidence 
Male 
, 52 75 10 1 228 
Population 23 924 25047 27092 76063 
Rate 9.88 13.6 1 16.95 13.63 
95% Cl 07.38-12.96 10.71-17.06 13.80-20.59 12.00-15.47 
13.48 
11.90-1 5.47 
Female 
, 44 95 121 260 
Populat ion 22 749 23 836 25 958 72543 
Rate 8.79 18.12 21.19 16.29 
95% Cl 6.39-11.80 14.66- 22. 15 17.58-25.32 14.49-1 8.38 
16.03 
14.14-18.10 
Total 
71 96 170 222 488 
Population 46673 48 883 53 050 148 606 
Rate 9.35 15.81 19.02 14.93 
95% Cl 7.57-11.42 13.52-18.37 16.44-21.51 13.58-16.16 
14.76 
13.54-16.1 9 
Cl, confidence interval. 
Poisson regression analysis indicated that the difference 
of incidence rates between sexes (males 13.6, females 16.3/ 
100 000 population/year, P = 0.049), three age groups (0-
4 years 9.35, 5-9 years 15.81 and 10-14 years 19.02/ 
100000 population/year, P<0.001) and 22years 
(P = 0.007) were statistically significant after adjusting for 
other factors, and there were no significant interactions 
between age, sex and year in this population. There was no 
statistically significant difference in incidence between the 
local administration districts (P = 0.31). However, the 
overall increase of incidence across the 22-year period 
was statistically significant (2.49% per year, 95% Cl 
1.08.9-3.91 ). Again, this increase is mainly a result of the 
marked increase in those diagnosed under 5 years of age 
(6.29% per year, 95% Cl 2.87-9.71), compared with 5-
9 years (1.52%, 95% er -0.87-3.91) and 10-14 years 
(1.76% -0.33-3.85%). The slight overlaps of the 95% Cl 
between the rates of increase in the 0-4 years age group and 
the two older age groups (Poisson regression x2 = 5.671, 
d.f. = 2, P = 0.0587) mean that the differences between the 
rates of increase in the three age groups do not quite reach a 
statistically significant level. A significant increase in 
incidence was also found in both sexes with 2.45% per 
year (95% Cl 0.51-4.39) for girls and 2.54% per year 
(95% Cl 0.47-4.62%) fo r boys. 
Substantial seasonal variation was found (/ = 23.25, 
d.f. = 2, P < 0.001) with autumn and winter peaks in 
incidence. Boys, but not girls, had the most statistically 
significant seasonal variation (boys, x2 = 22.48, d.f. = 2, 
P < 0.001; gi rls, x2 = 5.27, d.f. = 2, P = 0.07). The older age 
groups had most apparent seasonal va riations (0-4 years 
2 ' X = 0.972, P = 0.61; 5-9 yea rs, x2 = 6.286, P = 0.043 and 
10-14 years, x2 = 19.07, p < 0.001 ). 
Discussion 
Thjs is the first detailed and well-validated epidemio-
logical study of Type 1 OM in Devon and Cornwall 
counties in the far south-west of England in children 
under 16 years of age from 1975 to 1996. The case 
ascertainment is quite hlgh in this register over the 22-
year period, so reliable conclusions can be drawn. A 
standardized annual incidence rate of 14.8 per 100 000 
per year was found for children aged 0-14 years in the 
period 1975-1996, suggesting that the average in-
cidence in the far south-west of England falls in the 
middle to low range of risk within the UK, compared 
with other studies, such- as 18.6 in the Bart's- Oxford 
study (1985-1995) [8], 13.5 in Yorkshire (1978-1990) 
[12], 19.6 in Northern Ireland (1989-1994) [14), 23.9 
in Scotland (1984-1993) [13) and 13.5/100000 
population/year in the British Isles in the 'snapshot' 
study in 1988 [19). However, the most striking finding 
from the present study is that the incidence in children 
diagnosed under the age of 5 years shows a highly 
significant and very fast temporal increasing trend. 
An overall steady significant increase in incidence 
(2.49% per year) was found but, as in other studies around 
the world [2-5,20) it was those diagnosed under the age of 
5 years who have contributed most to the increase in trend 
(6.29% per year). The increased trend in the 0-4 years of 
age group in the present study is similar to that seen in the 
Finland during 1975-1992 [21], but only about half ofthat 
seen in Oxford between 1985 and 1995 [8). However, in 
the present study, the increase in this age group (0-4 year) 
has been more apparent since 1985. Therefore, considering 
the change of incidence only in the recent decade, the 
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Figure 1 Semi-logarithmic plots of annual 
incidence rates of childhood-onset Type 1 
diabetes and their linear trends in three age 
groups: (a) 10-14 year (0), (b) 5-9 year (.t. ) 
and (c) 0-4 year (X) in the counties of 
Devon and Cornwall, England, 
1975- 1996. 
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increase in rate is h igher th an that across the whole 22-year 
period. The difference in incidence rates among the three 
age groups (0-4, 5-9 and 10- 14 years) has almost 
disappeared during recent years because of the doubling 
of incidence in the 0-4 year children during the last 
seven years. Although the reason fo r this rapid increase in 
Cl 1999 Bnllsh D1abet1C Assoc1at10n. DtabetK Medtcine, 16, 1030--1035 
1980 1985 1990 1995 
1980 1985 1990 1995 
Diagnosis year 
incidence in the youngest age group is still unknown, it has 
been suggested that this may result from early exposure to 
environmental factors such as viral infections, infant 
feeding or early cow's milk ingesrion. An increase of the 
pool of genes conferring susceptibility to Type 1 OM is an 
alternative explanation [21 ]. 
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The increased numbers of children diagnosed under 
the age of 5 is of parriGular concern clinically. These 
very young children become sick very quickly and it is 
very difficult to achieve good diabetic control m 
chi ldren of rhis age, which is necessary to reduce the 
risk of microvascular complications (22]. Children who 
later develop proteinuria are ar high risk of later 
morbidity and morta lity . 
The finding of a rapid increase in incidence in the under 
fives is unlikely ro be a result of ascertainment bias. The 
case ascertai nment for this age group was 100% in all time 
periods except for 1975-1979, when it was still >91% . 
This small difference in ascertainment is unl ikely to 
account for the remarkable rise in incidence. M oreover, 
even after adj ustment for the underestimated cases, the 
incidence berween 1990 and 1996 was still more than rwice 
as high as that between 1975 and 1979. The relatively low 
ascertainment levels in 5-9 year age group during 1975-
1980 (80%) and 10-14 year age group during 1980-1984 
(84%) certainly made some contribution to the increase 
trends for both their own age groups and the overall 
increased trend. However, because the rates of increase in 
these rwo groups were not statistically significant (5-
9 years 1.52%, 95% Cl -0.87- 3.91 %; 10-14 years 
1.76%, 95% Cl -0.33-3.85%), their contributions had 
no statistical significance at all. Therefore, the overall 
increase trend would be less likely to be affected 
significantly by these slightly underestimated case num-
bers. 
The incidence in girls was higher than that of boys 
in this study, and this is simi lar to the results of a 10-
year study conducted in the north of England [23 ]. 
Other studies from the UK usually report that boys 
have a higher incidence than girls [6,8,12-14,19,24]. 
However, the rates of increase in boys and girls were 
similar, which means that both sexes have a parallel 
increase in incidence with time. 
By Poisson regression, no significant geographical 
variation in incidence according to the local administration 
district boundaries was detected, although the cases were 
nor evenly distributed in the study region, where more 
cases were fou nd around the Tamar valley (data not 
shown). The seasonal analysis also confirmed the world-
wide phenomenon (2] of a peak incidence in autumn and 
winter, and a trough in summer. 
The present data have confirmed the rising incidence of 
childhood onset Type 1 diabetes mellitus in children aged 
14 years or less. This effect was most apparent in those 
children in the 0-4 year age group. Continuation of the 
register and further studies are needed to monitor the 
development of the significant trend and to explore the 
possible causes of such fast increases in incidence in these 
children, especially in the very young age group. 
~ 1999 Bnt1sh D1abet1c AssoCiation. Diabetic Medteme, 16, 1030-1035 
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Letters 
diCled that efficiencies in heah.h care would 
reduce the number of beds needed by 500. 
Moreover, by combining these efficien-
cies with predictions of diminishing health 
needs in a dwindling population, they 
concluded that, by 200 I, Liverpool and its 
neighbouring districts would require up to 
1000 fewer beds.' 
Their case was supported by speculation 
l11at comprehensive care in l11e future would 
be more often delivered by general practi-
tioners and-despite 6erce opposition by 
local people and their doctors-it was 
accepted. The consequences have been dire. 
For want of beds anywhere in Liverpool, 
patients in the new "super'' emergency 
deparunent now routinely wait for 24 hours 
or more in conditions l11at make everyone 
miserable and angry. Even heroic efforts by 
the staff have not prevented care for many 
being seriously compromised. 
The CJisis here-as in so many other 
parts of the NH -results primarily fmm 
undue reliance on untested health eco-
nomic theories and prompts a number of 
questions. If transparent, evidence based 
practice and accountability arc required of 
clinicians, should l11ey not apply to health 
economists? The answer would mauer littJe 
if this government-like its predecessors-
did not so clearly depend on health 
economists to justify its policies. Indeed, 
much of l11e hostility toward doctors 
originates wim the privileged heahh econo-
mists of York.' Doctors' requests for a 
cautious approach to NHS refonns are 
treated with scorn,' but when ,,·ill heall11 
economists render l11emsclves accountable 
for the effects of meir prescriptions? 
L C Luke amndlanJ iu aa:idml aud ~uu:rgml)' mt'dicm~ 
Royal Liverpool Universi1y Hospilals. Liverpool 
L7 8XP 
cluke@rluh·tr.nwestnlls.uk 
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York: York Hcah.h F ..cunmnisi.S C'.<m~u• tuuu. L' tu\t.·nu) of 
York, 1992. 
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Maybe hospitals are not needed at all 
EotTOR-Wil11 reference to l'osnen's article 
on conccnrration in me provision or hospital 
care,' outside operating theatres and inten-
sive care units, me case for having hospitals 
rests on two assumptions: 6rstly. that l11ere are 
advantages (eitl1er in tem1s of reduced costs 
or impmved outcomes) to providing 24 hour 
care in a setting mat encourages bed rest; and, 
secondly, that l11ere are advantages (eitl1er in 
terms of reduced costs or impro,·ed out-
comes) to having casr access to a range of 
ol11er specialist st.alf. Our best estimate of the 
case for bed rest is l11at it is at best ineffective 
and at worst makes l11e outcome worse.' We 
all know how disorientating and incapacitat-
ing admission to hospital is for elderly people 
(and most patients are elderly). We also all 
know l11at social networks break down if 
admission is pmlonged. 
71() 
What is the case for economies of scope? 
ll1ere may be advantages in having a range 
of specialist services, but do these outweigh 
l11e disadvantages of cross infection and 
overinvestigation? 
Emergency abdominal surgery is carried 
out in the same theatres as elective 
procedures. In other settings where sterility 
is important (such as the food industry), it 
would be unthink.'lble to allow faeces to be 
processed in me same building. 
We are also all familiar with the way in 
which patients have unrelated and often qui-
escent problems "worked up~ by specialists 
while l11ey are in hospital In the community, 
me generaJ practitioner would deal with these 
problems, avoiding a great deal of unneces-
sary referral. Surely, with advances in technol-
ogy making changes possible, it is time for us 
to rethink me settings in which care is 
provided? Or are we simply wedded LO hospi-
tals because they are me familiar institutions 
in which we were trained? • 
Tom M.arshall ILcJur~ m publtc hMith rrtLduiiU 
University of Bim1ingham, Birmingham B 15 21T 
marsha1p@hsrc l.bham.ac.uk 
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uf St.'Condary care. IJ.ty 1999: 319: I 063-5. ( 16 October.) 
2 Alien C, Gla.ruoo P. Del Mar C. lkd rcoc a potentially 
ham1ful t:reaun<."fH net:dmg more: careful evaluation. Ltmut 
1999:354 : 1129-3~. 
Seasonality of birth m children 
with diabetes 
Results of various studies differ 
EotTOR-Rothwell et al have found evidence 
for seasonality of birth in children with 
diabetes from Great Britain but not else-
where.' They do not, however, give ascer-
tainmem estimates for the centres partici-
pating in the study. Consequenlly, selection 
bias may play a part in l11eir results, particu-
larly in those centres wil11 low case 
ascertainments. 
Although this is a large multicentre study, 
the authors have not analysed the pooled 
data. They point out l11at sample sizes from 
many centres were too small to provide 
enough power for the seasonality of birth in 
l11ese children to be assessed. IL would be 
interesting to know if the analysis of me 
pooled data still showed a significant pattern. 
The aul11ors have previously shown 
evidence of seasonality of birl11 in children 
wil11 diabetes in Scotland, Yorkshire, and 
England and Wales.' In contraSt, the current 
report shows no evidence for l11is effect in 
children born in England and Wales, 
although the x' value is greater than the one 
quoted in l11eir previous paper. It is difficult 
to reconcile these two sets of data. 
Rothwell et al also state that a similar pal-
tern has been found in the Netherlands.' The 
aumors who reponed the study l11ere found 
that more boys witl1 diabetes were born in 
April, May, and November but did not6nd an 
effect either for girls or for boys and girls 
combined.' ln contrast, Rol11well et al report a 
significant seasonal pattern of birth, with a 
peak in early summer and a trough in 
winter.' ' The pattern in Britain is clearly 
different from that in the Netherlands. 
We have examined this phenomenon by 
l11e same methodology in our locaJ register, 
l11e Cornwall and Plymoul11 children's 
diabetes register.• Children diagnosed with 
type I diabetes under the age of 16 were 
enrolled in our register, with 94.4% ascer-
tainmenL The analysis was of 4 17 children 
with diabetes born between 1970 and 1995. 
Our results showed that no significant 
seasonality of birth exists in the south west 
of England (x'=4.05, df=2, P =0. 13). l11is 
result is in line with results from Sardinia' 
and some other European counuies' but is 
contrary to l11e results presented by Roth-
well et al. In our opinion, the evidence 
derived from such registers and its support 
for the environmentaJ cause of childhood 
diabetes need to be assessed further. 
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Maternally transmitted infection might 
increase risk of diabetes 
EoiTOR-Rothwell et al write l11at further 
studies are required to determine whether 
abnormal seasonality of birth exists in dlild-
hood diabetes.' Studies have been done in 
Israel,' China,' and Japan• of which l11e 
authors seem not to be aware. These studies 
support l11e hypothesis that in populations 
with a higher incidence of type I diabetes a 
maternally transmitted infection to the fetus 
or newborn infant increases the risk of l11eir 
developing diabetes. 
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Birthweight is not a risk factor for 
childhood onset Type 1 diabetes mellitus 
In their recent article Kyvik et al. [ 1] found no association 
bcrwcen birthwcighr and Type 1 diabetes mellirus in their 
twin control srudy, and orher authors [2-4] support this 
result of non-association. 
We have performed a small pilot study for the purpose of 
measuring the accessibiliry of birrhweight data on rhe 
Plymouth Child Health Data Base (PCHDB) for cases on a 
high quality childhood diabetes register set up in the South-
west Region of England, the Cornwall and Plymo uth 
Diabetes Children's Register (CPCDR) [5]. Once access to 
rhe PCHDB was established, we examined rhc relationship 
of birth weight and Type 1 diabetes mellirus in childhood in 
a 1:4 case-control srudy. Birthwcights were retrieved from 
the PCHDB on 56 Type 1 diabetic patients in rhe CPCDR 
with 224 non-diabetic controls matched by dare of birth 
and sex. All subjects were singleton pregnancies. 
Birthweight ;:;., 4000 g was defined as exposure. 
Analysis of our data shows that larger birrhweight does 
nor increase the risk of developing Type 1 diabetes (ORMH 
0.84, 95% confidence interval 2.35-0.36, x2 = 0.11' 
P = 0. 74 ). No significant difference was detec ted between 
mean birthweights of patients and control cases (patients, 
n = 56, mean 3395 g :!: 495 g; controls: n = 224, mean 
3354 :!: 459 g; P = 0.55). Tbe birthweight ranged be-
tween 2510 g and 4840 gin patients and 2 100-4840 gin 
controls. 
We have confirmed the results of the study by Kyvik et al. 
[ 1] and in particular agree that a larger weight ar birth is not 
a risk factor for larer childhood onset Type 1 diabetes; there 
was no statistically significant difference of birthweight 
between the diabetic and non-diabetic children. The 
aetiology of Type I childhood onset diabetes is multi-
facroral. The intra-uterine environment is complex and the 
effects on the developing fetus are many fold. More 
information about maternal, paternal and perinatal health 
ma y be required to explore the risk factors related to this 
disease. 
E. Stenhouse, H. X. Zhao and B A. Millward 
Molecular Medicine Research Group, 
Plymouth Postgraduate Medical School, 
University of Plymouth, Plymouth, UK 
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Too hot to handle - an unusual location 
for an adverse effect of capsaicin 
Topical capsaicin is an additional treatment modality in 
the management of symptomatic neu ralgia associated with 
diabetic peripheral neuropathy. The principal mode of 
actio n of this plant-derived compound is mediated rh rough 
substance P depletion in the C fibres of sensory neurones 
and occurs shortly after treatment application. Limitations 
in its use have included, predominantly, local hyperaesthe-
sia or burning in addition to xeroderma, erythema, 
coughing and sneez ing. To reduce potential side-effects, 
it is recommended that patients be advised ro wash their 
hands immediate ly after application. We describe a case 
where the injudicious application of capsaicin hig hlights an 
unexpected haza rd of its use. 
!Cl 2000 D1abetes UK. D1abet1C Med•cme. 11. 550-560 
Letter 
The average age at onset is decreasing in 
children w ith Type 1 diabetes in Devon 
and Cornwall, England 
Childhood-onset Type 1 diabetes has seen a worldwide 
increase trend [1] in incidence. We have also recently 
reported such a trend [2], mirroring similar changes in 
other regions in the UK [3,4]. Here we report a significant 
decrease of the age at diagnosis of children with Type 1 
diabetes in the far south-west England during 1975-1996. 
Our results, described below, are especially timely in the 
context of the UK government's forthcoming National 
Service Framework (NSF) for diabetes and should put the 
care of patients with diabetes higher on the Government's 
agenda [5]. 
A total of 522 children (244 boys and 278 girls) aged 0-
15-year-old, diagnosed with Type 1 diabetes during 1975-
1996 according to 1985 WHO criteria, was analysed. The 
patients' information is held in the Cornwall and Plymouth 
Children's Diabetes Register (CPCDR), which is part of the 
WHO DIAMOND Project. Our study area covers the 
whole of Cornwall and Isles of Scilly and part of Devon, i.e. 
the old Plymouth Health Authority region with the entire 
South Hams District included. The case ascertainment for 
this register was 94.4% complete (95% confidence interval 
91.4-97.6%) and the details can be found elsewhere [2]. 
The average age at onset for each year of the 22-year srudy 
period was calculated. Spearman rank rest was used to 
examine the changing pattern of the age at onset in children 
with Type 1 diabetes. Each year during the 22-year study 
period, approximately 24 children were diagnosed with 
this disease (range from 11 to 34 cases) in the population-
based study area. The average age at onset was 8.80 years 
for the whole data, 8.59 years for boys and 8.98 years for 
girls. The average age at onset for all patients dropped 
2.79 years from 10.82 years in 1975to8.03yearsin 1996. 
The results of the Spearman rank analyses, based on the 
raw data (11 = 522), indicated that there was a significant 
decreasing trend of age at onset and the Spearman's 
correlation coefficient was -0.109, P = 0.0127 for all 
patients. The results show that children residing in the 
study area have been diagnosed with Type 1 diabetes at an 
ever younger age as time goes by. 
<e 2000 Diabetes UK. Diabetic Medicine. 17. 877 
The age at onset of childhood Type 1 diabetes in the far 
south-west of England has a scaciscically significant 
decrease in the childhood population as a whole, indicating 
that increasing numbers of younger children have been 
diagnosed with the disease, and that children tend to be 
affected by this disease at younger age. It is known that 
with earlier onset, patients are more likely to suffer before 
midlife from kidney failure, blindness, incapacitating 
neurological complications and premature cardiovascular 
death. Therefore, more attention should be paid and more 
NHS resources allocated for the surveillance, research and 
control of this disease in children and juveniles in the 
Government's forthcoming National Service Framework 
(NSF) for diabetes to further clarify the disease's nature, 
aetiology and control measures of its epidemic. 
H. X. Zhao, E. Stenhouse, A. G. Demaine and 
B. A. Millward 
Molecular Medicine Research Group, 
Plymouth Postgraduate Medical School, 
University of Plymouth, Tamar Science Park, 
Derriford, Plymouth, UK 
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EUltODWI REGISTER IN SAR.ll!NlA: TEN YEAJlS OF ACTIVTTI' (1989-1998) 
Maroo Soogioi, AJID> Casu, ThG SardinianiDDM EpidGmiology Study Group 
Departmeot of loterual Medicine- Azieoda Ospedaliera Brouu · Cagliari , llaly 
EmLil: sooginim@tiDjt 
Baclccroood oad alm.s: ID Sardiaia the iDcidGocc of TypG I Diabc:tu (Tl D) amoag 
people uadGr IS yG&rs of age ru>kes sccoad ia Lbe world. A loc:al register for aewly 
diagnosed n D patienls wu established si ace 1989 ia Lbe frum:wort of the EU 
collaborative projea Eurodiab. We present bere the dau of tea years of activity of 
!he Sa.rdioian Eurodiab ACE RegiJier. 
Mat<rials aod Methods: All aewly diagnosed TI D p>liealJ aged 0-29 in Sardinia 
were recorded from 1989 to 1998, aa:ording to Eurodiab ACE criteriJ. Primary 
uceruinmeat wu bued oa notificalioa by all Sardinian bospilals, outparieat clinic, 
eadocrinologist and paediatrieilDJ. The local TI D patient.. IWOciation and dislriCI 
ceatres of tbe Natioaal Healtb System served u a secoadary and indipeadeat source. 
The overall compiGteness of ucenainmGnt estimated by the capture·r.apture 
method wu 87'10. 
RHultJ: The oaoual standardized incidence ratio of Tl D over the tea yurs period 
was 36.1n<Xl.OOO ia tbe 0-1• age group and 18.9nOO.OOO in the IS-29 agG group. 
Male to female rati<n were l.S and 1.6 respec1ively. No significant temporal trend 
was observed «<Gpted for the Oristano province (middle wutem pan of the island), 
where a mariced increasing trend of risk was observed. 
PS8 
Time Trends in the Incidence 
of Type 1 Diabetes 
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Till: AVERAGE AG E AT ONSET IS DECREASING IN CHILDREN 
WITII TYPE I DIABETES IN THE FAR SOUTHWEST OF ENGLAND 
H.X. Zhao, E. Stenhouse, A . G . Demaine and B. A. Millward. Molecular 
Medicine Research Group, Plymouth Postgraduate Medical School, 
University of Plymouth, Plymouth, UK 
Bock&round and Aims: To describe the trend of age at onsel of type 
diabetes in children un&r 16 years old in the far Southwest of England 
between 1975 and 1996 for boys, girls and the combined data. Materio.l.s 
and M ethods: A trul of 522 children (244 boys and 278 girls) aged 0-15 
year-old. diagnosed with type I diabetes during 1975- 1996 according to 
1985 WHO criteria, from the Cornwall and Plymouth Olildten's Diabetes 
Register (CPCDR) was analysed. The case ascertainment for this register 
was 94.4% complete (95o/.CI 91.4-97.6%). Average age at onsel for each 
year of the 22-year study period was calculated. Speannan rank test was 
used to ex.amine the trend of the mean age at onset. Resulta: Each year 
during the 22-year period around 24 children were diagnosed with the 
disease (range from 11-34 cases) in the population-based study area . The 
average age at onset was 8 .80 +/- 4. 18 years for the whole dau, 8 .59+/· 
4.42 for boys and 8.98+/-4 .00 years for girls The average age at onsel for 
all patients dropped from 10.82 years in 1975 to 8 .03 in 1996. The results 
of the Speannan rank test.s indicated that there were significant decreasing 
trends of mean age at onset and the Speannan's correlnion coefficients 
were ~.5122, p=0.0045 for the combined, ~.5264, p=O.OIIB for boys and 
~.4805, p=0.0236 for girls . ConduJions: Average age at onsel of 
childhood type I diabetes in the fiar Southwest of England has shown a 
significant decreasing tnnd for both genders and the whole diabetic 
children population. The results indicate that the age at onset is gett.ing 
younger in children diagnosed with this disease. And therefore, more 
attention should be paid towards the research and conuol of the disease. 
Diahetologia (2000) -B: [Suppl I I: I- IV 
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TYl>E I DWIETES PIU:V AU:NCE AMONG IN SARDOOA: THE MIUTARY 
CONSCRIPT REGISTER. 
Anna Ca.su1, Cristian~ Pa.scuno1 , Luis.a Bcmardinelli1 and Marco Songini1 
1 Depanment of Internal Medicine- Azienda Ospedaliera Brotzu- Cagliari, Italy 
email : songinim@tinjt 
1 Dipartimento di Scienu Saniurie Applicate e Psicocomponamenuli - University 
of Pavia - Pavia , July 
Backgrouad and almJ Sardiaia bas tbe second highest incidence fo r Type I diabGtu 
(fl D) in the world reaching 36.1nOO.OOO new cases per year in the 0-14 age aroup. 
Furthennore, a rcuospcaive anaJy$-is on the Consc.ript Registries indicated an abrupt 
increasing of !he risk for T1 D among Sardinian malu cohon staning from 1946. 
The aim of the study was to update the point prevalence of T1 D amoog male anny 
conscript.. aged 18 years from 1992 to 1997, de.scribed in the previoUJ survey. 
Materials oad Mothods According to the Italian Jaw, all male citi:z.ens must appear 
before a Conscripl Board for a clinical examination prior 10 military service: and 
result.. of this examination are tiled. TI D patient• arc rejected with Tl D listed as the 
reason. 
We examined retrospee1ivcly a toul of 83.807 males agGd 18 born bGtween 
Ol,oOJn973 and Jln211979. They represent vinually the whole Sardinian population 
of that age and sex . 
Rosults A total of 307 subjects suffering from TID were identified. TID point 
prevalence for the binh cohon.. 1973-1979 was 3.66n.OOO (95" C.l. 3.28-4.()9). 
Bayesian analysis of the ac:ographical distribution of prevalencG shows tbc hi8hut 
nte in the Soutbem pan of the island (Cagliari province) and the lowest in tbc WGst· 
Nonbcm pan (Susari province). Similar pielure was produced by data from the 
Eurodiab register in Sardinia. No significant temporal trend of prevalence wu seen 
in the six years examined; pooling the.sc reGent binh cohon.. with those from the 
previous similar aoalysis (Songini et al.), confinned the increasing trend of 
prevalence. 
Coocluslon.s Our data confirmed the South to Nonh gradient o f T1 D risk and the 
progressive. increa.se of Tl D risk among males in Sardinia. 
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lNCREASING TR£ND O F TYPE I DIABETES IN BOTH CB.D..DR£N AND 
YOUNG ADULTS. ANALYSIS OF AGE, Pt::RJOD AND BlRTR COHORT 
EFFECT DURING 1984-96 
G. Bruno, 1F. Cerutti, N. Grosso, A. De Salvia, E. Viuli, G. Pagano and Piedmont 
Study Group for Diabetes Epidemiology. Dept. of Internal Medicine:, 1 Dept. of 
Pediatrics, University of Turin, Italy 
Background aod Metbods: lncreaJiDg incidence rates of type I diabeles have 
bc:en reported. As few studies have shown, time trends could bG analysed to 
disentangle the dfect of age, period, or cohort; this approach could suggest 
etiologic hypot.besis. Part of the temporal variation in incidGnce of the disease 
could bG due to the younger age at presentation with time, with corresponding 
decreasing risk for the disease in young adults. This worlcing bypot.besis has not 
been assessed until now, since almost all registry have only bc:en recruiting cases 
occurring in chiJdreD <IS yrs. Matcrials aod Metbods: The presenl study was 
conducted in the regiStry of Turin (Italy) which since 1984 is recruiting incident 
cases up to age 29 yrs. as part of the WHO Diamond Project. In this report we 
were interested to dGtermine whelher: I) the incidence was increasing over time in 
1984-96; 2) the pancm was linear; 3) the trend was heterogeneous by age at onset. 
sex or birth cohorts. Poisson regr=ion models have bc:en used to estimate the 
effect of age (6 S·yeat age groups). sex. calendal time (three periods, 1984-88, 
1989-93, 1994-96) and eight birth cohon.. on incidGnce rates. Results: Mean 
incidence rate/100,000 person-years in the age group 0· 29 in period 1984-96 was 
7.781100,000 (9S% Cl 7.26-8.32), with lower risk in women than in men: 6.72 
(6.0S-7.47) vs. &.78/100,000 (8.02-9.60). After contrOlling for age, increasing 
trends of incidGnce rates across botJt time periods and birth cohorts were ~dGnt 
(RR• 1.12, p=O.OI5). In Poisson regression analysis we found a liDear annual 
increase in risk (2.2SYo per year. 95% Cl 0 •4-4. 10), which could no! bG anibuted 
merely to a cohort or a penod effect. involving all age groups. Cooclusioas: this 
report shows in a Mediterranean area an increasing incidence trend which is similar 
to that reported in northern European countries, suggesting a changing in the 
prevalence of enviroruncntal factors. The increase was linear in panem (2.2S% per 
year) and affected botJt children and young adults in a similar way, providing no 
support to the hypothesis of a changing in the agc-<listribution of incident c:ases 
wit.h time. 
46 Annual Professional Meeting 
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A sirrple risk score predicts undiagnosed Type 2 d1 abetes 
P.Park, N.J. Ware ham, S.J. Griffin 
(Oepartment of Community Medicine, Institute of PubliC 
Health, Univers i ty of Cant>ridgel . 
The prevalence of undiagnosed Type 2 d iabetes I S h1gh 
and early detection and screening have been advocated . 
Many of the risk (actors for diabetes a re routi nel y 
recorded in general practice and could be used to 
tdentify individuals at high risk of havtng prevalent 
undiagnosed diabetes. We have previous ly denved and 
tested a sarrple diabetes risk score using data fran the 
Ely study and incorporating age, sex, body mass index, 
family history of diabetes, smoking and prescribed 
medication. The aim of this study was to test the 
perfonnance of this score in an independent population . 
This analysis was undertaken on 6567 people fran the 
EPIC-Norfolk study tested between 1995-98. Mean age 
was 60.0(50 9. 3 years) and mean BMl was 26.4 (SO 3.9) 
kg/ m' . Undiagnosed diabetes, defined for the purpose 
of this analysis as HbA1c of equal to or more than 7\ 
in an individual not kno.m to have diabetes, was present 
in 84 individuals (1.3\). 
The sensitivity of the risk score to prediCt undiagnosed 
diabetes at 78\ specificity was 51'1(95\Cis 40-62\). 
The total area under the receiver operating character-
istic curve was 74.2\ (95\Cis 74 . 1-74.3\). 
We conclude that this sirrple risk score using 
routinely available in general practice can identify 
people with an elevated HbA1c with reasonable 
sensitivity and specificity. It could therefore form 
part of a case detection strategy in Type 2 diabetes by 
limiting the number of people who would require a 
diagnostic test. 
PSS 
Diabetes PrevaleDce ID The UK 
R. Williams, G Reiber 
University of Leeds, UK, University of Washington, Seanle, USA 
The true diabetes prevalence in the UK is unknown. This methodological 
abstract discusses the strengths and weaknesses of four data soun:es 
available to make estimates. (I) National surveys are infrequenl and 
expensive but offer advantages of uniform definilions, standardised data 
collection and laboratOty measures. The 1993 Health Survey for England 
involved 16,569 adults. Diagnosed diabetes or high glycated haemoglobin 
was present in 4% of men and 2% of women. (2) A number of local 
~ exist which provide valuable information on prevalence and aid 
patient monitoring and follow-up. Those submitting data to the UKDIABS 
project cover about I 0% of the UK population. Limitations are the lack of 
uniform definitions and practices, limited electronic compatibility with 
other registers and hospital data systems and uneven financial suppon. The 
range of recently publ ished age-adjusted diabetes prevalence is from 1.0% 
to 2.3%. (3) General practice mod!iditv surveys cover large populations, 
however, panicipating practices are self·selecled, use non standardised 
diabete& definitions and are likely to under repon diet·only treated 
diabetes. Also, publications are infrequent and usually relate to peri· 
census years. (4) Four automaled databases are available [MEMO, DIN· 
LINK, VAMP (now the UK Department of Heahh General Practice 
Research database) and MEDIPLUS). They are large and more timely than 
general practice morbidity surveys, but have similar disadvantages in 
estimating prevalence. 
UK diabetes prevalence is low by international standards. bu1 is increasing. 
Undiagnosed diabetes is present in a significant number of people. 11 is 
unfonunate that, I 0 years after the St Vincent Declaration and as a 
National Service Framework for diabetes services is being compiled, we 
have no reliable, national eslimate of prevalence thus. no reliable 
denominalor on which to base estimates of the incidence and prevalence of 
complica1ions. There is a need for more frequcnl NHS population surveys 
to monilor lhe impact of bolh diagnosed and undiagnosed diabeles in I he 
UK populo1ion. 
Posters: Epidemiology 
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A I :4 Matched Case Conlrol Study On Relotion Ort"rcn Birth 
Weight And Childhood Onset Type l Diabrtrs 
E STENHOUSE. H ZHAO AND BA MILL WARD 
(Molecular Medicme Research Group, Plymoulh Postgraduale 
Medical School, Uni1·ersity of Plymoulh, Devon) 
Large btnh wetght has been suggested as a risk fac1or for childhood 
onset type I diabetes in several studies bu1 this has not been 
confinned. We aimed to investigate the relationship between binh 
weight and childhood onse1 type I diabetes and test lhis hypotheses 
using a cohon of children diagnosed wilh type I diabetes under the 
age of 16 years between 1975 to dale on lhe Cornwall and Plymou1h 
Childhood Diabetic Register (CPCDR). Binh weight dala have been 
recorded on the Plymoulh Child Heallh Dalabase (PCHDB) since 
1980. Binh weights have been retrieved from the PCHDB on 56 type 
I diabetic patients in CPCDR and 224 non·diabelic controls matched 
by date of binh and gender. All subjects were singleton pregnancies. 
Binh weight <: 4000g was defined as exposure. Analysis of our data 
shows that larger binh weight does not increase I he risk of developing 
diabetes (ORMH • 0.84, 95% Cl, 2.35·0.36, x1=0.11, P=0.74). No 
significant difference has been detected belwecn mean binh weights 
of patients and controls (cases: n=56 mean• 3395 ± 495g; con1rols: 
n=224, mean=3354 ± 459g; P=0.55). The binh weight ranges 
between 2510g-4750g in palients and 2100-4840g in controls. 
Therefore, from this pilot siUdy, we conclude that heavier weight at 
binh could nol be confirmed as a risk factor for childhood onsel type 
I diabetes and no slatis1ical difference of binh weight between the 
diabetic and non-diabetic children. TI1e inlra uterine en1•ironment is 
complex and mullifactoral, therefore more infonnation related to 
maternal and paternal heallh is required to analyse this data funher. 
·~. 
~·, 
.10. 
316 
SPA Cl-TUoU CLUSTl:RING OP CIIILDBOOD DIAJI ETES' AT 
DIAGNOSIS DC DIVOH AND CORNWALL. ~NCI...AND 
llX. Zh8o, E. ~ R. ~ A.O. DcmaiDe md B.A. Millwmd. 
Molccu1at McdiciDe R.cacatdl ~. Plymoulh ~c.c Ma1ical 
School. Ullhu1ily ol Pl,.-11. DcYoa. UK 
Ala: To i<M:stipte wbdh<r lbae ;, CYidcDcc ol ~ dustcrinc iD 
1bc octtct ol childbood Type I diobcct:a ID Dcwa md c..m-11. ~ 
from 197s-96. Previous IIUdicl U...: &bowD ClOCII1idiD& rcsWu. PositM 
rcsulu IDlY Imply 111 di'CCI of CIIVinJiuDc:ala 6cton ill lbc ~ of this 
dacue. S.bjcctl u4 Mc:Ood&: All Sll oewly cliap>ecd Type I diabetic 
childral qcd o.u )'Can old from 1975 • 1996 coalaiDcd ill ~ popul.ttioa-
t.sod Conrwall md 1'1,.-h Olildrca'& DUbc:tes Rqisla were USClf1 ill lbc 
~ lk CUt uccnaiDmcat foe tbiJ rqistcr ...... cstimaud ~.4% 
oomplcte. Mamd't modification ol "- II'ICibod ...... employed 10 cak:olac.c 
z ata:ti.ua ror ex~~ COIIlbillalioa oiiJ*lC and time llnstlolds md a value o1 
z J;I'CIIct U. 1.6H or 2.326 iDdic:alcllipifialooe 11 5% or I% lcYd (one· 
llilod). 1\mc • ciqllod& wu dcfiDcd 11 lbc dale ol finl insuJiD. illjcaioa 
lad lpli.al rdeteDCi.D& ID lbe au1J11s wu clcriwd by pa1lclw' ~·of 
rcsi&:nce • d>e time ol diapod&. Tbe IJ*lC and time lhrcsbolds wcrc I, S, 
10, IS, 20, 25,11101 SO km ODd 21, 90, l60, S40, and 900 cioyl. rcspcr::lMiy. 
a.-tu: Sipific:aDIJy ,_ IIWIIbcn ol ot.cNcd cloce pain !haD ..ouJd 
be c:xpcoacd by dwloe U...: bccD bmd Ill d>e rotlowiA& CX>CDbinaliocu o( 
critical Qlldf value&, 2$ km IIDd 360 days (p < 0.05 ~ so km and 90 (p < 
O.OS~ S40(p < O.OS), IDd 900 days (p < O.OS) with d>e biPcst si&Dl.ficaDoc 
found Ill so tm aall60 days (p < 0.01). c-duloe: Tbcrc is CYidcDcc ol 
~ c:1us1aiq ID 1be - o1 dllldbood Type I ~ iD lbc fat 
IOUIII 1IUl ol EqiiDd. Tbcac reAIII lead aomc IUppOit 10 lbc bypotbcdJ 
lbal m C>:la'II.J ap, -=11 • a lalcaica. IDlY be ilrYolwd ID d>e 
dc¥dopmeal ol cbildbood - diabdcL 
Diabetologia ( 1999) 42: (Suppl 1 ]: A 87 
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RISlNG INCIDENCE OF CHILDHOOD DIABETES IN 
YORKSHIRE, UK IS SEEN AT AU... AGES AND lN URBAN AND 
RURAL SETTINGS. 
RG Feltbowcr,IU Bodanslcy, PA McKiMey, P Holland, F C&mpbcll, 
RC Panlow. Pacdialric cpidcmioloa Group, Centre for Health S<rvi= 
Research, Univcnily of Leeds, uf '-
Aim: To detenninc wbctha the iotickncc of childhood Type I diabetes in 
Yorl<shire, UK continues to ri.e and in which age groups. AJao 10 compare 
incidence trends in urbul and ruralldtinga. 
Metbods: 220S children .•acd 0-1<4 years from the population-based 
Yorlcshirc Children'& Diabetes R.caistcr diagnosed over a 20 year period 
{1978-97) wen: analysed. Usina annual mid-year population estimates, &eX· 
standardised incidence rates per lo'lyr by age group (0-<4, S-9, 10..1<4) WCI'e 
tested by linear rcercuioo modelling. Dislricts (n•22) were classified as 
mainly urban or mainly rural by levels of person-based population clcnsily 
( <7 per hectare - rural, > 7 per hottarc - urban) and incidcntc trends tested.. 
Results: There wu a aiplifi<:ant riJe in incidence ovcnU and in each age 
group (0-1<4: 2.2Y.Iyr p<O.OI, 0-<4: 2.1Y.Iyr p-O.o3, S-9: 1.7Y.Iyr p-0.03, 
10..1<4: 3.1%/yr p<O.OI). Urtu incidcntc inaca.scd aignificantly from 11.7 
per lo'/yr to 18.7 (p<X).Ol) and nnl incidence from 1<4.7 10 19.S (p-0.06). 
On average, incidcncc in rural areas was <4.9 per 101 higher compucd 10 
urban areas (p<X).OI). l'bc$c: diffacnces were reflected in eaeb age group. 
There was no evidcncc of epidcmicily. 
CoachuloJU: In Ycxbhire, UK ~has been 1 rteady llld aicnific.ant 
increase in the incidc'occ of Type I diabetes in children of all aces. Thia is 
5ecn in urllan and rural popu.lations. ThiJ contrasts with data from other 
areas wbc:re the !nacasca in incidcntc were rcs1rictcd to the under Ss. 
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DifTercnt Urinary Albumin Concentrations Predict Progression 
to Diabetic Nephropathy and Diabetic Retinopathy in Insulin-
Treated Diabetic Patients: A Prospective, Multi-Centre, Cohort 
Study. 
S.J. LEWIS, J.A. McKNIGHT, A.D. MORRIS, R.J. PRESCOTT and 
J.D. WALKER on behalf of the Royal College of Physicians of 
Edinburgh (RCPE) Diabetes Register Group. 
(Department of Diabetes, Royal Infirmary, Edinburgh, EH3 9YW) 
The level of elevated urinary albumin concentration (UAC) that 
predicts microvascular complications in diabetes is .controversial. We . . 
determined the level of UAC associated with progression to diabetic ·:; 
nephropathy (ON) and retinopathy (OR) in a prospective, six centre, 
cohort study of 2087 insulin treated diabetic patients aged 35 years or 
less at diagnosis on the RCPE Diabetes Register. 1550 patients with 
sufficient baseline were followed up for a median (interquartile 
range) of 4.0 (2.5 - 5.5) years. DN and DR developed in 46 and 98 
subjects respectively. In univariate analyses development of DN and 
DR was associated with higher baseline UAC, longer duration of 
diabetes at enrolment, a baseline blood pressure > 140190 rrunHg and 
higher baseline HbAlc quartiles. A baseline UAC ofabove 7.4 mgll 
(geometric mean) was associated with the development of DN 
whereas the risk of developing DR was significantly higher with a 
baseline UAC of above 55 mgll. Multivariate analyses showed that 
the development ofDN was associated with increased baseline UAC; 
the development of DR with a baseline blood pressure >140/90 
mmHg. Both DN and DR were associat~ with a longer duration of 
diabetes at enrolment and higher HbAlc quartiles. These data show 
for the first time differential predictive values of baseline UAC for 
the development ofDN and DR. We speculate that intervention with 
ACE inhloitors may be justifiable at lower UAC in Type I diabetes. 
P107 
Rdiaopatby la Type 1 diabetic 1ubjects eaterlar: a rdia.al 
ICrCallar: proiramme witbla 5 years or diapolil 
GREENWOOD R.H., FLATMAN M.F.S., GLENN AM, 
JENKINS C.M., HEYBURN P.H., SAMPSON M.J., TEMPLE R. 
(B«tram Diabetic E~ Cinic, We$. Norwich Hospital, Bowthorpe 
Road, Norwich, NR2 JTU). 
RdiDopathy has been reported in 20-40"/o of recently diagnosed 
Type 2 patiems. 
We have reviewed the prevalence of retinopathy in 5627 patiems 
cmaiug a district photographic screening programme between 
1990-1997, who wm: within 5 years of diagnosis. 
Results: duration of diabeteslnW!lber of subjecWretinopathy('/o): 
0-lyfJ028/23.1~o; 1-2y/IOI3n6.0%; 2-3y/650fl6.6%; 3-
4y/495131.1 %; 4-5y/441fJ6. I%; 
Retioopathy was present in 23 . I% of patients < I year of diagnosis 
increasing to 36.1% in those diagnosed S years previously. Of this 
"MA'• only" contn"buted 4.6% and 5.2% respectivdy and these can 
occur in non-diabetic subjects. (Kiein R. 1994). ~was a lineae 
rdation.ship between retinopathy and diabetes duration (R -o .936 
M .007) which wben extnpola1ed intenccted the X uis at minus 
6.7 years. If patients with "MA'• only" were excluded the linear 
rdatiooship remained (R-<>.904 P-<>.013) but the intcncction wu 
at 6.2 years before diagnosis. 
These results indicate that I) significant retinopathy (more than 
MA'• only) is present in approximately 18% of newly diagnosed 
Type 2 patients 2) diabetes may have been present for about 6 
~before diagnosis in these patients 3) miaoancurysms alone are 
of questionable significance in diabetic patients without other retinal 
lesions. 
Posttrs: Epidemiology 
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A population based surver. of the prevalence of diabetel.iA. 
North Wales • ~ 
J.N.HARVEY, L CRANEY and D.KELL Y 
(University of Wales College of Medicine Wrexham Academic 
Unit, Maelor Hospitai,Y/rexharn) 
The prevalence of diabetes (WHO criteria) in Clwyd (population 
418,200, >99% caucasian, residence defined by postcode) was 
assessed in a two source capture-recapture model. The hospital 
source (three trusts) included data from clinic attendances, 
diabetes nurses records and PAS coding. The primary care source 
comprised lists of patients supplied by all 74 practices in Clwyd 
on multiple occassions. Patients who did not appear in both lists 
were checked for vital status and residence using the NHS Wales 
Administrative Register. After excluding gestational diabetes and 
IGT the predicted number of cases was 10,280 giving an 
unadjusted prevalence~-:<46%.• We identified by name 9156 
(89%). Of these, 1307 had type I diabetes (onset before-40y):-
3957 had type 2 diabetes on oral therapy, 991 type 2 on insulin 
and 2534 on diet alone, 84 had secondary/genetic diabetes (3.1% 
WICiassified). There was a male preponderance in type I and type 
2 diabetes (both p<O.OOI). Primary care data identified 7910 
(77%). 49% of identified cases were cared for in primary care 
alone, including 176 with type I diabetes. Comparison with other 
surveys suggests the number of ascertained cases of diabetes is 
increasing. Surveys relying on primary care data alone will 
underestimate prevalence. 
P108 
Microvascular Complication Rata la the ConawaU and 
Plymouth Children's Diabetes Rqister(CPCDR) la 1996 
E. S'ICNHOUSE, N. COX, S. JAY ARAMAN, H. ZHAO AND 
B. A. MILL WARD 
(Molecular Medicine Research Group, Plymouth Postgraduate 
Medical &:boot, University of Plymouth, Plymouth) 
Children diagnosed under 16 years of age with type I diabetes have 
been completely ascertained in the Cornwall and Plymouth 
Children's Diabetes Rcgi.ster(CPCDR) since 01.01.1975. At 
31.12.1996 there wm: 522 children, 230 ofwbom wm: in Plymouth 
and Caradon. We aimed to document thoroughly the complication 
rates in this cohort. As a pilot study, the resuhs of the 230 children 
wm: audited for retinopathy, microalbuminuria and hyperteasion. 
Patients diagnosed for >- S ~ were eligible for sc:rceni.ng and 
their case notes were reviewed for retinal phoiOgraphy, albumin-
aeatinine ratio (ACR), HBAic and blood pressure(BP). The 
prevalence of retinopathy increased with duration of diabetes [ 0-5y, 
0/12 (0%); 6-9y, 1129(3.4%); I t-1Sy, 1/19(5.3%); 0-15y, 
2/60(3.3%) vs 16-23y, 6131(19.4%), x1=5.43, p<0.02). The HBAic 
was higher in those with compared to those without retiDopelhy 
(9.25 % vs 9.03%; NR <5.6%). Of 96 patients with ACR results 
available, 24 (25%) had a ratio of>-3 (ACR>-9 in IO.fl4 (42%)], 
the HBAic was significantly higher as the ACR increued ( ACR 
<3; 3-8.9; >=9: HBAtc +/- SD%: 1.05+/-1.7; 8.12+/-1.62; 9.12+/-
2.5; p-0.015). BP rose with increasing ACR (NS) and with duration 
of diabetes(X~. > 9s• centile for age - llllllcllcd controls). This 
database will enable accurate e$.imalion of complications rates 10 be 
made in type I diabetes from research and clinical data. 
I 
.I 
1 
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Drinking Water Quality and Childhood Onset Diabetes 
H. ZHAO, E. STENHOUSE, A.G. DEMAINE, M. MOLD. S. BIRD 1nd 
B.A.MILLWARD 
(Molecular Medicine Research Group, Plymouth Postgraduate 
Medical School, University of Plymouth, Plymouth, UK) 
Nitrate levels in drinking water have been associated with childhood 
Type I diabetes mellitus in several reports, but the evidence is sti ll · 
not convincing enough. The complete Cornwall and Plymouth 
Children's Diabetes Registry during 1975-96 and the water quality 
·.:: 
data during 1990-97 provided by the South West Water Services 
Limited enable us to examine the relation between the drinking ,I 
water quality and childhood onset Type I diabetes with nitrate, 
nitrite, copper, zinc, iron, aluminium, hlagnesium and manganese 
levels in the water. 518 diabetic children were assigned to 28 water 
supply zones and the 1991 census population were used to calculate 
the incidence. The Speannan's rank test and multiple regression 
were employed in the analysis. The results showed that only copper 
was significantly correlated with the incidence of childhood 
diabetes, Cu, Rs=- 0.58, n=l7, p<0.02; nitrate, Rs=- 0.22, n=28, 
p>0.05; nitrite, Rs• - 0.06, n• 28, p>0.05; Fe, Rs= - 0.13, n• l7, 
p>0.05; Mg. Rs-- 0.06, n• l7, p>0.05; Zn, Rs• - 0.21, p>0.05 and 
AI, Rs= - 0.14, p>0.05. However, the multiple regression results 
showed DO significant relationship between incidence and the other 
water quality indices measured. Therefore our results suggest that 
copper in water might be a protective factor against developing 
childhood diabetes, but the results do not confirm the association 
between the childhood Type I diabetes and nitrate content or any 
other water chemical$ in the far south west of England. 
Posters: Epidemiology 
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REGIONAL VARIATION IN niE INCDENCE OF CHILDHOOD DIABETES 
IN NSW AUSTIV.UA . 
tu Howonl. ME Cni&. M Silinlt. and A Cl>ln. EndocrinolocY lrlltinM. Nnt 
Olildlenl Hoopilal. Sydney, Australia. 
Geocnphic variation in childhood diabelel incidence within countries has betn 
euribuf.ed 10 vuyin&&enetic populetions and 10 veriaiM>ns in local envitonm<ftL In 1 
youn& councry. without Ion& established res;on.J populltionl. environment.! 
differences II\IY be more relevetliiO varietions in disease incldenoe. 
AJm: To compare lhe resional incidence of lOOM in children qod 0-14 yean 
(population I 286 000) in lhe state of NSW over 1 period of risin& incidence 1992-
96. 
Metbocls: Slandenlisod incidence rates of lOOM f0t NSW and rea;on.J incidence 
,_were calculated usin&lhe NSW Children's Dilbdes Reaisler end lhe Aus&nlian 
Bureau of Statistics 1991 and 1996 population census dal&. The relative c:lwlae in 
IDDM incidence over time was c.alculated lrom Jocarillvnl of incidence usin& linear 
rearession, w~ lhe resression co..:lfocienl is lhe c:hanae per yeor upressed as • 
percenta&•· Confodence intervals were c.alcullted usumin& 1 Poiuon dissribution. 
OU-squorod analysis end lhe Coclvane-Atmila&e trend leSt (~ IUI.islical 
lOft were) were used 10 compare re&;onal incidences. • 
R.esulll: The 5-year aa• siAndanlisod incidence wu 19.1 per 100 000 (95~ Cls 
16.9-21.8) lOt lhe entire Slate ol NSW with an avenae rise in boys ol 2.K end &iris 
of 3 .5~ per year. The incidence in children acrou the 12 awisUcal subdivisM>ns ol 
NSW ran&od from 12.8 (95~ Cls O.JZ-71.5) 10 25.2 per 100 000 (95~ Cb 17.0-
36.0) 101 the whole aroup and 2.4 (95~ Os 0.1-13.1) 1o 30.7 per 100 ooo (95~ Cls 
0.1 10 171) lOt •ae 0-4 yeara. There wu 1 si.,UfiCIIII variation in incidence by 
re&ion f0t the whole sroup(X1=175, lldl, p=O.OOS) end (X1 •125.5, p=O.OOOS). 
Slandardisod incidence ratios ranaod from 67~ 10 Ill~ fOt 0-14 yean and 20'11\ 10 
253~ fOt 0-4 feat$. When the 12 resions were ranked by populalion density (IOial 
population per square km), • sisnifiCIIII trend in Incidence was found (p= 0.005) 
wiCh • pooilive condition between inciclenoe end populltion density in the 0-4 ye.r 
olds bul not for the whole populetion. 
c...dusloa: At 1 timl! of risin& incidence ol lOOM in children in NSW there is 1 
rea;onal variation in incidence end a relllionship between incidence end population 
density in 0-4 ye.r olds. 
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tDIPOKAL TR£NDS lN rNCIDUfCE OF CRIIJ)HOOD ONSET n'P~ 
.1 DLUinS lH DEVON AND CORNWAL41.NCIAND,It75 ·I"' 
K.X. Zlw:t, E. Slalllouoc, C. Soper, P . ...-..E. s-trn.,ll a.-, A. G. 
o-u.c ..s aA. MiDward. Mo~ec:ooW Mcdic:iDc ~Group.~ 
~Medical School, Ulliwnay oiPI,...., Plymoulh. UK 
ne •• o1 the 1111e1y - 10 cldcnaiDc the ~a~~p~a~~ra~o~s m iDciclc:Dce o1 Type 
I diobda ia ~ ap 0-14 yean old la doe fir Sold- ol l!qlaDd 
cConnwaU..s '*' oiDcYoa Ollllllliesl rro. 197S.., 1996. ne iDciclc:Dce c111a ill 
this 111111y wa-c oblaincd from rwo IOIIIIlCL ne pn_,. -= .. 6"0111 
diatJdolociiiS, Diobcscs Spcc:Wia Nunes IDd llolpilal Jnodica1 ROX1II IDd die 
ICCOIIdory - from GtncnJ l'laailioocn. 410 eewly d.iapolod QICII --
-=auincd bdwcCII OUOI/197S and ll/ll/1996. The OYCI'd ......,..._. ol 
~Mine the 22.,.eat lllldy period- 9S.6% (9S% Cl: 92.1-91.6%) 
bylhe ~method. Tbe--~--- cabllllcd per 
100,000 populalioo and the • edjuslmciC o( the - - clone lllin& s-,ar 
lalcnoala with lbe proportiona 1n. 1n ..s l/3 ~ • doe .-~an~ 
popalallioa as .-mcndod bJ lhe DElU ScDdy Groap. The lac:ftale !raids w= 
atimMcd by fillin& the linear repeaiool wida lbe-- iDddcDce dilL Bc:nlccD 
197S IDd 1996, lhe naqe 111111a1 aude illc:ideJr:c rile- 14.7nOO,OOOt')ar. 
The IIIDdardi...t incidence raae - 14.5/IOO,OOOt'yar. The ---.a 
ODmiCicd iacidcna: r11.t - IS.4/IOO,Cl00i)ar. The a.,ur.c:.. ilocidcBoe 
~ - ot.:n-cd clurin& the lll1dy period (lbe slope codfiC:ic:lof - 0.40, p 
• 0.0025). Tbe recr-ioo~---.: ~ ialncidcaa: -1.7% per 
r-. Tbe ~iD incidcncc-- atMoulla prta ...... ia boys (3.1 
\'1. 2.3% per ye.r). Tbe incidcncc iacrealod la doe line • I'"Cq) (0-4, s-9 -s 
10-14 yn) oo---.: by 7.7, 2.0 and 2.0% per,._, rapcandy. We C>OIIdllde 
tlt.ll lbe iDcidcllce ,.e ol childhood dialldca ~ IIQdiJy ~ 197S 
lnCf 1996 ill tbillllldy populatioa; dlildrat lP 0-4 )QlW ~bowed • oipi6cully 
fulcr iDaase iD incidonoe dwllhe older chi ....... Md prta '*I • fulcr - o( 
lncn:ue u- boy&. 
., 
., 
Diabetologia ( 1998) 41 : (Suppl 11: A 83 
322 
no: I:TIINIC FACIOR rN ODLDR.J:N WITH INSULIN. DUI:NDENT 
DlABt:TU Mt:LLITUS IN ROMANIA 
V ~for tit. ONROCAD-Study Growp. D.p...- o/DIIIh.toloo, TIMUotra 
-R-• 
Nllionwidc epickrniolosica inYaliption pcr{ocmod in children ~16 
yean) in the period or 199'2-1997 PQitllecl OUI an annual inc:idalce of lOOM 
betwa:n l.S7-3.76/IOO,OOO and I c:urriuW\od ineidcnc:e of O.lno, 1 fact lhat plaood 
Romania unona the countrico with the loWest frequency of lhat cliscue. Thia 
lindinc .iuslili<d !he und<rtakina or • dacripliw ~ dudy in c:trrStz 1o 
correlalt the inc:i<knce with IIO<nt."plrlmden: clhnic '"""'· larilorill clietribulion, 
diabetes heredity, breut-feedini I!F.i<>cl and multi-annual epidemic ~ or 
various vinJ infections. The mulli-V"Iriant llllllylis only rendered • llia;nilieanl 
luppoct for the dilferenlill &equcncy of lOOM in difl"ercnt e1hnic JltOUPI in 
Roomnil. Thus, the moot endana<nd e1hnic poup wu that of the HUI1Prian, 
~by an 111111111 incidt:noe of7.8Q/JOO,OOO and 1 amtulalod ineidcnc:e of 
O. ~S'III., aVnilar to the puemeten reportod in Hunpry. We ftll1ha-lpoc:i6ed dial IN 
annual incidcncc for the other ethnic: JltOUPI rankod 11 3.291100,000 for Romanimu, 
3.401100,000 for GypGes and 4.10/100,000 for aam.n., the cumulaled inc:idaiCC 
beint of 0.24'111. for ROIIIU1ians, O.lno for Oyplia md 0.26'111. for aan-o. The 
~~ mlislic difl"erenoe (p<O.OOI) moeivatod the IICICOnd pet oflhio lludy,lbe 
11:orrd.tive analysis or the lfGUpl COIIIIi1ulecl on ethnic criteria wilh the ~hove· 
· menbonod paramcten. The epidemioJosical peculiuiO.. could not be lltn""btUd 1o 
the breast- feeding period. ceosnPhic facton or lbe infectious dileael. In 
ca!clusion. the fad« pominins lo dilbetcs heredity remained M1htr lo be 
cliscuuod, u il sccmod 1o confer 111 cpidcmiolosicU in&viduality 1o lhe people 
beloncin& lo the aame ethnic lfoup, not depc:ndin& on lbe ~ tenitory or 
lhe counlly 1o live in. The diJfer"cnce repttlina lbe &equency of lOOM in German 
childten tivin3 in Romania VertUI thoee in Germaty could be cxploinod by lbe &d 
lhat all of the children bcloncing to the Oerman minority in Romania come &om 
mixod marriqes. 
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INCIDENCE OF INSULIN-DEPENDENT (TYPE I) DIAB£Il!S 
MELUTUS OVER SIX CX>NSEClmVB YEARS AMONG 15-39-YEAR 
AGED UIHUANIAN POPUU.nON 
R. o.tnuatu, R. ~us, A. Nortua aDd lbe UlhuaniaD Ppkkmlok>&Y 
Diabelcl Study Oroup•. 
l.llltitutc oC Eodoc:rioolo&Y. Kauaaa Medical A<:ademy, Kau.au, Ulbuaaia 
Ob,Jeclhor- To documcotlbc iDcideoce ol iDiuliJMScpcodct diabetca mdlitua ill 
Ulhuaaian 15-39 yean oC qe populalioD from 1991to 1996. 
ltaeua dalp .....S lldlaod.I-A lpCCi6callJ dcYdopccl conlad I)'Sicm with all 
codoc:riooJocisWdiabctoJociata aDd ccocnJ Jndltiooen iiMIIwd ill the 
diabelcl care COYCrin& 100910 of tbe lJihuaniaa populalioa ICed JS-39, - the 
initial data IOUCCC. Amlual reports from rqiooal ~~
/diabetolopt&, statistical DOI.c-iDalb oC diabetic patients wbo vialtcd Medical 
Unit&. death oerti!icalcl aDd patieola' lisll from Diabelcl Sodetiel rcmalocd u 
ac:c:oodaly iDdepeodent IOUI"CICI for cue ucertahlmeot 
Raulll - The totals of 649 ocw cuea (42o males aDd 229 females) ot lmuiin-
dc:peodent diabetes mellitu& were recorded amoac the populalioa ts-39-ycar of 
qe duriDc the period 1 JanUary 1991 • 31 Dcc:cmba 1996. The Qllllulative 
incidcocc dc:Dsity per year wu 7.691100.000 (9S" Poiuoa dialributioa 
c:oDfidc:oce intc!Val 7.12..!.31) aDd wu qblly hi&lJer amooc males 
(9.86.'100,000, 9S~a 8.96-10.&S) 11w1 amoac females (S,431100.000. 9S~ 
4.81-6.23), p<O.OOOl. A&• ataDdaidizcd CMta1l incldc:oce ralcl for malea ud 
females were 9.89 and 5.49, reapcc:ti¥dy. Mak.lfemale ratio wu UO. R.eaulta of 
lhe l.ineu tcgn:u.ion IIIOdc:ls ahowcd that the incidc:ooc dc:DSily o( lnlulln-
dc:pendc:nl diabelcl mellitu& in 15-39-yur ... croup bad the tcndc:ocy lo 
incrcue. 
CoechllloDI - The raulll aucaest that the incldc:oce data of lnrulin-dc:peodeDI 
diabelcl meUitu& in Ulhuaola I& appropriate lo thooc iD Poland aDd Jo.u liwl 
in other c:ountria of Baltic Sea n:,locL The data contn"bulcl to the mo.tcd&c 
of the incidc:noc of in&ull~H~ependcl diabelcl mellitul iD Eutem Baltic 
countries, an area which until now bu been lacldna epidemiolocical data on 
diabetea &1110"1 lS-39-year qed population. 
. 
. 
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HREE TNF MICROSATELLITE MARKERS IN FINNISH IDDM 
APLOTYPES 
. Koskinen, M. Sj~roos, H. Re ijonen , J. llonen, 
.K. Akerblom and Childhood Diabetes 1n Finland 
tud y Group. Departments of Virology and Blo-
echnology. University of Turku. Turku. Fin lanc:l, 
h 1ldrens' Hospital , Univers1ty o f Hels 1nk1. 
els1nk1, Finland 
he polymorphic gene region encod1ng and regula-
ing tumor necrosis factor is located bet ween 
lass I and class II HLA genes. It 1s a candida-
efor an additional suscept1bil 1 ty gene i n IDDM. 
e stud1ed with in HLA gene reg ion three TNF mic-
osatellite markers (a-b-c) in D1Me (Chl1dhood 
1abetes in Finland Study) fam1l 1es . TNFabc mar-
ers were identified in 249 IDDM assoc1ated and 
02 control haplotypes . We used PCR and ABI 
RISM 377 DNA sequencer GENESCAN fragment analy-
is program to identify these markers. TNF2-3-l 
as significantly increased among IDDM haploty-
es 16.4 % vs 8.9 % (p~0 . 0260) and TNF5-5-2 de-
reased 11.4 % vs 5 . 6 % (p=0.0408). TNF2-3-l was 
ssociated with DQB1 * 0201 allele and there was 
o significant difference in the frequency of 
h is TNF combination between IDDM associated and 
ontrol DQB1*0201 posite haplotypes . When TNF 
icrosatellite markers were compared in other 
aplotypes with defined DQBl alleles with IDDM 
isk, no significant differences were found . In 
onolusion, we didn ' t find any conclusive evi-
ence for an independent role of TNFabc micro-
atellite polymorphism in IODM susceptibility. 
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ll!E INCIDENCE OF INSULIN DEPENDENT DIABETES MELLlllJS (!DD M) 
IN ll!E UNDER 16'S IN DEVON AND CORNWALL FROM 1985 TO 1996 
H Zhao, C Soper, P Hughes. E Sanderson. H Baumer. AG Demaine and BA Mill· 
ward. Dep.1rtments of Diabetes. Paediatrics and Medicine. University of Plymouth. 
Plymouth, UK. 
We aimed to study the incidence rates of insulin dependent d iabetes mellitus 
(lDDM) in children under 16 years of age living in Cornwall (C)and Plymouth 
Health DistriC1 (PIID) from 1985 to 1996. 310 children 11ith lOOM were 
identified from 2 independent sources; a)paediatric and adult diabetes registers 
from Treliske and Derriford Hospitals. b) admissioolS for lDDM recorded in 
hospillll records. All were diagnosed between 0 1/0111985.311211996. 
Ascertainment was 99%. Overall incidences were C.11ctolated nsing the 1991 
census. The average annual incidence rates per 100.000 in C was 17.1 
(boys 17.8. girls 16.5); in PIID was 19.7(boys 17.4. girls 22.3). noe 
incidences differed between d istricts. lowest in ohe far south-west ( 10.2 
Restorrnal). and highest in Caradon (25.4) around the Tamar Valley . noese 
d ifferences in incidence mirrored the prevalence of the Hl..A haplotype 
conferring low risk for lDDM (844 DR4 • 0301) which are most prevalent 
in the Celtic population . These observations may help us tounderstand 
the aetiology ortDOM 
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THE RISK OF INSULIN-DEPENDENT DIABETES MELLITUS IS 
INDEPENDENT OF BlRTH WEIGHT - A DANISH TWIN-CONTROL 
STUDY. 
lnstituttet, Copenhagen and Odense University, Derunark. I. Bache, K.O. 
Kyvik, K. Buschard, A. Green and H Beck-Nielsen. Bartholin 
A relationship between birth weight and risk of developing insulin-
dependent diabetes mellitus (IDDM) has been suggested. We conducted a 
nested twin-control study in order to investigate this. Twin partners of 
discordant pairs are matched for gestational age, maternal age, weight and 
parity. Furthermore, monozygotic twins are genetically identical. 
In the 1953 through 1982 birth cohorts of the population-based Danish 
Twin Register, 95 twin pairs (26 monzygotic and 69 dizygotic) where one 
or both had IDDM were identified. These twins were found by ~cling 
questionnaire to the 20888 pairs of these birth cohorts. Zygosity was 
determined by questionnaire and by using serological methods. Information 
about birth weight and -length, prematurity, maternal age and parity was 
obtained from mid-wives records for the birth cohorts 1953 • 72 (incl.) and 
from the Danish Medical Birth Registry for the cohorts 1973 - 82 (incl.). 
Data regarding birth were available for 82 diabetic and 50 healthy twin 
individuals (67 twin pairs: 21 monozygotic and 46 dizygotic). 
A paired t-test of discordant twins showed no difference in mean birth 
weight between diabetic and non-diabetic twin partners (253 8 g vs 2549 g. p 
> 0.05, n = 51 pairs). Twin pairs divided according to zygosity showed a 
similar pattern. Paired t-test of twins who were born full term did not show 
any significant difference in birth weight between diabetic and non-diabetic 
twin partners (29 11 g vs 2904 g. p > 0.05, n = 20 pairs). Concordant and 
discordant twin pairs did not differ significantly in gestational age (p > 0.05). 
In conclusion, no significant differences were found in birth weight between 
the twin individuals who later developed IDDM compared to the non-
diabetic individuals in this material. 
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